[
  {
    "id": [
      "32905132"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32905132"
    ],
    "pmcid": [
      "PMC7465925"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7465925"
        ]
      }
    ],
    "doi": [
      "10.7759/cureus.9536"
    ],
    "title": [
      "Neuropsychiatric Effects of Antiviral Drugs."
    ],
    "authorString": [
      "Zareifopoulos N, Lagadinou M, Karela A, Kyriakopoulou O, Velissaris D."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zareifopoulos N"
            ],
            "firstName": [
              "Nicholas"
            ],
            "lastName": [
              "Zareifopoulos"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Psychiatry, University of Patras, School of Health Sciences, Patras, GRC."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lagadinou M"
            ],
            "firstName": [
              "Maria"
            ],
            "lastName": [
              "Lagadinou"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Emergency Department, General University Hospital of Patras, Patras, GRC."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Karela A"
            ],
            "firstName": [
              "Anastasia"
            ],
            "lastName": [
              "Karela"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Emergency Department, General University Hospital of Patras, Patras, GRC."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kyriakopoulou O"
            ],
            "firstName": [
              "Ourania"
            ],
            "lastName": [
              "Kyriakopoulou"
            ],
            "initials": [
              "O"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Emergency Department, General University Hospital of Patras, Patras, GRC."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Velissaris D"
            ],
            "firstName": [
              "Dimitrios"
            ],
            "lastName": [
              "Velissaris"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Internal Medicine, University of Patras, School of Health Sciences, Patras, GRC.",
                  "Emergency Department, General University Hospital of Patras, Patras, GRC."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "8"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2994145"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Cureus"
            ],
            "ISOAbbreviation": [
              "Cureus"
            ],
            "medlineAbbreviation": [
              "Cureus"
            ],
            "NLMid": [
              "101596737"
            ],
            "ISSN": [
              "2168-8184"
            ],
            "ESSN": [
              "2168-8184"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "e9536"
    ],
    "abstractText": [
      "The adverse events of antiviral drugs are dose-dependent and often reversible. The nervous system is often affected and to date, many studies have been published regarding the central nervous system toxicity of antiviral agents. They may cause significant neuropsychiatric complications, which range from mild symptoms such as irritability and difficulty sleeping to severe complications such as depression, psychosis, and painful peripheral neuropathy, side effects which may necessitate discontinuation of treatment. The pathogenetic mechanisms may involve molecular targets common to other centrally active drugs, including human monoamine oxidase-A (MAO-A), serotonin receptors, gamma-aminobutyric acid (GABA) GABA-A receptors, 5-HT2A and 5-HT2C receptors and others. Notable examples include oseltamivir which may act as MAO inhibitor and efavirenz, which has an affinity for serotonin 5-HT2 and GABA-A receptors, the serotonin transporter, the MAO enzyme, and the vesicular monoamine transporter, with subjective effects which may be similar to those of the psychedelic hallucinogen lysergic acid diethylamide (LSD). Other antiviral drugs with prominent nervous system effects include nucleoside reverse transcriptase inhibitors, which are associated with the development of peripheral neuropathy after prolonged use (an effect strongly associated with older drugs which have since fallen into disfavor such as stavudine) and interferons, which may cause depression. Clinicians should be familiar with such adverse effects in order to recognise them promptly once they occur and manage them appropriately."
    ],
    "affiliation": [
      "Department of Psychiatry, University of Patras, School of Health Sciences, Patras, GRC."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Central nervous system",
          "Monoamine oxidase",
          "Antiviral",
          "Peripheral Neuropathy",
          "Efavirenz"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.7759/cureus.9536"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7465925"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7465925?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-09"
    ],
    "firstIndexDate": [
      "2020-09-10"
    ],
    "fullTextReceivedDate": [
      "2020-09-05"
    ],
    "dateOfRevision": [
      "2020-09-09"
    ],
    "electronicPublicationDate": [
      "2020-08-03"
    ],
    "firstPublicationDate": [
      "2020-08-03"
    ]
  },
  {
    "id": [
      "32815099"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32815099"
    ],
    "pmcid": [
      "PMC7438026"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7438026"
        ]
      }
    ],
    "doi": [
      "10.1007/s12079-020-00579-y"
    ],
    "title": [
      "Repurposing calcium channel blockers as antiviral drugs."
    ],
    "authorString": [
      "Jayaseelan VP, Paramasivam A."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Jayaseelan VP"
            ],
            "firstName": [
              "Vijayashree Priyadharsini"
            ],
            "lastName": [
              "Jayaseelan"
            ],
            "initials": [
              "VP"
            ],
            "authorId": [
              {
                "_": "0000-0001-7884-5466",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "BRULAC-DRC, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu, 600077, India. vijayashreej.sdc@saveetha.com."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Paramasivam A"
            ],
            "firstName": [
              "Arumugam"
            ],
            "lastName": [
              "Paramasivam"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "BRULAC-DRC, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu, 600077, India."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7884-5466",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2994390"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of cell communication and signaling"
            ],
            "ISOAbbreviation": [
              "J Cell Commun Signal"
            ],
            "medlineAbbreviation": [
              "J Cell Commun Signal"
            ],
            "NLMid": [
              "101308338"
            ],
            "ISSN": [
              "1873-9601"
            ],
            "ESSN": [
              "1873-961X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "The current pandemic caused by the SARS-CoV-2 has claimed over a half a million lives within a very short span of time. A therapeutic drug which could prevent the entry and propagation of the virus is the need of the hour. Several lines of evidence collected from experimental studies older than three decades have pointed out the fact that inhibiting calcium entry into cells can affect vital steps in the lifecycle of viruses. Hence, calcium channel blockers may be considered as an effective measure in the containment of the viruses. This commentary throws light two scientific papers although with divergent facts converging at a point by suggesting a promising treatment option for CoVID-19 (Fang et al. Lancet Respir Med 8:e21, 2020; Straus et al. J Virol 94:e00426, 2020)."
    ],
    "affiliation": [
      "BRULAC-DRC, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu, 600077, India. vijayashreej.sdc@saveetha.com."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "CRG/2019/003756"
            ],
            "agency": [
              "Science and Engineering Research Board"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Calcium channels",
          "Virus",
          "Calcium homeostasis",
          "Verapamil",
          "SARS",
          "Ccb"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1007/s12079-020-00579-y"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7438026"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7438026?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-21"
    ],
    "firstIndexDate": [
      "2020-08-21"
    ],
    "fullTextReceivedDate": [
      "2020-08-22"
    ],
    "dateOfRevision": [
      "2020-09-09"
    ],
    "electronicPublicationDate": [
      "2020-08-19"
    ],
    "firstPublicationDate": [
      "2020-08-19"
    ]
  },
  {
    "id": [
      "32664669"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32664669"
    ],
    "pmcid": [
      "PMC7404195"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7404195"
        ]
      }
    ],
    "doi": [
      "10.3390/ijms21144920"
    ],
    "title": [
      "The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease."
    ],
    "authorString": [
      "Iqbal UH, Zeng E, Pasinetti GM."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Iqbal UH"
            ],
            "firstName": [
              "Umar H"
            ],
            "lastName": [
              "Iqbal"
            ],
            "initials": [
              "UH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zeng E"
            ],
            "firstName": [
              "Emma"
            ],
            "lastName": [
              "Zeng"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Pasinetti GM"
            ],
            "firstName": [
              "Giulio M"
            ],
            "lastName": [
              "Pasinetti"
            ],
            "initials": [
              "GM"
            ],
            "authorId": [
              {
                "_": "0000-0002-1524-5196",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-1524-5196",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "14"
        ],
        "volume": [
          "21"
        ],
        "journalIssueId": [
          "2978122"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "International journal of molecular sciences"
            ],
            "ISOAbbreviation": [
              "Int J Mol Sci"
            ],
            "medlineAbbreviation": [
              "Int J Mol Sci"
            ],
            "NLMid": [
              "101092791"
            ],
            "ISSN": [
              "1422-0067"
            ],
            "ESSN": [
              "1422-0067"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "The aggregation and accumulation of amyloid-β plaques and tau proteins in the brain have been central characteristics in the pathophysiology of Alzheimer's disease (AD), making them the focus of most of the research exploring potential therapeutics for this neurodegenerative disease. With success in interventions aimed at depleting amyloid-β peptides being limited at best, a greater understanding of the physiological role of amyloid-β peptides is needed. The development of amyloid-β plaques has been determined to occur 10-20 years prior to AD symptom manifestation, hence earlier interventions might be necessary to address presymptomatic AD. Furthermore, recent studies have suggested that amyloid-β peptides may play a role in innate immunity as an antimicrobial peptide. These findings, coupled with the evidence of pathogens such as viruses and bacteria in AD brains, suggests that the buildup of amyloid-β plaques could be a response to the presence of viruses and bacteria. This has led to the foundation of the antimicrobial hypothesis for AD. The present review will highlight the current understanding of amyloid-β, and the role of bacteria and viruses in AD, and will also explore the therapeutic potential of antimicrobial and antiviral drugs in Alzheimer's disease."
    ],
    "affiliation": [
      "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "P50 AT008661-01"
            ],
            "agency": [
              "NCCIH NIH HHS"
            ],
            "acronym": [
              "AT"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antimicrobial",
          "Antimicrobial peptide",
          "Antiviral",
          "Alzheimer’s disease",
          "Amyloid-β"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/ijms21144920"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7404195"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7404195?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "doi"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-07-16"
    ],
    "firstIndexDate": [
      "2020-07-16"
    ],
    "fullTextReceivedDate": [
      "2020-08-13"
    ],
    "dateOfRevision": [
      "2020-08-12"
    ],
    "electronicPublicationDate": [
      "2020-07-12"
    ],
    "firstPublicationDate": [
      "2020-07-12"
    ]
  },
  {
    "id": [
      "32908736"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32908736"
    ],
    "pmcid": [
      "PMC7475736"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7475736"
        ]
      }
    ],
    "doi": [
      "10.1155/2020/8814249"
    ],
    "title": [
      "Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs."
    ],
    "authorString": [
      "Yatomi M, Takazawa T, Yanagisawa K, Kanamoto M, Matsui Y, Tsukagoshi H, Saruki N, Saito S, Tokue Y, Maeno T."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Yatomi M"
            ],
            "firstName": [
              "Masakiyo"
            ],
            "lastName": [
              "Yatomi"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Takazawa T"
            ],
            "firstName": [
              "Tomonori"
            ],
            "lastName": [
              "Takazawa"
            ],
            "initials": [
              "T"
            ],
            "authorId": [
              {
                "_": "0000-0002-0119-3532",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Intensive Care Unit, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yanagisawa K"
            ],
            "firstName": [
              "Kunio"
            ],
            "lastName": [
              "Yanagisawa"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infection Control and Prevention Center, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kanamoto M"
            ],
            "firstName": [
              "Masafumi"
            ],
            "lastName": [
              "Kanamoto"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Intensive Care Unit, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Matsui Y"
            ],
            "firstName": [
              "Yusuke"
            ],
            "lastName": [
              "Matsui"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Intensive Care Unit, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tsukagoshi H"
            ],
            "firstName": [
              "Hiroyuki"
            ],
            "lastName": [
              "Tsukagoshi"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Gunma Prefectural Institute of Public Health and Environmental Sciences, 378 Kamioki-machi, Maebashi, Gunma, Japan 371-0052."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Saruki N"
            ],
            "firstName": [
              "Nobuhiro"
            ],
            "lastName": [
              "Saruki"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Gunma Prefectural Institute of Public Health and Environmental Sciences, 378 Kamioki-machi, Maebashi, Gunma, Japan 371-0052."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Saito S"
            ],
            "firstName": [
              "Shigeru"
            ],
            "lastName": [
              "Saito"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Intensive Care Unit, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tokue Y"
            ],
            "firstName": [
              "Yutaka"
            ],
            "lastName": [
              "Tokue"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infection Control and Prevention Center, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Maeno T"
            ],
            "firstName": [
              "Toshitaka"
            ],
            "lastName": [
              "Maeno"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-0119-3532",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "2020"
        ],
        "journalIssueId": [
          "2904223"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "Case reports in infectious diseases"
            ],
            "ISOAbbreviation": [
              "Case Rep Infect Dis"
            ],
            "medlineAbbreviation": [
              "Case Rep Infect Dis"
            ],
            "NLMid": [
              "101573243"
            ],
            "ISSN": [
              "2090-6625"
            ],
            "ESSN": [
              "2090-6633"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "8814249"
    ],
    "abstractText": [
      "Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. However, after administration of another antiviral drug, remdesivir, we were able to terminate invasive interventions, including ECMO, and subsequently obtained negative polymerase chain reaction results. Although further validation is needed, remdesivir might be effective in treating COVID-19."
    ],
    "affiliation": [
      "Department of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Case Reports",
          "case-report"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1155/2020/8814249"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7475736"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7475736?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-10"
    ],
    "firstIndexDate": [
      "2020-09-12"
    ],
    "fullTextReceivedDate": [
      "2020-09-10"
    ],
    "dateOfRevision": [
      "2020-09-13"
    ],
    "electronicPublicationDate": [
      "2020-09-05"
    ],
    "firstPublicationDate": [
      "2020-09-05"
    ]
  },
  {
    "id": [
      "32707768"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32707768"
    ],
    "pmcid": [
      "PMC7463695"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7463695"
        ]
      }
    ],
    "doi": [
      "10.3390/ph13080157"
    ],
    "title": [
      "Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?"
    ],
    "authorString": [
      "Berzal-Herranz A, Romero-López C."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Berzal-Herranz A"
            ],
            "firstName": [
              "Alfredo"
            ],
            "lastName": [
              "Berzal-Herranz"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0003-3722-7973",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Av. del Conocimiento 17, PTS Granada, Armilla, 18016 Granada, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Romero-López C"
            ],
            "firstName": [
              "Cristina"
            ],
            "lastName": [
              "Romero-López"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Av. del Conocimiento 17, PTS Granada, Armilla, 18016 Granada, Spain."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-3722-7973",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "8"
        ],
        "volume": [
          "13"
        ],
        "journalIssueId": [
          "2984575"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Pharmaceuticals (Basel, Switzerland)"
            ],
            "ISOAbbreviation": [
              "Pharmaceuticals (Basel)"
            ],
            "medlineAbbreviation": [
              "Pharmaceuticals (Basel)"
            ],
            "NLMid": [
              "101238453"
            ],
            "ISSN": [
              "1424-8247"
            ],
            "ESSN": [
              "1424-8247"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "The current Covid-19 pandemic has pointed out some major deficiencies of the even most advanced societies to fight against viral RNA infections. Once more, it has been demonstrated that there is a lack of efficient drugs to control RNA viruses. Aptamers are efficient ligands of a great variety of molecules including proteins and nucleic acids. Their specificity and mechanism of action make them very promising molecules for interfering with the function encoded in viral RNA genomes. RNA viruses store essential information in conserved structural genomic RNA elements that promote important steps for the consecution of the infective cycle. This work describes two well documented examples of RNA aptamers with antiviral activity against highly conserved structural domains of the HIV-1 and HCV RNA genome, respectively, performed in our laboratory. They are two good examples that illustrate the potential of the aptamers to fill the therapeutic gaps in the fight against RNA viruses."
    ],
    "affiliation": [
      "Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Av. del Conocimiento 17, PTS Granada, Armilla, 18016 Granada, Spain."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "brief-report",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Aptamers",
          "Rna Structure/function",
          "Antiviral Rnas",
          "Viral Rna Genome",
          "Functional Rna Domains",
          "Rna Tools"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/ph13080157"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7463695"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7463695?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-07-26"
    ],
    "firstIndexDate": [
      "2020-07-26"
    ],
    "fullTextReceivedDate": [
      "2020-09-04"
    ],
    "dateOfRevision": [
      "2020-09-04"
    ],
    "electronicPublicationDate": [
      "2020-07-22"
    ],
    "firstPublicationDate": [
      "2020-07-22"
    ]
  },
  {
    "id": [
      "PPR207469"
    ],
    "source": [
      "PPR"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PPR207469"
        ]
      }
    ],
    "doi": [
      "10.1101/2020.08.28.271569"
    ],
    "title": [
      "A Transferable Deep Learning Approach to Fast Screen Potent Antiviral Drugs against SARS-CoV-2"
    ],
    "authorString": [
      "Wang S, Sun Q, Xu Y, Pei J, Lai L."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Wang S"
            ],
            "firstName": [
              "Shiwei"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "S"
            ]
          },
          {
            "fullName": [
              "Sun Q"
            ],
            "firstName": [
              "Qi"
            ],
            "lastName": [
              "Sun"
            ],
            "initials": [
              "Q"
            ]
          },
          {
            "fullName": [
              "Xu Y"
            ],
            "firstName": [
              "Youjun"
            ],
            "lastName": [
              "Xu"
            ],
            "initials": [
              "Y"
            ]
          },
          {
            "fullName": [
              "Pei J"
            ],
            "firstName": [
              "Jianfeng"
            ],
            "lastName": [
              "Pei"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0002-8482-1185",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          },
          {
            "fullName": [
              "Lai L"
            ],
            "firstName": [
              "Luhua"
            ],
            "lastName": [
              "Lai"
            ],
            "initials": [
              "L"
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-8482-1185",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "Abstract The COVID-19 pandemic calls for rapid development of effective treatments. Although various drug repurpose approaches have been used to screen the FDA-approved drugs and drug candidates in clinical phases against SARS-CoV-2, the coronavirus that causes this disease, no magic bullets have been found until now. We used directed message passing neural network to first build a broad-spectrum anti-beta-coronavirus compound prediction model, which gave satisfactory predictions on newly reported active compounds against SARS-CoV-2. Then we applied transfer learning to fine-tune the model with the recently reported anti-SARS-CoV-2 compounds. The fine-tuned model was applied to screen a large compound library with 4.9 million drug-like molecules from ZINC15 database and recommended a list of potential anti-SARS-CoV-2 compounds for further experimental testing. As a proof-of-concept, we experimentally tested 7 high-scored compounds that also demonstrated good binding strength in docking study against the 3C-like protease of SARS-CoV-2 and found one novel compound that inhibited the enzyme with an IC 50 of 37.0 μM. Our model is highly efficient and can be used to screen large compound databases with billions or more compounds to accelerate the drug discovery process for the treatment of COVID-19."
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Preprint"
        ]
      }
    ],
    "bookOrReportDetails": [
      {
        "publisher": [
          "bioRxiv"
        ],
        "yearOfPublication": [
          "2020"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1101/2020.08.28.271569"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/article/PPR/PPR207469"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/api/fulltextRepo?pprId=PPR207469&type=FILE&fileName=EMS94342-pdf.pdf&mimeType=application/pdf"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "N"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-30"
    ],
    "firstIndexDate": [
      "2020-08-30"
    ],
    "fullTextReceivedDate": [
      "2020-09-16"
    ],
    "firstPublicationDate": [
      "2020-08-28"
    ]
  },
  {
    "id": [
      "32162405"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32162405"
    ],
    "pmcid": [
      "PMC7318677"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7318677"
        ]
      }
    ],
    "doi": [
      "10.1002/anie.202001300"
    ],
    "title": [
      "Repurposing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling of RNA."
    ],
    "authorString": [
      "Ghaem Maghami M, Dey S, Lenz AK, Höbartner C."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ghaem Maghami M"
            ],
            "firstName": [
              "Mohammad"
            ],
            "lastName": [
              "Ghaem Maghami"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Universität Würzburg, Institut für Organische Chemie, Am Hubland, 97074, Würzburg, Germany.",
                  "International Max Planck Research School Molecular Biology, University of Göttingen, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dey S"
            ],
            "firstName": [
              "Surjendu"
            ],
            "lastName": [
              "Dey"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Universität Würzburg, Institut für Organische Chemie, Am Hubland, 97074, Würzburg, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lenz AK"
            ],
            "firstName": [
              "Ann-Kathrin"
            ],
            "lastName": [
              "Lenz"
            ],
            "initials": [
              "AK"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Universität Würzburg, Institut für Organische Chemie, Am Hubland, 97074, Würzburg, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Höbartner C"
            ],
            "firstName": [
              "Claudia"
            ],
            "lastName": [
              "Höbartner"
            ],
            "initials": [
              "C"
            ],
            "authorId": [
              {
                "_": "0000-0002-4548-2299",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Universität Würzburg, Institut für Organische Chemie, Am Hubland, 97074, Würzburg, Germany.",
                  "International Max Planck Research School Molecular Biology, University of Göttingen, Germany."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-4548-2299",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "24"
        ],
        "volume": [
          "59"
        ],
        "journalIssueId": [
          "2961348"
        ],
        "dateOfPublication": [
          "2020 Jun"
        ],
        "monthOfPublication": [
          "6"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-06-01"
        ],
        "journal": [
          {
            "title": [
              "Angewandte Chemie (International ed. in English)"
            ],
            "ISOAbbreviation": [
              "Angew. Chem. Int. Ed. Engl."
            ],
            "medlineAbbreviation": [
              "Angew Chem Int Ed Engl"
            ],
            "NLMid": [
              "0370543"
            ],
            "ISSN": [
              "1433-7851"
            ],
            "ESSN": [
              "1521-3773"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "9335-9339"
    ],
    "abstractText": [
      "In vitro selected ribozymes are promising tools for site-specific labeling of RNA. Previously known nucleic acid catalysts attached fluorescently labeled adenosine or guanosine derivatives through 2',5'-branched phosphodiester bonds to the RNA of interest. Herein, we report new ribozymes that use orthogonal substrates, derived from the antiviral drug tenofovir, and attach bioorthogonal functional groups, as well as affinity handles and fluorescent reporter units through a hydrolytically more stable phosphonate ester linkage. The tenofovir transferase ribozymes were identified by in vitro selection and are orthogonal to nucleotide transferase ribozymes. As genetically encodable functional RNAs, these ribozymes may be developed for potential cellular applications. The orthogonal ribozymes addressed desired target sites in large RNAs in vitro, as shown by fluorescent labeling of E. coli 16S and 23S rRNAs in total cellular RNA."
    ],
    "affiliation": [
      "Universität Würzburg, Institut für Organische Chemie, Am Hubland, 97074, Würzburg, Germany."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "brief-report",
          "Research Support, Non-U.S. Gov't",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "682586"
            ],
            "agency": [
              "European Research Council"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Ribozymes",
          "Tenofovir",
          "In vitro Selection",
          "Site-specific Rna Labeling",
          "Antiviral Nucleoside Analogues"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1002/anie.202001300"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7318677"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7318677?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc-nd"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-03-13"
    ],
    "firstIndexDate": [
      "2020-03-13"
    ],
    "fullTextReceivedDate": [
      "2020-07-01"
    ],
    "dateOfRevision": [
      "2020-08-31"
    ],
    "electronicPublicationDate": [
      "2020-04-01"
    ],
    "firstPublicationDate": [
      "2020-04-01"
    ]
  },
  {
    "id": [
      "32586336"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32586336"
    ],
    "pmcid": [
      "PMC7315692"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7315692"
        ]
      }
    ],
    "doi": [
      "10.1186/s12916-020-01636-4"
    ],
    "title": [
      "A prospect on the use of antiviral drugs to control local outbreaks of COVID-19."
    ],
    "authorString": [
      "Torneri A, Libin P, Vanderlocht J, Vandamme AM, Neyts J, Hens N."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Torneri A"
            ],
            "firstName": [
              "Andrea"
            ],
            "lastName": [
              "Torneri"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Libin P"
            ],
            "firstName": [
              "Pieter"
            ],
            "lastName": [
              "Libin"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Interuniversity Institute of Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium.",
                  "Artificial Intelligence Lab, Department of Computer Science, Vrije Universiteit Brussel, Brussels, Belgium.",
                  "Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven - University of Leuven, Leuven, Belgium."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Vanderlocht J"
            ],
            "firstName": [
              "Joris"
            ],
            "lastName": [
              "Vanderlocht"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Interuniversity Institute of Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Vandamme AM"
            ],
            "firstName": [
              "Anne-Mieke"
            ],
            "lastName": [
              "Vandamme"
            ],
            "initials": [
              "AM"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven - University of Leuven, Leuven, Belgium.",
                  "Center for Global Health and Tropical Medicine, Unidade de Microbiologia, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Neyts J"
            ],
            "firstName": [
              "Johan"
            ],
            "lastName": [
              "Neyts"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0002-0033-7514",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, KU Leuven - University of Leuven, Leuven, Belgium."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hens N"
            ],
            "firstName": [
              "Niel"
            ],
            "lastName": [
              "Hens"
            ],
            "initials": [
              "N"
            ],
            "authorId": [
              {
                "_": "0000-0003-1881-0637",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium. niel.hens@uhasselt.be.",
                  "Interuniversity Institute of Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium. niel.hens@uhasselt.be."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-0033-7514",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-1881-0637",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "18"
        ],
        "journalIssueId": [
          "2960637"
        ],
        "dateOfPublication": [
          "2020 Jun"
        ],
        "monthOfPublication": [
          "6"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-06-01"
        ],
        "journal": [
          {
            "title": [
              "BMC medicine"
            ],
            "ISOAbbreviation": [
              "BMC Med"
            ],
            "medlineAbbreviation": [
              "BMC Med"
            ],
            "NLMid": [
              "101190723"
            ],
            "ISSN": [
              "1741-7015"
            ],
            "ESSN": [
              "1741-7015"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "191"
    ],
    "abstractText": [
      "BACKGROUND:Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation, contact tracing, and quarantine, can decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, recent modeling work shows that these interventions may be inadequate to control local outbreaks, even when perfect isolation is assumed. The effect of infectiousness prior to symptom onset combined with asymptomatic infectees further complicates the use of contact tracing. We aim to study whether antivirals, which decrease the viral load and reduce infectiousness, could be integrated into control measures in order to augment the feasibility of controlling the epidemic. METHODS:Using a simulation-based model of viral transmission, we tested the efficacy of different intervention measures to control local COVID-19 outbreaks. For individuals that were identified through contact tracing, we evaluate two procedures: monitoring individuals for symptoms onset and testing of individuals. Additionally, we investigate the implementation of an antiviral compound combined with the contact tracing process. RESULTS:For an infectious disease in which asymptomatic and presymptomatic infections are plausible, an intervention measure based on contact tracing performs better when combined with testing instead of monitoring, provided that the test is able to detect infections during the incubation period. Antiviral drugs, in combination with contact tracing, quarantine, and isolation, result in a significant decrease of the final size and the peak incidence, and increase the probability that the outbreak will fade out. CONCLUSION:In all tested scenarios, the model highlights the benefits of control measures based on the testing of traced individuals. In addition, the administration of an antiviral drug, together with quarantine, isolation, and contact tracing, is shown to decrease the spread of the epidemic. This control measure could be an effective strategy to control local and re-emerging outbreaks of COVID-19."
    ],
    "affiliation": [
      "Centre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "101003688"
            ],
            "agency": [
              "EpiPose project from the European Union's SC1-PHE-CORONAVIRUS-2020 programme"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "101003627"
            ],
            "agency": [
              "the European Union's Horizon 2020 research and innovation program"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "682540"
            ],
            "agency": [
              "European Union's Horizon 2020 research and innovation programme"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TM"
                    ],
                    "qualifierName": [
                      "transmission"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TM"
                    ],
                    "qualifierName": [
                      "transmission"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Contact Tracing"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Incidence"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Disease Outbreaks"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Quarantine"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Computer Simulation"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s12916-020-01636-4"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7315692"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7315692?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "PPR118147"
            ],
            "source": [
              "PPR"
            ],
            "type": [
              "Preprint in"
            ],
            "note": [
              "Link created based on a title-first author match"
            ],
            "orderIn": [
              "10002"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-07-15"
    ],
    "dateOfCreation": [
      "2020-06-27"
    ],
    "firstIndexDate": [
      "2020-06-27"
    ],
    "fullTextReceivedDate": [
      "2020-07-11"
    ],
    "dateOfRevision": [
      "2020-07-15"
    ],
    "electronicPublicationDate": [
      "2020-06-25"
    ],
    "firstPublicationDate": [
      "2020-06-25"
    ]
  },
  {
    "id": [
      "32199468"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32199468"
    ],
    "pmcid": [
      "PMC7104000"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7104000"
        ]
      }
    ],
    "doi": [
      "10.1016/s2214-109x(20)30114-5"
    ],
    "title": [
      "Use of antiviral drugs to reduce COVID-19 transmission."
    ],
    "authorString": [
      "Mitjà O, Clotet B."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Mitjà O"
            ],
            "firstName": [
              "Oriol"
            ],
            "lastName": [
              "Mitjà"
            ],
            "initials": [
              "O"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases Department-Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address: omitja@flsida.org."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Clotet B"
            ],
            "firstName": [
              "Bonaventura"
            ],
            "lastName": [
              "Clotet"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases Department-Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; IrsiCaixa Foundation, Barcelona, Spain."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "5"
        ],
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2947962"
        ],
        "dateOfPublication": [
          "2020 May"
        ],
        "monthOfPublication": [
          "5"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-05-01"
        ],
        "journal": [
          {
            "title": [
              "The Lancet. Global health"
            ],
            "ISOAbbreviation": [
              "Lancet Glob Health"
            ],
            "medlineAbbreviation": [
              "Lancet Glob Health"
            ],
            "NLMid": [
              "101613665"
            ],
            "ISSN": [
              "2214-109X"
            ],
            "ESSN": [
              "2214-109X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "e639-e640"
    ],
    "affiliation": [
      "Infectious Diseases Department-Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Electronic address: omitja@flsida.org."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Letter",
          "Comment"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Feasibility Studies"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Disease Outbreaks"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/S2214-109X(20)30114-5"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7104000"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7104000?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "32119825"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "Lancet Glob Health. 2020 Apr;8(4):e488-e496"
            ],
            "type": [
              "Comment on"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "16"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-05-05"
    ],
    "dateOfCreation": [
      "2020-03-23"
    ],
    "firstIndexDate": [
      "2020-03-23"
    ],
    "fullTextReceivedDate": [
      "2020-04-02"
    ],
    "dateOfRevision": [
      "2020-06-05"
    ],
    "electronicPublicationDate": [
      "2020-03-19"
    ],
    "firstPublicationDate": [
      "2020-03-19"
    ]
  },
  {
    "id": [
      "32295237"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32295237"
    ],
    "pmcid": [
      "PMC7232184"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7232184"
        ]
      }
    ],
    "doi": [
      "10.3390/v12040445"
    ],
    "title": [
      "Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs."
    ],
    "authorString": [
      "Calligari P, Bobone S, Ricci G, Bocedi A."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Calligari P"
            ],
            "firstName": [
              "Paolo"
            ],
            "lastName": [
              "Calligari"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bobone S"
            ],
            "firstName": [
              "Sara"
            ],
            "lastName": [
              "Bobone"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ricci G"
            ],
            "firstName": [
              "Giorgio"
            ],
            "lastName": [
              "Ricci"
            ],
            "initials": [
              "G"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bocedi A"
            ],
            "firstName": [
              "Alessio"
            ],
            "lastName": [
              "Bocedi"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "recommended_reviews",
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "4"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2932536"
        ],
        "dateOfPublication": [
          "2020 Apr"
        ],
        "monthOfPublication": [
          "4"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-04-01"
        ],
        "journal": [
          {
            "title": [
              "Viruses"
            ],
            "ISOAbbreviation": [
              "Viruses"
            ],
            "medlineAbbreviation": [
              "Viruses"
            ],
            "NLMid": [
              "101509722"
            ],
            "ISSN": [
              "1999-4915"
            ],
            "ESSN": [
              "1999-4915"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "A new Coronavirus strain, named SARS-CoV-2, suddenly emerged in early December 2019. SARS-CoV-2 resulted in being dramatically infectious, with thousands of people infected. In this scenario, and without effective vaccines available, the importance of an immediate tool to support patients and against viral diffusion becomes evident. In this study, we exploit the molecular docking approach to analyze the affinity between different viral proteins and several inhibitors, originally developed for other viral infections. Our data show that, in some cases, a relevant binding can be detected. These findings support the hypothesis to develop new antiviral agents against COVID-19, on the basis of already established therapies."
    ],
    "affiliation": [
      "Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Proteins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Molecular Docking Simulation"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Development"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Molecular modeling",
          "Spike protein",
          "Molecular docking",
          "Coronavirus",
          "Antiviral Drug",
          "Viral Protease",
          "Rna-dependent Rna-polymerase",
          "Covid-19",
          "Sars–cov-2",
          "Viral Protein N"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Viral Proteins"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/v12040445"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7232184"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7232184?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "6"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "refseq",
          "pdb"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-04-20"
    ],
    "dateOfCreation": [
      "2020-04-17"
    ],
    "firstIndexDate": [
      "2020-04-17"
    ],
    "fullTextReceivedDate": [
      "2020-07-09"
    ],
    "dateOfRevision": [
      "2020-05-23"
    ],
    "electronicPublicationDate": [
      "2020-04-14"
    ],
    "firstPublicationDate": [
      "2020-04-14"
    ]
  },
  {
    "id": [
      "32606836"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32606836"
    ],
    "pmcid": [
      "PMC7308127"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7308127"
        ]
      }
    ],
    "doi": [
      "10.2147/idr.s241948"
    ],
    "title": [
      "Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed."
    ],
    "authorString": [
      "Hassany SM, Hassan W, Abo-Alam H, Khalaf M, Nafeh AM, Nasr-Eldin E, Mostafa EF."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Hassany SM"
            ],
            "firstName": [
              "Sahar M"
            ],
            "lastName": [
              "Hassany"
            ],
            "initials": [
              "SM"
            ],
            "authorId": [
              {
                "_": "0000-0003-1772-506X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Tropical Medicine and Gastroenterology Department, Alrajhi University Hospital, Assiut University, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hassan W"
            ],
            "firstName": [
              "Wesam"
            ],
            "lastName": [
              "Hassan"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Hepatology Centre, Ministry of Heath, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Abo-Alam H"
            ],
            "firstName": [
              "Hany"
            ],
            "lastName": [
              "Abo-Alam"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Hepatology Centre, Ministry of Heath, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Khalaf M"
            ],
            "firstName": [
              "Marwa"
            ],
            "lastName": [
              "Khalaf"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Hepatology Centre, Ministry of Heath, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Nafeh AM"
            ],
            "firstName": [
              "Amany M"
            ],
            "lastName": [
              "Nafeh"
            ],
            "initials": [
              "AM"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Microbiology and Immunity Department, Assiut University, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Nasr-Eldin E"
            ],
            "firstName": [
              "Eman"
            ],
            "lastName": [
              "Nasr-Eldin"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinical Pathology Department, Assiut University, Assiut, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mostafa EF"
            ],
            "firstName": [
              "Ehab F"
            ],
            "lastName": [
              "Mostafa"
            ],
            "initials": [
              "EF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Tropical Medicine and Gastroenterology Department, Alrajhi University Hospital, Assiut University, Assiut, Egypt."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-1772-506X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "13"
        ],
        "journalIssueId": [
          "2909391"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "Infection and drug resistance"
            ],
            "ISOAbbreviation": [
              "Infect Drug Resist"
            ],
            "medlineAbbreviation": [
              "Infect Drug Resist"
            ],
            "NLMid": [
              "101550216"
            ],
            "ISSN": [
              "1178-6973"
            ],
            "ESSN": [
              "1178-6973"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1873-1880"
    ],
    "abstractText": [
      "Purpose:In interferon-free era, direct-acting antiviral agents (DAAs) have achieved high eradication rates with an excellent safety profile since revolutionized the management of hepatitis c virus (HCV) patients. Published papers have suggested a possible increased incidence of hepatocellular carcinoma (HCC) after successful DAAs treatment. Other papers have been published about the problem but without conclusive results. Because of this debate, we aim to evaluate the effects of antiviral therapy (Sofosbuvir plus Daclatasvir with or without Ribavirin) on the de novo occurrence of HCC in patients with liver cirrhosis (LC). Patients and Methods:A prospective cohort study has included 350 patients who have visited our center for HCV treatment. Pretreatment history, examination, complete blood picture, liver function tests, kidney function tests, HA1C for diabetic patients, HCV PCR, HBsAg, alpha-fetoprotein (AFP), and abdominal ultrasound have been done, also Child-Pogh (CP) and Model for End-Stage Liver Disease (MELD) score before treatment. These investigations have been repeated for 3 months after the end of treatment. Abdominal ultrasound (US) has been done for 3 months after treatment and every 4 months for 2 years after the end of treatment to detect HCC occurrence. Results:Patients age (58.11 ± 7.48), 55.4% of patients were males, 30.3% of patients were diabetic, 84.3% of them were treatment naïve and sustained virological response (SVR) occured in 94% of them. HCC occurrence after treatment was 6.7% in patients with SVR and 23.8% in patients with non-SVR (P value=0.016) during follow-up period. There is significant improvement of CP score. No significant changes in MELD score. Conclusion:Treatment of HCV-related LC patients with sofosbuvir and daclatasvir with or without ribavirin for 3 or 6 months showed high SVR and significant improvement in CP score, but still at risk of HCC even if treated and should be followed up regularly according to screening programs with special meticulous attention to those with non-SVR."
    ],
    "affiliation": [
      "Tropical Medicine and Gastroenterology Department, Alrajhi University Hospital, Assiut University, Assiut, Egypt."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Hcv Treatment",
          "De-novo Hcc Occurrence"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.2147/IDR.S241948"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7308127"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7308127?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-07-02"
    ],
    "firstIndexDate": [
      "2020-07-02"
    ],
    "fullTextReceivedDate": [
      "2020-07-01"
    ],
    "dateOfRevision": [
      "2020-07-02"
    ],
    "electronicPublicationDate": [
      "2020-06-18"
    ],
    "firstPublicationDate": [
      "2020-06-18"
    ]
  },
  {
    "id": [
      "32875166"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32875166"
    ],
    "pmcid": [
      "PMC7452913"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7452913"
        ]
      }
    ],
    "doi": [
      "10.1016/j.genrep.2020.100860"
    ],
    "title": [
      "In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors."
    ],
    "authorString": [
      "Gurung AB."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Gurung AB"
            ],
            "firstName": [
              "Arun Bahadur"
            ],
            "lastName": [
              "Gurung"
            ],
            "initials": [
              "AB"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong 793022, Meghalaya, India."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "21"
        ],
        "journalIssueId": [
          "3004667"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Gene reports"
            ],
            "ISOAbbreviation": [
              "Gene Rep"
            ],
            "medlineAbbreviation": [
              "Gene Rep"
            ],
            "NLMid": [
              "101680713"
            ],
            "ISSN": [
              "2452-0144"
            ],
            "ESSN": [
              "2452-0144"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "100860"
    ],
    "abstractText": [
      "The high mortality rate from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in humans and the lack of effective therapeutic regime for its treatment necessitates the identification of new antivirals. SARS-CoV-2 relies on non-structural proteins such as Nsp13 helicase and nsp14 which are the key components of the replication-transcription complex (RTC) to complete its infectious life cycle. Therefore, targeting these essential viral proteins with small molecules will most likely to halt the disease pathogenesis. The lack of experimental structures of these proteins deters the process of structure-based identification of their specific inhibitors. In the present study, the in silico models of SARS-CoV-2 nsp13 helicase and nsp14 protein were elucidated using a comparative homology modelling approach. These in silico model structures were validated using various parameters such as Ramachandran plot, Verify 3D score, ERRAT score, knowledge-based energy and Z-score. The in silico models were further used for virtual screening of the Food and Drug Administration (FDA) approved antiviral drugs. Simeprevir (SMV), Paritaprevir (PTV) and Grazoprevir (GZR) were the common leads identified which show higher binding affinity to both nsp13 helicase and nsp14 as compared to the control inhibitors and therefore, they might be potential dual-target inhibitors. The leads also establish a network of hydrogen bonds and hydrophobic interactions with the key residues lining the active site pockets. The present findings suggest that these FDA approved antiviral drugs can be subjected to repurposing against SARS-CoV-2 infection after verifying the in silico results through in vitro and in vivo studies."
    ],
    "affiliation": [
      "Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong 793022, Meghalaya, India."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Molecular docking",
          "Homology Modelling",
          "Pdb, Protein Data Bank",
          "Fda, Food And Drug Administration",
          "Nsp14",
          "Covid-19",
          "Sars-cov-2",
          "Rmsd, Root Mean Square Deviation",
          "Rdrp, Rna-dependent Rna Polymerase",
          "Sars-cov, Severe Acute Respiratory Syndrome Coronavirus",
          "Ptv, Paritaprevir",
          "Smv, Simeprevir",
          "Dope, Discrete Optimized Protein Energy",
          "Nsp13 Helicase",
          "Zbd, Zinc Binding Domain",
          "3Clpro, 3C-like Proteinase",
          "Gpppa, Guanosine-p3-adenosine-5′,5′-triphosphate",
          "N7-mtase, S-adenosyl Methionine (Sam)-dependent (Guanine-n7) Methyltransferase",
          "Nsps, Non-structural Proteins",
          "Plpro, Papain-like Proteinase",
          "Rtc, Replication-transcription Complex",
          "Sf, Sinefungin",
          "Tmhs, Transmembrane Helices",
          "Gravy, Grand Average Of Hydropathicity",
          "Mers-cov, Middle East Respiratory Syndrome Coronavirus",
          "Gzr, Grazoprevir",
          "Saves, Structure Analysis And Verification Server",
          "Sah, S-adenosyl Homocysteine",
          "Covid-19, Coronavirus Disease 2019",
          "Sars-cov-2, Severe Acute Respiratory Syndrome Coronavirus 2",
          "Fda Approved Antiviral Drugs"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.genrep.2020.100860"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7452913"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7452913?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "uniprot"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-09-03"
    ],
    "firstIndexDate": [
      "2020-09-03"
    ],
    "fullTextReceivedDate": [
      "2020-08-30"
    ],
    "dateOfRevision": [
      "2020-09-03"
    ],
    "electronicPublicationDate": [
      "2020-08-28"
    ],
    "firstPublicationDate": [
      "2020-08-28"
    ]
  },
  {
    "id": [
      "PMC7485524"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7485524"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7485524"
        ]
      }
    ],
    "title": [
      "A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease"
    ],
    "authorString": [
      "Shiri I, Abdollahi H, Atashzar M, Rahmim A, Zaidi H."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Shiri I"
            ],
            "firstName": [
              "Isaac"
            ],
            "lastName": [
              "Shiri"
            ],
            "initials": [
              "I"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Abdollahi H"
            ],
            "firstName": [
              "Hamid"
            ],
            "lastName": [
              "Abdollahi"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Department of Radiologic Sciences and Medical Physics, Faculty of Allied Medicine, Kerman University of Medical Science, Kerman"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Atashzar M"
            ],
            "firstName": [
              "Mohammad Reza"
            ],
            "lastName": [
              "Atashzar"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "c Department of Immunology, School of Medicine, Fasa University of Medical Science, Fasa, Iran"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Rahmim A"
            ],
            "firstName": [
              "Arman"
            ],
            "lastName": [
              "Rahmim"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "e Department of Integrative Oncology, BC Cancer Research Centre, Vancouver BC, Canada"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zaidi H"
            ],
            "firstName": [
              "Habib"
            ],
            "lastName": [
              "Zaidi"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "h Department of Nuclear Medicine, University of Southern Denmark, Odense, Denmark"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2993480"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Nuclear medicine communications"
            ],
            "ISOAbbreviation": [
              "Nucl Med Commun"
            ],
            "medlineAbbreviation": [
              "Nucl Med Commun"
            ],
            "NLMid": [
              "8201017"
            ],
            "ISSN": [
              "0143-3636"
            ],
            "ESSN": [
              "1473-5628"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Editorial"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485524/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485524/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7485524"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7485524?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-13"
    ],
    "firstIndexDate": [
      "2020-09-13"
    ],
    "fullTextReceivedDate": [
      "2020-09-13"
    ],
    "dateOfRevision": [
      "2020-09-14"
    ],
    "electronicPublicationDate": [
      "2020-08-14"
    ],
    "firstPublicationDate": [
      "2020-08-14"
    ]
  },
  {
    "id": [
      "32837118"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32837118"
    ],
    "pmcid": [
      "PMC7376526"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7376526"
        ]
      }
    ],
    "doi": [
      "10.1007/s11224-020-01586-w"
    ],
    "title": [
      "Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy."
    ],
    "authorString": [
      "Ahmed SA, Abdelrheem DA, El-Mageed HRA, Mohamed HS, Rahman AA, Elsayed KNM, Ahmed SA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ahmed SA"
            ],
            "firstName": [
              "Shimaa A"
            ],
            "lastName": [
              "Ahmed"
            ],
            "initials": [
              "SA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Abdelrheem DA"
            ],
            "firstName": [
              "Doaa A"
            ],
            "lastName": [
              "Abdelrheem"
            ],
            "initials": [
              "DA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "El-Mageed HRA"
            ],
            "firstName": [
              "H R Abd"
            ],
            "lastName": [
              "El-Mageed"
            ],
            "initials": [
              "HRA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Micro-analysis and Environmental Research and Community Services Center, Faculty of Science, Beni-Suef University, Beni Suef, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mohamed HS"
            ],
            "firstName": [
              "Hussein S"
            ],
            "lastName": [
              "Mohamed"
            ],
            "initials": [
              "HS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Research Institute of Medicinal and Aromatic Plants (RIMAP), Beni-Suef University, Beni Suef, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Rahman AA"
            ],
            "firstName": [
              "Aziz A"
            ],
            "lastName": [
              "Rahman"
            ],
            "initials": [
              "AA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, University of Rajshahi, Rajshahi, 6205 Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Elsayed KNM"
            ],
            "firstName": [
              "Khaled N M"
            ],
            "lastName": [
              "Elsayed"
            ],
            "initials": [
              "KNM"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Botany, Faculty of Science, Beni-Suef University, Beni-Suef, 62511 Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ahmed SA"
            ],
            "firstName": [
              "Sayed A"
            ],
            "lastName": [
              "Ahmed"
            ],
            "initials": [
              "SA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3000163"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Structural chemistry"
            ],
            "ISOAbbreviation": [
              "Struct Chem"
            ],
            "medlineAbbreviation": [
              "Struct Chem"
            ],
            "NLMid": [
              "101582397"
            ],
            "ISSN": [
              "1040-0400"
            ],
            "ESSN": [
              "1572-9001"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1-22"
    ],
    "abstractText": [
      "Presently, the SARS-CoV-2 (COVID-19) pandemic has been spreading throughout the world. Some drugs such as lopinavir, simeprevir, hydroxychloroquine, chloroquine, and amprenavir have been recommended for COVID-19 treatment by some researchers, but these drugs were not effective enough against this virus. This study based on in silico approaches was aimed to increase the anti-COVID-19 activities of these drugs by using caulerpin and its derivatives as an adjunct drug against SARS-CoV-2 receptor proteins: the SARS-CoV-2 main protease and the SARS-CoV-2 spike protein. Caulerpin exhibited antiviral activities against chikungunya virus and herpes simplex virus type 1. Caulerpin and some of its derivatives showed inhibitory activity against Alzheimer's disease. The web server ANCHOR revealed higher protein stability for the two receptors with disordered score (< 0.6). Molecular docking analysis showed that the binding energies of most of the caulerpin derivatives were higher than all the suggested drugs for the two receptors. Also, we deduced that inserting NH2, halogen, and vinyl groups can increase the binding affinity of caulerpin toward 6VYB and 6LU7, while inserting an alkyl group decreases the binding affinity of caulerpin toward 6VYB and 6LU7. So, we can modify the inhibitory effect of caulerpin against 6VYB and 6LU7 by inserting NH2, halogen, and vinyl groups. Based on the protein disordered results, the SARS-CoV-2 main protease and SARS-CoV-2 spike protein domain are highly stable proteins, so it is quite difficult to unstabilize their integrity by using individual drugs. Also, molecular dynamics (MD) simulation indicates that binding of the combination therapy of simeprevir and the candidate studied compounds to the receptors was stable and had no major effect on the flexibility of the protein throughout the simulations and provided a suitable basis for our study. So, this study suggested that caulerpin and its derivatives could be used as a combination therapy along with lopinavir, simeprevir, hydroxychloroquine, chloroquine, and amprenavir for disrupting the stability of SARS-CoV2 receptor proteins to increase the antiviral activity of these drugs."
    ],
    "affiliation": [
      "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Molecular docking",
          "Caulerpin",
          "Simeprevir",
          "Sars-cov-2",
          "Anchor And Md Simulation"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1007/s11224-020-01586-w"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7376526"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7376526?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-08-25"
    ],
    "firstIndexDate": [
      "2020-08-26"
    ],
    "fullTextReceivedDate": [
      "2020-07-28"
    ],
    "dateOfRevision": [
      "2020-09-09"
    ],
    "electronicPublicationDate": [
      "2020-07-23"
    ],
    "firstPublicationDate": [
      "2020-07-23"
    ]
  },
  {
    "id": [
      "32274268"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32274268"
    ],
    "pmcid": [
      "PMC7127483"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7127483"
        ]
      }
    ],
    "doi": [
      "10.7717/peerj.8855"
    ],
    "title": [
      "Prediction of antiviral drugs against African swine fever viruses based on protein-protein interaction analysis. "
    ],
    "authorString": [
      "Zhu Z, Fan Y, Liu Y, Jiang T, Cao Y, Peng Y."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhu Z"
            ],
            "firstName": [
              "Zhaozhong"
            ],
            "lastName": [
              "Zhu"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, Hunan University, Changsha, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Fan Y"
            ],
            "firstName": [
              "Yunshi"
            ],
            "lastName": [
              "Fan"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, Hunan University, Changsha, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu Y"
            ],
            "firstName": [
              "Yang"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jiang T"
            ],
            "firstName": [
              "Taijiao"
            ],
            "lastName": [
              "Jiang"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Center for Systems Medicine, Institute of Basic Medical Sciences, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Cao Y"
            ],
            "firstName": [
              "Yang"
            ],
            "lastName": [
              "Cao"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Peng Y"
            ],
            "firstName": [
              "Yousong"
            ],
            "lastName": [
              "Peng"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, Hunan University, Changsha, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2899974"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "PeerJ"
            ],
            "ISOAbbreviation": [
              "PeerJ"
            ],
            "medlineAbbreviation": [
              "PeerJ"
            ],
            "NLMid": [
              "101603425"
            ],
            "ISSN": [
              "2167-8359"
            ],
            "ESSN": [
              "2167-8359"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "e8855"
    ],
    "abstractText": [
      "The African swine fever virus (ASFV) has severely influenced the swine industry of the world. Unfortunately, there is currently no effective antiviral drug or vaccine against the virus. Identification of new anti-ASFV drugs is urgently needed. Here, an up-to-date set of protein-protein interactions between ASFV and swine were curated by integration of protein-protein interactions from multiple sources. Thirty-eight swine proteins were observed to interact with ASFVs and were defined as ASFV-interacting swine proteins. The ASFV-interacting swine proteins were found to play a central role in the swine protein-protein interaction network, with significant larger degree, betweenness and smaller shortest path length than other swine proteins. Some of ASFV-interacting swine proteins also interacted with several other viruses and could be taken as potential targets of drugs for broad-spectrum effect, such as HSP90AB1. Finally, the antiviral drugs which targeted ASFV-interacting swine proteins and ASFV proteins were predicted. Several drugs with either broad-spectrum effect or high specificity on ASFV-interacting swine proteins were identified, such as Polaprezinc and Geldanamycin. Structural modeling and molecular dynamics simulation showed that Geldanamycin could bind with swine HSP90AB1 stably. This work could not only deepen our understanding towards the ASFV-swine interactions, but also help for the development of effective antiviral drugs against the ASFVs."
    ],
    "affiliation": [
      "College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, Hunan University, Changsha, China."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.7717/peerj.8855"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7127483"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7127483?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "PPR75418"
            ],
            "source": [
              "PPR"
            ],
            "type": [
              "Preprint in"
            ],
            "note": [
              "CrossRef Pre-print loader"
            ],
            "orderIn": [
              "10002"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-04-11"
    ],
    "firstIndexDate": [
      "2020-04-11"
    ],
    "fullTextReceivedDate": [
      "2020-04-12"
    ],
    "dateOfRevision": [
      "2020-04-13"
    ],
    "electronicPublicationDate": [
      "2020-04-01"
    ],
    "firstPublicationDate": [
      "2020-04-01"
    ]
  },
  {
    "id": [
      "32117168"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32117168"
    ],
    "pmcid": [
      "PMC7026129"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7026129"
        ]
      }
    ],
    "doi": [
      "10.3389/fmicb.2020.00150"
    ],
    "title": [
      "Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection."
    ],
    "authorString": [
      "Takayama-Ito M, Saijo M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Takayama-Ito M"
            ],
            "firstName": [
              "Mutsuyo"
            ],
            "lastName": [
              "Takayama-Ito"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Saijo M"
            ],
            "firstName": [
              "Masayuki"
            ],
            "lastName": [
              "Saijo"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0001-5458-7298",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-5458-7298",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "11"
        ],
        "journalIssueId": [
          "2907387"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "Frontiers in microbiology"
            ],
            "ISOAbbreviation": [
              "Front Microbiol"
            ],
            "medlineAbbreviation": [
              "Front Microbiol"
            ],
            "NLMid": [
              "101548977"
            ],
            "ISSN": [
              "1664-302X"
            ],
            "ESSN": [
              "1664-302X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "150"
    ],
    "abstractText": [
      "Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease caused by SFTS virus (SFTSV), which is a novel bunyavirus. SFTSV was first isolated from patients who presented with fever, thrombocytopenia, leukocytopenia, and multiorgan dysfunction in China. Subsequently, it was found to be widely distributed in Southeast Asia (Korea, Japan, and Vietnam). SFTSV can be transmitted not only from ticks but also from domestic animals, companion animals, and humans. Because the case fatality rate of SFTS is high (6-30%), development of specific and effective treatment for SFTS is required. Studies of potential antiviral drugs for SFTS-specific therapy have been conducted on existing or newly discovered agents in vitro and in vivo, with ribavirin and favipiravir being the most promising candidates. While animal experiments and retrospective studies have demonstrated the limited efficacy of ribavirin, it was also speculated that ribavirin would be effective in patients with a viral load <1 × 106 copies/mL. Favipiravir showed higher efficacy than ribavirin against SFTSV in in vitro assays and greater efficacy in animal models, even administrated 3 days after the virus inoculation. Although clinical trials evaluating the efficacy of favipiravir in SFTS patients in Japan are underway, this has yet to be confirmed. Other drugs, including hexachlorophene, calcium channel blockers, 2'-fluoro-2'-deoxycytidine, caffeic acid, amodiaquine, and interferons, have also been evaluated for their inhibitory efficacy against SFTSV. Among them, calcium channel blockers are promising because in addition to their efficacy in vitro and in vivo, retrospective clinical data have indicated that nifedipine, one of the calcium channel blockers, reduced the case fatality rate by >5-fold. Although further research is necessary to develop SFTS-specific therapy, considerable progress has been achieved in this area. Here we summarize and discuss recent advances in antiviral drugs against SFTSV."
    ],
    "affiliation": [
      "Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral",
          "Ribavirin",
          "Severe Fever With Thrombocytopenia Syndrome Virus",
          "Favipiravir",
          "Severe Fever With Thrombocytopenia Syndrome"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3389/fmicb.2020.00150"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7026129"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7026129?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-03-03"
    ],
    "firstIndexDate": [
      "2020-03-03"
    ],
    "fullTextReceivedDate": [
      "2020-03-01"
    ],
    "dateOfRevision": [
      "2020-03-05"
    ],
    "electronicPublicationDate": [
      "2020-02-11"
    ],
    "firstPublicationDate": [
      "2020-02-11"
    ]
  },
  {
    "id": [
      "32834766"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32834766"
    ],
    "pmcid": [
      "PMC7292951"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7292951"
        ]
      }
    ],
    "doi": [
      "10.1016/j.ijms.2020.116377"
    ],
    "title": [
      "Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes, influenza and other viral infections."
    ],
    "authorString": [
      "Niessen WMA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Niessen WMA"
            ],
            "firstName": [
              "W M A"
            ],
            "lastName": [
              "Niessen"
            ],
            "initials": [
              "WMA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "hyphen MassSpec, Margrietstraat 34, 2215 HJ, Voorhout, the Netherlands."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "455"
        ],
        "journalIssueId": [
          "2979707"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "International journal of mass spectrometry"
            ],
            "ISOAbbreviation": [
              "Int J Mass Spectrom"
            ],
            "medlineAbbreviation": [
              "Int J Mass Spectrom"
            ],
            "NLMid": [
              "101137096"
            ],
            "ISSN": [
              "1387-3806"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "116377"
    ],
    "abstractText": [
      "For the treatment of various viral infections, antiviral drugs may be used. Liquid chromatography-mass spectrometry (LC-MS) with tandem mass spectrometry (MS-MS) operated in selected-reaction monitoring (SRM) mode is the method of choice in quantitative bioanalysis of drugs, e.g., to establish bioavailability, to study pharmacokinetics, and later on possibly for therapeutic drug monitoring. In this study, the fragmentation in MS-MS of small-molecule antiviral drugs against herpes and influenza viruses is reviewed. In this way, insight is gained on the identity of the product ions used in SRM. Fragmentation schemes of antiviral agents are also relevant in the identification of drug metabolites or (forced) degradation products. As information of the fragmentation of antiviral drugs in MS-MS and the identity of the product ions is very much scattered in the scientific literature, it was decided to collect this information and to review it. In this third study, attention is paid to small-molecule antiviral agents used against herpes and influenza virus infections. In addition, some attention is paid to broad-spectrum antiviral agents, that are investigated with respect to their efficacy in challenging virus infections of this century, e.g., involving Ebola, Zika and corona viruses, like SARS-CoV-2, which is causing a world-wide pandemic at this very moment. The review provides fragmentation schemes of ca. 35 antiviral agents. The identity of the product ions used in SRM, i.e., elemental composition and exact-m/z, is tabulated, and more detailed fragmentation schemes are provided."
    ],
    "affiliation": [
      "hyphen MassSpec, Margrietstraat 34, 2215 HJ, Voorhout, the Netherlands."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Influenza viruses",
          "Protein inhibitors",
          "Fragmentation",
          "Tandem mass spectrometry",
          "Antiviral drugs",
          "Neuraminidase inhibitors",
          "Nucleoside Analogues",
          "Herpes Viruses",
          "Broad-spectrum Antiviral Agents"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.ijms.2020.116377"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7292951"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7292951?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-25"
    ],
    "firstIndexDate": [
      "2020-08-26"
    ],
    "fullTextReceivedDate": [
      "2020-07-12"
    ],
    "dateOfRevision": [
      "2020-08-24"
    ],
    "electronicPublicationDate": [
      "2020-06-13"
    ],
    "firstPublicationDate": [
      "2020-06-13"
    ]
  },
  {
    "id": [
      "32837113"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32837113"
    ],
    "pmcid": [
      "PMC7366079"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7366079"
        ]
      }
    ],
    "doi": [
      "10.1016/j.jksus.2020.07.007"
    ],
    "title": [
      "Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme."
    ],
    "authorString": [
      "Bahadur Gurung A, Ajmal Ali M, Lee J, Abul Farah M, Mashay Al-Anazi K."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Bahadur Gurung A"
            ],
            "firstName": [
              "Arun"
            ],
            "lastName": [
              "Bahadur Gurung"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong 793022, Meghalaya, India."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ajmal Ali M"
            ],
            "firstName": [
              "Mohammad"
            ],
            "lastName": [
              "Ajmal Ali"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lee J"
            ],
            "firstName": [
              "Joongku"
            ],
            "lastName": [
              "Lee"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Environment and Forest Resources, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Abul Farah M"
            ],
            "firstName": [
              "Mohammad"
            ],
            "lastName": [
              "Abul Farah"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Genetics Laboratory, Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mashay Al-Anazi K"
            ],
            "firstName": [
              "Khalid"
            ],
            "lastName": [
              "Mashay Al-Anazi"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Genetics Laboratory, Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "6"
        ],
        "volume": [
          "32"
        ],
        "journalIssueId": [
          "3000160"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of King Saud University. Science"
            ],
            "ISOAbbreviation": [
              "J King Saud Univ Sci"
            ],
            "medlineAbbreviation": [
              "J King Saud Univ Sci"
            ],
            "NLMid": [
              "9886378"
            ],
            "ISSN": [
              "1018-3647"
            ],
            "ESSN": [
              "2213-686X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "2845-2853"
    ],
    "abstractText": [
      "Coronaviruses are enveloped positive-strand RNA viruses belonging to family Coronaviridae and order Nidovirales which cause infections in birds and mammals. Among the human coronaviruses, highly pathogenic ones are Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome coronavirus (MERS-CoV) which have been implicated in severe respiratory syndrome in humans. There are no approved antiviral drugs or vaccines for the treatment of human CoV infection to date. The recent outbreak of new coronavirus pandemic, coronavirus disease 2019 (COVID-19) has caused a high mortality rate and infections around the world which necessitates the need for the discovery of novel anti-coronaviral drugs. Among the coronaviruses proteins, 3C-like protease (3CLpro) is an important drug target against coronaviral infection as the auto-cleavage process catalysed by the enzyme is crucial for viral maturation and replication. The present work is aimed at the identification of suitable lead molecules for the inhibition of 3CLpro enzyme via a computational screening of the Food and Drug Administration (FDA) approved antiviral drugs and phytochemicals. Based on binding energies and molecular interaction studies, we shortlisted five lead molecules (both FDA approved drugs and phytochemicals) for each enzyme targets (SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro). The lead molecules showed higher binding affinity compared to the standard inhibitors and exhibited favourable hydrophobic interactions and a good number of hydrogen bonds with their respective targets. A few promising leads with dual inhibition potential were identified among FDA approved antiviral drugs which include DB13879 (Glecaprevir), DB09102 (Daclatasvir), molecule DB09297 (Paritaprevir) and DB01072 (Atazanavir). Among the phytochemicals, 11,646,359 (Vincapusine), 120,716 (Alloyohimbine) and 10,308,017 (Gummadiol) showed triple inhibition potential against all the three targets and 102,004,710 (18-Hydroxy-3-epi-alpha-yohimbine) exhibited dual inhibition potential. Hence, the proposed lead molecules from our findings can be further investigated through in vitro and in vivo studies to develop into potential drug candidates against human coronaviral infections."
    ],
    "affiliation": [
      "Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong 793022, Meghalaya, India."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Molecular docking",
          "Antiviral drugs",
          "SARS-Cov",
          "Coronaviruses",
          "Phytochemicals",
          "Virtual Screening",
          "Mers-cov",
          "3C-like Protease",
          "Fda Approved Drugs"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.jksus.2020.07.007"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7366079"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7366079?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-08-25"
    ],
    "firstIndexDate": [
      "2020-08-26"
    ],
    "fullTextReceivedDate": [
      "2020-07-20"
    ],
    "dateOfRevision": [
      "2020-08-27"
    ],
    "electronicPublicationDate": [
      "2020-07-17"
    ],
    "firstPublicationDate": [
      "2020-07-17"
    ]
  },
  {
    "id": [
      "32375574"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32375574"
    ],
    "pmcid": [
      "PMC7232887"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7232887"
        ]
      }
    ],
    "doi": [
      "10.1080/07391102.2020.1765876"
    ],
    "title": [
      "Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus."
    ],
    "authorString": [
      "Adeoye AO, Oso BJ, Olaoye IF, Tijjani H, Adebayo AI."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Adeoye AO"
            ],
            "firstName": [
              "Akinwunmi O"
            ],
            "lastName": [
              "Adeoye"
            ],
            "initials": [
              "AO"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry, Federal University Oye-Ekiti, Oye-Ekiti, Nigeria."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Oso BJ"
            ],
            "firstName": [
              "Babatunde Joseph"
            ],
            "lastName": [
              "Oso"
            ],
            "initials": [
              "BJ"
            ],
            "authorId": [
              {
                "_": "0000-0001-8667-7108",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry, McPherson University, Seriki Sotayo, Nigeria."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Olaoye IF"
            ],
            "firstName": [
              "Ige Francis"
            ],
            "lastName": [
              "Olaoye"
            ],
            "initials": [
              "IF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry, McPherson University, Seriki Sotayo, Nigeria."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tijjani H"
            ],
            "firstName": [
              "Habibu"
            ],
            "lastName": [
              "Tijjani"
            ],
            "initials": [
              "H"
            ],
            "authorId": [
              {
                "_": "0000-0001-5466-322X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry, Natural Product Research Laboratory, Bauchi State University, Gadau, Nigeria."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Adebayo AI"
            ],
            "firstName": [
              "Ahmed I"
            ],
            "lastName": [
              "Adebayo"
            ],
            "initials": [
              "AI"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry, University of Ilorin, Ilorin, Nigeria."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-8667-7108",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-5466-322X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2949917"
        ],
        "dateOfPublication": [
          "2020 May"
        ],
        "monthOfPublication": [
          "5"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-05-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of biomolecular structure & dynamics"
            ],
            "ISOAbbreviation": [
              "J. Biomol. Struct. Dyn."
            ],
            "medlineAbbreviation": [
              "J Biomol Struct Dyn"
            ],
            "NLMid": [
              "8404176"
            ],
            "ISSN": [
              "0739-1102"
            ],
            "ESSN": [
              "1538-0254"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1-11"
    ],
    "abstractText": [
      "The reemergence of coronavirus prompts the need for the development of effective therapeutics to prevent the cellular entry and replication of coronavirus. This study demonstrated the putative inhibitory potential of lopinavir, remdesivir, oseltamir, azithromycin, ribavirin, and chloroquine towards V-ATPase, protein kinase A, SARS-CoV spike glycoprotein/ACE-2 complex and viral proteases. The pharmacodynamic and pharmacokinetic properties were predicted through the pkCSM server while the corresponding binding affinity of the selected drugs towards the proteins was computed using AutodockVina Screening tool. The ADMET properties revealed all the drugs possess drug-like properties. Lopinavir has the highest binding affinities to the pocket site of SARS-CoV spike glycoprotein/ACE-2 complex, cyclic AMP-dependent protein kinase A and 3-Chymotrypsin like protease while redemsivir has the highest binding affinities for vacuolar proton-translocating ATPase (V-ATPase) and papain-like proteins. The amino acids Asp269, Leu370, His374, and His345 were predicted as the key residues for lopinavir binding to human SARS-CoV spike glycoprotein/ACE-2 complex while His378, Tyr515, Leu73, Leu100, Phe32 and Phe40 for remdesivir and Tyr510, Phe504, Met62, Tyr50, and His378 were predicted for azithromycin as the key residues for binding to SARS-CoV spike glycoprotein/ACE-2 complex. Moreover, it was also observed that chloroquine has appreciable binding affinities for 3-Chymotrpsin- like protease and cyclic AMP-dependent protein kinase A when compared to Oseltamivir and ribavirin. The study provided evidence suggesting putative repurposing of the selected drugs for the development of valuable drugs for the prevention of cellular entry and replication of coronavirus. Communicated by Ramaswamy H. Sarma."
    ],
    "affiliation": [
      "Department of Biochemistry, Federal University Oye-Ekiti, Oye-Ekiti, Nigeria."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral drugs",
          "Coronavirus",
          "chloroquine",
          "Autodock Tool",
          "Pkcsm Tool"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/07391102.2020.1765876"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7232887"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7232887?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "32633620"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "J Biomol Struct Dyn. 2020 Jul 7;:1"
            ],
            "type": [
              "Erratum in"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "9"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-05-08"
    ],
    "firstIndexDate": [
      "2020-05-12"
    ],
    "fullTextReceivedDate": [
      "2020-07-12"
    ],
    "dateOfRevision": [
      "2020-07-07"
    ],
    "electronicPublicationDate": [
      "2020-05-15"
    ],
    "firstPublicationDate": [
      "2020-05-15"
    ]
  },
  {
    "id": [
      "32720571"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32720571"
    ],
    "pmcid": [
      "PMC7441766"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7441766"
        ]
      }
    ],
    "doi": [
      "10.1080/07391102.2020.1796804"
    ],
    "title": [
      "Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2."
    ],
    "authorString": [
      "Ahmed S, Mahtarin R, Ahmed SS, Akter S, Islam MS, Mamun AA, Islam R, Hossain MN, Ali MA, Sultana MUC, Parves MR, Ullah MO, Halim MA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ahmed S"
            ],
            "firstName": [
              "Sinthyia"
            ],
            "lastName": [
              "Ahmed"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mahtarin R"
            ],
            "firstName": [
              "Rumana"
            ],
            "lastName": [
              "Mahtarin"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ahmed SS"
            ],
            "firstName": [
              "Sayeda Samina"
            ],
            "lastName": [
              "Ahmed"
            ],
            "initials": [
              "SS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Akter S"
            ],
            "firstName": [
              "Shaila"
            ],
            "lastName": [
              "Akter"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Islam MS"
            ],
            "firstName": [
              "Md Shamiul"
            ],
            "lastName": [
              "Islam"
            ],
            "initials": [
              "MS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mamun AA"
            ],
            "firstName": [
              "Abdulla Al"
            ],
            "lastName": [
              "Mamun"
            ],
            "initials": [
              "AA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Soft Chemistry and Functional Materials of MOE, School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Islam R"
            ],
            "firstName": [
              "Rajib"
            ],
            "lastName": [
              "Islam"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hossain MN"
            ],
            "firstName": [
              "Md Nayeem"
            ],
            "lastName": [
              "Hossain"
            ],
            "initials": [
              "MN"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ali MA"
            ],
            "firstName": [
              "Md Ackas"
            ],
            "lastName": [
              "Ali"
            ],
            "initials": [
              "MA"
            ],
            "authorId": [
              {
                "_": "0000-0002-8235-3517",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sultana MUC"
            ],
            "firstName": [
              "Mossammad U C"
            ],
            "lastName": [
              "Sultana"
            ],
            "initials": [
              "MUC"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Parves MR"
            ],
            "firstName": [
              "Md Rimon"
            ],
            "lastName": [
              "Parves"
            ],
            "initials": [
              "MR"
            ],
            "authorId": [
              {
                "_": "0000-0003-1379-7410",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ullah MO"
            ],
            "firstName": [
              "M Obayed"
            ],
            "lastName": [
              "Ullah"
            ],
            "initials": [
              "MO"
            ],
            "authorId": [
              {
                "_": "0000-0002-1175-3636",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Halim MA"
            ],
            "firstName": [
              "Mohammad A"
            ],
            "lastName": [
              "Halim"
            ],
            "initials": [
              "MA"
            ],
            "authorId": [
              {
                "_": "0000-0002-1698-7044",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh.",
                  "Department of Physical Sciences, University of Arkansas - Fort Smith, Fort Smith, Arkansas, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-8235-3517",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-1379-7410",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-1175-3636",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-1698-7044",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2972293"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of biomolecular structure & dynamics"
            ],
            "ISOAbbreviation": [
              "J. Biomol. Struct. Dyn."
            ],
            "medlineAbbreviation": [
              "J Biomol Struct Dyn"
            ],
            "NLMid": [
              "8404176"
            ],
            "ISSN": [
              "0739-1102"
            ],
            "ESSN": [
              "1538-0254"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1-16"
    ],
    "abstractText": [
      "SARS-CoV-2 virus outbreak poses a major threat to humans worldwide due to its highly contagious nature. In this study, molecular docking, molecular dynamics, and structure-activity relationship are employed to assess the binding affinity and interaction of 76 prescription drugs against RNA dependent RNA polymerase (RdRp) and Main Protease (Mpro) of SARS-CoV-2. The RNA-dependent RNA polymerase is a vital enzyme of coronavirus replication/transcription complex whereas the main protease acts on the proteolysis of replicase polyproteins. Among 76 prescription antiviral drugs, four drugs (Raltegravir, Simeprevir, Cobicistat, and Daclatasvir) that are previously used for human immunodeficiency virus (HIV), hepatitis C virus (HCV), Ebola, and Marburg virus show higher binding energy and strong interaction with active sites of the receptor proteins. To explore the dynamic nature of the interaction, 100 ns molecular dynamics (MD) simulation is performed on the selected protein-drug complexes and apo-protein. Binding free energy of the selected drugs is performed by MM/PBSA. Besides docking and dynamics, partial least square (PLS) regression method is applied for the quantitative structure activity relationship to generate and predict the binding energy for drugs. PLS regression satisfactorily predicts the binding energy of the effective antiviral drugs compared to binding energy achieved from molecular docking with a precision of 85%. This study highly recommends researchers to screen these potential drugs in vitro and in vivo against SARS-CoV-2 for further validation of utility."
    ],
    "affiliation": [
      "Division of Infectious Diseases and Division of Computer Aided Drug Design, The Red-Green Research Centre, BICCB, Tejgaon, Dhaka, Bangladesh."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Principal component analysis",
          "Molecular docking",
          "Molecular dynamics",
          "Antiviral drugs",
          "Quantitative structure-activity relationship",
          "Sars-cov-2"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/07391102.2020.1796804"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7441766"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7441766?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-07-29"
    ],
    "firstIndexDate": [
      "2020-07-29"
    ],
    "fullTextReceivedDate": [
      "2020-08-27"
    ],
    "dateOfRevision": [
      "2020-08-25"
    ],
    "electronicPublicationDate": [
      "2020-07-28"
    ],
    "firstPublicationDate": [
      "2020-07-28"
    ]
  },
  {
    "id": [
      "32720577"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32720577"
    ],
    "pmcid": [
      "PMC7441777"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7441777"
        ]
      }
    ],
    "doi": [
      "10.1080/07391102.2020.1796810"
    ],
    "title": [
      "Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis."
    ],
    "authorString": [
      "Singh S, Sk MF, Sonawane A, Kar P, Sadhukhan S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Singh S"
            ],
            "firstName": [
              "Satyam"
            ],
            "lastName": [
              "Singh"
            ],
            "initials": [
              "S"
            ],
            "authorId": [
              {
                "_": "0000-0003-2341-9544",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sk MF"
            ],
            "firstName": [
              "Md Fulbabu"
            ],
            "lastName": [
              "Sk"
            ],
            "initials": [
              "MF"
            ],
            "authorId": [
              {
                "_": "0000-0003-4341-8370",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sonawane A"
            ],
            "firstName": [
              "Avinash"
            ],
            "lastName": [
              "Sonawane"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kar P"
            ],
            "firstName": [
              "Parimal"
            ],
            "lastName": [
              "Kar"
            ],
            "initials": [
              "P"
            ],
            "authorId": [
              {
                "_": "0000-0001-8451-9739",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sadhukhan S"
            ],
            "firstName": [
              "Sushabhan"
            ],
            "lastName": [
              "Sadhukhan"
            ],
            "initials": [
              "S"
            ],
            "authorId": [
              {
                "_": "0000-0002-3302-5875",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Discipline of Chemistry, Indian Institute of Technology Palakkad, Palakkad, India."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-2341-9544",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-4341-8370",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-8451-9739",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-3302-5875",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2972293"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of biomolecular structure & dynamics"
            ],
            "ISOAbbreviation": [
              "J. Biomol. Struct. Dyn."
            ],
            "medlineAbbreviation": [
              "J Biomol Struct Dyn"
            ],
            "NLMid": [
              "8404176"
            ],
            "ISSN": [
              "0739-1102"
            ],
            "ESSN": [
              "1538-0254"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1-16"
    ],
    "abstractText": [
      "The sudden outburst of Coronavirus disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a massive threat to global public health. Currently, no therapeutic drug or vaccine exists to treat COVID-19. Due to the time taking process of new drug development, drug repurposing might be the only viable solution to tackle COVID-19. RNA-dependent RNA polymerase (RdRp) catalyzes SARS-CoV-2 RNA replication and hence, is an obvious target for antiviral drug design. Interestingly, several plant-derived polyphenols effectively inhibit the RdRp of other RNA viruses. More importantly, polyphenols have been used as dietary supplementations for a long time and played beneficial roles in immune homeostasis. We were curious to study the binding of polyphenols with SARS-CoV-2 RdRp and assess their potential to treat COVID-19. Herein, we made a library of polyphenols that have shown substantial therapeutic effects against various diseases. They were successfully docked in the catalytic pocket of RdRp. The investigation reveals that EGCG, theaflavin (TF1), theaflavin-3'-O-gallate (TF2a), theaflavin-3'-gallate (TF2b), theaflavin 3,3'-digallate (TF3), hesperidin, quercetagetin, and myricetin strongly bind to the active site of RdRp. Further, a 150-ns molecular dynamic simulation revealed that EGCG, TF2a, TF2b, TF3 result in highly stable bound conformations with RdRp. The binding free energy components calculated by the MM-PBSA also confirm the stability of the complexes. We also performed a detailed analysis of ADME prediction, toxicity prediction, and target analysis for their druggability. Overall, our results suggest that EGCG, TF2a, TF2b, TF3 can inhibit RdRp and represent an effective therapy for COVID-19. Communicated by Ramaswamy H. Sarma."
    ],
    "affiliation": [
      "Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, India;"
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Molecular docking",
          "Molecular dynamics",
          "Natural Polyphenols",
          "Mm-pbsa",
          "Sars-cov-2 And Rna‐dependent Rna Polymerase (Rdrp)"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/07391102.2020.1796810"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7441777"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7441777?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-07-29"
    ],
    "firstIndexDate": [
      "2020-07-29"
    ],
    "fullTextReceivedDate": [
      "2020-08-27"
    ],
    "dateOfRevision": [
      "2020-08-25"
    ],
    "electronicPublicationDate": [
      "2020-07-28"
    ],
    "firstPublicationDate": [
      "2020-07-28"
    ]
  },
  {
    "id": [
      "31474954"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31474954"
    ],
    "pmcid": [
      "PMC6702965"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6702965"
        ]
      }
    ],
    "doi": [
      "10.3389/fmicb.2019.01853"
    ],
    "title": [
      "Inhibition of Porcine Viruses by Different Cell-Targeted Antiviral Drugs."
    ],
    "authorString": [
      "de León P, Bustos MJ, Torres E, Cañas-Arranz R, Sobrino F, Carrascosa AL."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "de León P"
            ],
            "firstName": [
              "Patricia"
            ],
            "lastName": [
              "de León"
            ],
            "initials": [
              "P"
            ],
            "authorId": [
              {
                "_": "0000-0003-2518-2245",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bustos MJ"
            ],
            "firstName": [
              "María José"
            ],
            "lastName": [
              "Bustos"
            ],
            "initials": [
              "MJ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Torres E"
            ],
            "firstName": [
              "Elisa"
            ],
            "lastName": [
              "Torres"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Cañas-Arranz R"
            ],
            "firstName": [
              "Rodrigo"
            ],
            "lastName": [
              "Cañas-Arranz"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sobrino F"
            ],
            "firstName": [
              "Francisco"
            ],
            "lastName": [
              "Sobrino"
            ],
            "initials": [
              "F"
            ],
            "authorId": [
              {
                "_": "0000-0003-4968-8291",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Carrascosa AL"
            ],
            "firstName": [
              "Angel L"
            ],
            "lastName": [
              "Carrascosa"
            ],
            "initials": [
              "AL"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-2518-2245",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-4968-8291",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "10"
        ],
        "journalIssueId": [
          "2776217"
        ],
        "dateOfPublication": [
          "2019 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-01-01"
        ],
        "journal": [
          {
            "title": [
              "Frontiers in microbiology"
            ],
            "ISOAbbreviation": [
              "Front Microbiol"
            ],
            "medlineAbbreviation": [
              "Front Microbiol"
            ],
            "NLMid": [
              "101548977"
            ],
            "ISSN": [
              "1664-302X"
            ],
            "ESSN": [
              "1664-302X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "1853"
    ],
    "abstractText": [
      "Antiviral compounds targeting cellular metabolism instead of virus components have become an interesting issue for preventing and controlling the spread of virus infection, either as sole treatment or as a complement of vaccination. Some of these compounds are involved in the control of lipid metabolism and/or membrane rearrangements. Here, we describe the effect of three of these cell-targeting antivirals: lauryl gallate (LG), valproic acid (VPA), and cerulenin (CRL) in the multiplication of viruses causing important porcine diseases. The results confirm the antiviral action in cultured cells of LG against African swine fever virus (ASFV), foot and mouth disease virus (FMDV), vesicular stomatitis virus (VSV), and swine vesicular disease virus (SVDV), as well as the inhibitory effect of VPA and CRL on ASFV infection. Other gallate esters have been also assayed for their inhibition of FMDV growth. The combined action of these antivirals has been also tested in ASFV infections, with some synergistic effects when LG and VPA were co-administered. Regarding the mode of action of the antivirals, experiments on the effect of the time of its addition in infected cell cultures indicated that the inhibition by VPA and CRL occurred at early times after ASFV infection, while LG inhibited a late step in FMDV infection. In all the cases, the presence of the antiviral reduced or abolished the induction of virus-specific proteins. Interestingly, LG also reduced mortality and FMDV load in a mouse model. The possible use of cell-targeted antivirals against porcine diseases is discussed."
    ],
    "affiliation": [
      "Centro de Biología Molecular \"Severo Ochoa\" (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Virus",
          "Porcine",
          "Antiviral",
          "Valproic acid",
          "Cerulenin",
          "Lauryl Gallate"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3389/fmicb.2019.01853"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6702965"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6702965?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2019-09-03"
    ],
    "firstIndexDate": [
      "2019-09-03"
    ],
    "fullTextReceivedDate": [
      "2019-09-01"
    ],
    "dateOfRevision": [
      "2019-09-05"
    ],
    "electronicPublicationDate": [
      "2019-08-14"
    ],
    "firstPublicationDate": [
      "2019-08-14"
    ]
  },
  {
    "id": [
      "32395351"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32395351"
    ],
    "pmcid": [
      "PMC7201615"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7201615"
        ]
      }
    ],
    "doi": [
      "10.1155/2020/6438753"
    ],
    "title": [
      "Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus."
    ],
    "authorString": [
      "Mada PK, Malus ME, Parvathaneni A, Chen B, Castano G, Adley S, Moore M, Hieda M, Alam MJ, Feldman M, King JW."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Mada PK"
            ],
            "firstName": [
              "Pradeep Kumar"
            ],
            "lastName": [
              "Mada"
            ],
            "initials": [
              "PK"
            ],
            "authorId": [
              {
                "_": "0000-0001-7855-7982",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Internal Medicine Department, Texas Health Presbyterian Hospital, Dallas, TX, USA.",
                  "Infectious Diseases, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Malus ME"
            ],
            "firstName": [
              "Matthew E"
            ],
            "lastName": [
              "Malus"
            ],
            "initials": [
              "ME"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Internal Medicine, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Parvathaneni A"
            ],
            "firstName": [
              "Arvin"
            ],
            "lastName": [
              "Parvathaneni"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Neurology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Chen B"
            ],
            "firstName": [
              "Bing"
            ],
            "lastName": [
              "Chen"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Internal Medicine, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Castano G"
            ],
            "firstName": [
              "Gabriel"
            ],
            "lastName": [
              "Castano"
            ],
            "initials": [
              "G"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Pediatrics, UT Health Sciences Center, San Antonio, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Adley S"
            ],
            "firstName": [
              "Sharon"
            ],
            "lastName": [
              "Adley"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Moore M"
            ],
            "firstName": [
              "Maureen"
            ],
            "lastName": [
              "Moore"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hieda M"
            ],
            "firstName": [
              "Michinari"
            ],
            "lastName": [
              "Hieda"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0003-3434-6184",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Exercise and Environmental Medicine, University of Texas Southwestern Medical Center, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alam MJ"
            ],
            "firstName": [
              "Mohammed J"
            ],
            "lastName": [
              "Alam"
            ],
            "initials": [
              "MJ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Feldman M"
            ],
            "firstName": [
              "Mark"
            ],
            "lastName": [
              "Feldman"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0003-4448-3991",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Internal Medicine Department, Texas Health Presbyterian Hospital, Dallas, TX, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "King JW"
            ],
            "firstName": [
              "John William"
            ],
            "lastName": [
              "King"
            ],
            "initials": [
              "JW"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Infectious Diseases, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7855-7982",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-3434-6184",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-4448-3991",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "2020"
        ],
        "journalIssueId": [
          "2908439"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "International journal of hepatology"
            ],
            "ISOAbbreviation": [
              "Int J Hepatol"
            ],
            "medlineAbbreviation": [
              "Int J Hepatol"
            ],
            "NLMid": [
              "101564967"
            ],
            "ISSN": [
              "2090-3448"
            ],
            "ESSN": [
              "2090-3456"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "6438753"
    ],
    "abstractText": [
      "Aim:To assess the effect of treating chronic hepatitis C virus (HCV) infection with direct acting antiviral drugs (DAAs) on glycemic control in patients with concomitant diabetes mellitus (DM). Methods:We performed a retrospective case-control study in a viral hepatitis ambulatory clinic in Shreveport, Louisiana, during the period 11/01/2014 to 12/31/2017. All the clinic patient ages 18 years and above with treatment-naïve/biopsy-proven chronic hepatitis C and DM (hemoglobin A1C level ≥ 6.5%) who were eligible for treatment were included in the study. Of 118 such patients, 59 were treated with oral DAAs for 8-12 weeks with the goal of achieving a sustained virologic response (SVR). A control group of 59 patients did not receive treatment for their hepatitis C and was followed in the clinic. Patients in the control group did not receive treatment either due to insurance issues or refusal of hepatitis C treatment. Results:Fifty-five of the 59 patients treated with DAAs (93%) achieved a SVR. Six months after treatment completion, their mean ± SEM HbA1C level had decreased by 1.1 ± 0.03% (P < 0.0001). Four of the 59 patients treated with DAAs did not achieve a SVR. Their mean HbA1C 6 months after treatment completion had increased by 0.8 ± 0.2%. Furthermore, there was no improvement in HbA1C levels over time in the untreated group (mean HbA1C increase, 0.2 ± 0.05%; P < 0.0001 vs. the treatment group, which had a mean HbA1C decrease of 0.9 ± 0.2%). Conclusion:This controlled study demonstrated that treatment of chronic hepatitis C with DAAs results in statistically significant and meaningful reductions in hemoglobin A1C levels in patients with coexisting diabetic mellitus if a SVR is achieved."
    ],
    "affiliation": [
      "Internal Medicine Department, Texas Health Presbyterian Hospital, Dallas, TX, USA."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1155/2020/6438753"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7201615"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7201615?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-05-13"
    ],
    "firstIndexDate": [
      "2020-05-14"
    ],
    "fullTextReceivedDate": [
      "2020-05-13"
    ],
    "dateOfRevision": [
      "2020-05-15"
    ],
    "electronicPublicationDate": [
      "2020-01-13"
    ],
    "firstPublicationDate": [
      "2020-01-13"
    ]
  },
  {
    "id": [
      "32280433"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32280433"
    ],
    "pmcid": [
      "PMC7118541"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7118541"
        ]
      }
    ],
    "doi": [
      "10.1016/j.csbj.2020.03.025"
    ],
    "title": [
      "Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model."
    ],
    "authorString": [
      "Beck BR, Shin B, Choi Y, Park S, Kang K."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Beck BR"
            ],
            "firstName": [
              "Bo Ram"
            ],
            "lastName": [
              "Beck"
            ],
            "initials": [
              "BR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Deargen, Inc., Daejeon, Republic of Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shin B"
            ],
            "firstName": [
              "Bonggun"
            ],
            "lastName": [
              "Shin"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Deargen, Inc., Daejeon, Republic of Korea.",
                  "Department of Computer Science, Emory University, Atlanta, GA, United States."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Choi Y"
            ],
            "firstName": [
              "Yoonjung"
            ],
            "lastName": [
              "Choi"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Deargen, Inc., Daejeon, Republic of Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Park S"
            ],
            "firstName": [
              "Sungsoo"
            ],
            "lastName": [
              "Park"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Deargen, Inc., Daejeon, Republic of Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kang K"
            ],
            "firstName": [
              "Keunsoo"
            ],
            "lastName": [
              "Kang"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology, College of Science & Technology, Dankook University, Cheonan, Republic of Korea."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "18"
        ],
        "journalIssueId": [
          "2895444"
        ],
        "dateOfPublication": [
          "2020 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "Computational and structural biotechnology journal"
            ],
            "ISOAbbreviation": [
              "Comput Struct Biotechnol J"
            ],
            "medlineAbbreviation": [
              "Comput Struct Biotechnol J"
            ],
            "NLMid": [
              "101585369"
            ],
            "ISSN": [
              "2001-0370"
            ],
            "ESSN": [
              "2001-0370"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "784-790"
    ],
    "abstractText": [
      "The infection of a novel coronavirus found in Wuhan of China (SARS-CoV-2) is rapidly spreading, and the incidence rate is increasing worldwide. Due to the lack of effective treatment options for SARS-CoV-2, various strategies are being tested in China, including drug repurposing. In this study, we used our pre-trained deep learning-based drug-target interaction model called Molecule Transformer-Drug Target Interaction (MT-DTI) to identify commercially available drugs that could act on viral proteins of SARS-CoV-2. The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing an inhibitory potency with Kd of 94.94 nM against the SARS-CoV-2 3C-like proteinase, followed by remdesivir (113.13 nM), efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM). Interestingly, lopinavir, ritonavir, and darunavir are all designed to target viral proteinases. However, in our prediction, they may also bind to the replication complex components of SARS-CoV-2 with an inhibitory potency with Kd  < 1000 nM. In addition, we also found that several antiviral agents, such as Kaletra (lopinavir/ritonavir), could be used for the treatment of SARS-CoV-2. Overall, we suggest that the list of antiviral drugs identified by the MT-DTI model should be considered, when establishing effective treatment strategies for SARS-CoV-2."
    ],
    "affiliation": [
      "Deargen, Inc., Daejeon, Republic of Korea."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "brief-report",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Coronavirus",
          "Drug Repurposing",
          "Atazanavir",
          "Deep Learning",
          "Covid-19",
          "Sars-cov-2",
          "Mt-dti"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.csbj.2020.03.025"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7118541"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7118541?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "19"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "refseq",
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-04-14"
    ],
    "firstIndexDate": [
      "2020-04-13"
    ],
    "fullTextReceivedDate": [
      "2020-07-11"
    ],
    "dateOfRevision": [
      "2020-06-05"
    ],
    "electronicPublicationDate": [
      "2020-03-30"
    ],
    "firstPublicationDate": [
      "2020-03-30"
    ]
  },
  {
    "id": [
      "PMC7509319"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7509319"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7509319"
        ]
      }
    ],
    "title": [
      "Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19"
    ],
    "authorString": [
      "Zhang W, Lv Y, Yang J, Chen Y, He Y, Huang J."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhang W"
            ],
            "firstName": [
              "Weilong"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Center for Drug Clinical Research,  Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine ,  Shanghai \n 201203 ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lv Y"
            ],
            "firstName": [
              "Yinghua"
            ],
            "lastName": [
              "Lv"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Center for Drug Clinical Research,  Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine ,  Shanghai \n 201203 ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yang J"
            ],
            "firstName": [
              "Juan"
            ],
            "lastName": [
              "Yang"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Center for Drug Clinical Research,  Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine ,  Shanghai \n 201203 ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Chen Y"
            ],
            "firstName": [
              "Yunhui"
            ],
            "lastName": [
              "Chen"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "2 College of Basic Medicine,  Chengdu University of Traditional Chinese Medicine ,  Chengdu \n 610075 ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "He Y"
            ],
            "firstName": [
              "Yingchun"
            ],
            "lastName": [
              "He"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Center for Drug Clinical Research,  Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine ,  Shanghai \n 201203 ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Huang J"
            ],
            "firstName": [
              "Jihan"
            ],
            "lastName": [
              "Huang"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Center for Drug Clinical Research,  Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine ,  Shanghai \n 201203 ,"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "14"
        ],
        "journalIssueId": [
          "2981455"
        ],
        "dateOfPublication": [
          "2020 Jan"
        ],
        "monthOfPublication": [
          "1"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-01-01"
        ],
        "journal": [
          {
            "title": [
              "Drug design, development and therapy"
            ],
            "ISOAbbreviation": [
              "Drug Des Devel Ther"
            ],
            "medlineAbbreviation": [
              "Drug Des Devel Ther"
            ],
            "NLMid": [
              "101475745"
            ],
            "ISSN": [
              "1177-8881"
            ],
            "ESSN": [
              "1177-8881"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "3803-3813"
    ],
    "abstractText": [
      "Objective This study aimed to evaluate the pharmacological mechanisms of antiviral drugs against the novel coronavirus disease (COVID-19) and the study designs in clinical trials registered with the International Clinical Trials Registry Platform (ICTRP). Methods Clinical trials involving antiviral drugs for treating COVID-19 were retrieved from the ICTRP database. For each trial, the study design, number of participants, primary endpoints, source register, antiviral mechanism, and results were evaluated. Results On June 10, 2020, 145 eligible clinical trials were retrieved from the ICTRP, of which 99 (68.3%) were randomized trials, 109 (75.2%) were parallel assignment trials, 38 (26.2%) were double or single blinded, 130 (89.7%) involved two groups, and 75 (51.6%) included more than 100 participants; and clinical improvement or recovery and virus-negative conversion were the two most common endpoints, accounting for 40.7% and 18.6%, respectively. The drugs were divided according to the antiviral mechanism into HIV reverse transcriptase inhibitors, RNA-dependent RNA polymerase inhibitors, HIV protease inhibitors (PIs), hepatitis C virus NS3 PIs, and anti-influenza drugs. Conclusion The design characteristics of clinical trials of antiviral drugs for treating COVID-19 as well as the mechanism of action and antiviral efficacy of the drugs were evaluated in this study. The results of these trials could constitute a reference for future clinical trials to be executed on COVID-19 treatment and prevention."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral Agents",
          "Research Design",
          "Clinical Trials As Topic",
          "Covid-19"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509319/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509319/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7509319"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7509319?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "N"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-28"
    ],
    "firstIndexDate": [
      "2020-09-28"
    ],
    "fullTextReceivedDate": [
      "2020-09-28"
    ],
    "dateOfRevision": [
      "2020-09-28"
    ],
    "electronicPublicationDate": [
      "2020-01-01"
    ],
    "firstPublicationDate": [
      "2020-01-01"
    ]
  },
  {
    "id": [
      "31485670"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31485670"
    ],
    "pmcid": [
      "PMC6755163"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6755163"
        ]
      }
    ],
    "doi": [
      "10.3892/mmr.2019.10628"
    ],
    "title": [
      "hNTCP‑expressing primary pig hepatocytes are a valuable tool for investigating hepatitis B virus infection and antiviral drugs."
    ],
    "authorString": [
      "Zhou M, Qin B, Deng XS, Zeng XL, Lu Y, Huang ZG, Wu CC, Mou LS."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhou M"
            ],
            "firstName": [
              "Ming"
            ],
            "lastName": [
              "Zhou"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shenzhen Xenotransplantation Research and Development Center, Institute of Translational Medicine, Health Science Center, Shenzhen University School of Medicine, Shenzhen Second People's Hospital, The First Afﬁliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Qin B"
            ],
            "firstName": [
              "Bo"
            ],
            "lastName": [
              "Qin"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Deng XS"
            ],
            "firstName": [
              "Xue-Song"
            ],
            "lastName": [
              "Deng"
            ],
            "initials": [
              "XS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Hepatobiliary Surgery, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zeng XL"
            ],
            "firstName": [
              "Xiao-Li"
            ],
            "lastName": [
              "Zeng"
            ],
            "initials": [
              "XL"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Internal Medicine, The Second People's Hospital of Futian District, Shenzhen, Guangdong 518049, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lu Y"
            ],
            "firstName": [
              "Ying"
            ],
            "lastName": [
              "Lu"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shenzhen Xenotransplantation Research and Development Center, Institute of Translational Medicine, Health Science Center, Shenzhen University School of Medicine, Shenzhen Second People's Hospital, The First Afﬁliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Huang ZG"
            ],
            "firstName": [
              "Zi-Gang"
            ],
            "lastName": [
              "Huang"
            ],
            "initials": [
              "ZG"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Liver‑Biotechnology (Shenzhen) Co., Ltd., Shenzhen, Guangdong 518110, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wu CC"
            ],
            "firstName": [
              "Chun-Chen"
            ],
            "lastName": [
              "Wu"
            ],
            "initials": [
              "CC"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, P.R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mou LS"
            ],
            "firstName": [
              "Li-Sha"
            ],
            "lastName": [
              "Mou"
            ],
            "initials": [
              "LS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shenzhen Xenotransplantation Research and Development Center, Institute of Translational Medicine, Health Science Center, Shenzhen University School of Medicine, Shenzhen Second People's Hospital, The First Afﬁliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "4"
        ],
        "volume": [
          "20"
        ],
        "journalIssueId": [
          "2860972"
        ],
        "dateOfPublication": [
          "2019 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-10-01"
        ],
        "journal": [
          {
            "title": [
              "Molecular medicine reports"
            ],
            "ISOAbbreviation": [
              "Mol Med Rep"
            ],
            "medlineAbbreviation": [
              "Mol Med Rep"
            ],
            "NLMid": [
              "101475259"
            ],
            "ISSN": [
              "1791-2997"
            ],
            "ESSN": [
              "1791-3004"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "3820-3828"
    ],
    "abstractText": [
      "Primary human hepatocytes (PHHs) are the 'gold standard' for investigating hepatitis B virus (HBV) infection and antiviral drugs. However, poor availability, variation between batches and ethical issues regarding PHHs limit their applications. The discovery of human sodium taurocholate co‑transporting polypeptide (hNTCP) as a functional HBV receptor has enabled the development of a surrogate model to supplement the use of PHHs. In the present study, the evolutionary distance of seven species was assessed based on single‑copy homologous genes. Based on the evolutionary distance and availability, PHHs and primary rabbit hepatocytes (PRHs) were isolated and infected with hNTCP‑recombinant lentivirus, and susceptibility to HBV infection in the two cell types was tested and compared. In addition, HBV infection efficiency of hNTCP‑expressing PPHs with pooled HBV‑positive serum and purified particles was determined. The potential use of HBV‑infected hNTCP‑expressing PPHs for drug screening was assessed. The results demonstrated that pigs and rabbits are closer to humans in the divergence tree compared with mice and rats, indicating that pigs and rabbits were more likely to facilitate the HBV post‑entry lifecycle. Following hNTCP complementation and HBV infection, PPHs and Huh7D human hepatocellular carcinoma cells, but not PRHs, exhibited increased hepatitis B surface antigen and hepatitis B e‑antigen secretion, covalently closed circular DNA formation and infectious particle secretion. hNTCP‑expressing PPHs were susceptible to infection with HBV particles purified from pooled HBV‑positive sera, but were poisoned by raw HBV‑positive sera. The use of HBV‑infected hNTCP‑expressing PPHs for viral entry inhibitor screening was revealed to be applicable and reproducible. In conclusion, hNTCP‑expressing PPHs may be valuable tool for investigating HBV infection and antiviral drugs."
    ],
    "affiliation": [
      "Shenzhen Xenotransplantation Research and Development Center, Institute of Translational Medicine, Health Science Center, Shenzhen University School of Medicine, Shenzhen Second People's Hospital, The First Afﬁliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cells, Cultured"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatocytes"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Swine"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Rabbits"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mice"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Rats"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis B virus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis B"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Organic Anion Transporters, Sodium-Dependent"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Symporters"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Microbial Sensitivity Tests"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Species Specificity"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Gene Expression"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "sodium-bile acid cotransporter"
            ],
            "registryNumber": [
              "145420-23-1"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Symporters"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Organic Anion Transporters, Sodium-Dependent"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3892/mmr.2019.10628"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6755163"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6755163?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc-nd"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "hpa"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-02-19"
    ],
    "dateOfCreation": [
      "2019-09-06"
    ],
    "firstIndexDate": [
      "2019-09-06"
    ],
    "fullTextReceivedDate": [
      "2019-10-06"
    ],
    "dateOfRevision": [
      "2020-02-19"
    ],
    "electronicPublicationDate": [
      "2019-08-29"
    ],
    "firstPublicationDate": [
      "2019-08-29"
    ]
  },
  {
    "id": [
      "29899236"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29899236"
    ],
    "pmcid": [
      "PMC6025560"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6025560"
        ]
      }
    ],
    "doi": [
      "10.3390/cancers10060197"
    ],
    "title": [
      "Antiviral Drugs for EBV."
    ],
    "authorString": [
      "Pagano JS, Whitehurst CB, Andrei G."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Pagano JS"
            ],
            "firstName": [
              "Joseph S"
            ],
            "lastName": [
              "Pagano"
            ],
            "initials": [
              "JS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. joseph_pagano@med.unc.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Whitehurst CB"
            ],
            "firstName": [
              "Christopher B"
            ],
            "lastName": [
              "Whitehurst"
            ],
            "initials": [
              "CB"
            ],
            "authorId": [
              {
                "_": "0000-0003-4740-2317",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. cbwhiteh@med.unc.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Andrei G"
            ],
            "firstName": [
              "Graciela"
            ],
            "lastName": [
              "Andrei"
            ],
            "initials": [
              "G"
            ],
            "authorId": [
              {
                "_": "0000-0003-2609-4896",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology and Immunology, University of Leuven, BE-3000 Leuven, Belgium. Graciela.Andrei@rega.kuleuven.be."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-4740-2317",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-2609-4896",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "recommended_reviews",
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "6"
        ],
        "volume": [
          "10"
        ],
        "journalIssueId": [
          "2692326"
        ],
        "dateOfPublication": [
          "2018 Jun"
        ],
        "monthOfPublication": [
          "6"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-06-01"
        ],
        "journal": [
          {
            "title": [
              "Cancers"
            ],
            "ISOAbbreviation": [
              "Cancers (Basel)"
            ],
            "medlineAbbreviation": [
              "Cancers (Basel)"
            ],
            "NLMid": [
              "101526829"
            ],
            "ISSN": [
              "2072-6694"
            ],
            "ESSN": [
              "2072-6694"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "abstractText": [
      "Epstein⁻Barr virus (EBV) infects up to 95% of the adult human population, with primary infection typically occurring during childhood and usually asymptomatic. However, EBV can cause infectious mononucleosis in approximately 35⁻50% cases when infection occurs during adolescence and early adulthood. Epstein⁻Barr virus is also associated with several B-cell malignancies including Burkitt lymphoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disease. A number of antiviral drugs have proven to be effective inhibitors of EBV replication, yet have resulted in limited success clinically, and none of them has been approved for treatment of EBV infections."
    ],
    "affiliation": [
      "Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. joseph_pagano@med.unc.edu."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "discussion",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "P01 CA019014"
            ],
            "agency": [
              "NCI NIH HHS"
            ],
            "acronym": [
              "CA"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Ganciclovir",
          "Acyclovir",
          "Antiviral",
          "Maribavir",
          "Epstein–barr Virus"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/cancers10060197"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6025560"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6025560?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "6"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCreation": [
      "2018-06-15"
    ],
    "firstIndexDate": [
      "2018-06-15"
    ],
    "fullTextReceivedDate": [
      "2018-07-11"
    ],
    "dateOfRevision": [
      "2019-04-26"
    ],
    "electronicPublicationDate": [
      "2018-06-13"
    ],
    "firstPublicationDate": [
      "2018-06-13"
    ]
  },
  {
    "id": [
      "31614784"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31614784"
    ],
    "pmcid": [
      "PMC6843332"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6843332"
        ]
      }
    ],
    "doi": [
      "10.3390/biom9100603"
    ],
    "title": [
      "Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs."
    ],
    "authorString": [
      "Thaljeh LF, Rothschild JA, Naderi M, Coghill LM, Brown JM, Brylinski M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Thaljeh LF"
            ],
            "firstName": [
              "Lana F"
            ],
            "lastName": [
              "Thaljeh"
            ],
            "initials": [
              "LF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. lthalj1@lsu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Rothschild JA"
            ],
            "firstName": [
              "J Ainsley"
            ],
            "lastName": [
              "Rothschild"
            ],
            "initials": [
              "JA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. jroths2@lsu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Naderi M"
            ],
            "firstName": [
              "Misagh"
            ],
            "lastName": [
              "Naderi"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. mnader5@lsu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Coghill LM"
            ],
            "firstName": [
              "Lyndon M"
            ],
            "lastName": [
              "Coghill"
            ],
            "initials": [
              "LM"
            ],
            "authorId": [
              {
                "_": "0000-0002-6258-9194",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. lcoghill@lsu.edu.",
                  "Center for Computation & Technology, Louisiana State University, Baton Rouge, LA 70803, USA. lcoghill@lsu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Brown JM"
            ],
            "firstName": [
              "Jeremy M"
            ],
            "lastName": [
              "Brown"
            ],
            "initials": [
              "JM"
            ],
            "authorId": [
              {
                "_": "0000-0002-1447-8633",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. jembrown@lsu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Brylinski M"
            ],
            "firstName": [
              "Michal"
            ],
            "lastName": [
              "Brylinski"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0002-6204-2869",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. michal@brylinski.org.",
                  "Center for Computation & Technology, Louisiana State University, Baton Rouge, LA 70803, USA. michal@brylinski.org."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-6258-9194",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-1447-8633",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-6204-2869",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "10"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2867035"
        ],
        "dateOfPublication": [
          "2019 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-10-01"
        ],
        "journal": [
          {
            "title": [
              "Biomolecules"
            ],
            "ISOAbbreviation": [
              "Biomolecules"
            ],
            "medlineAbbreviation": [
              "Biomolecules"
            ],
            "NLMid": [
              "101596414"
            ],
            "ISSN": [
              "2218-273X"
            ],
            "ESSN": [
              "2218-273X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "abstractText": [
      "Approximately 80% of adults are infected with a member of the herpesviridae family. Herpesviruses establish life-long latent infections within neurons, which may reactivate into lytic infections due to stress or immune suppression. There are nine human herpesviruses (HHV) posing health concerns from benign conditions to life threatening encephalitis, including cancers associated with viral infections. The current treatment options for most HHV conditions mainly include several nucleoside and nucleotide analogs targeting viral DNA polymerase. Although these drugs help manage infections, their common mechanism of action may lead to the development of drug resistance, which is particularly devastating in immunocompromised patients. Therefore, new classes of drugs directed against novel targets in HHVs are necessary to alleviate this issue. We analyzed the conservation rates of all proteins in herpes simplex virus 1 (HHV-1), a representative of the HHV family and one of the most common viruses infecting the human population. Furthermore, we generated a full-length structure model of the most conserved HHV-1 protein, the DNA packaging terminase pUL15. A series of computational analyses were performed on the model to identify ATP and DNA binding sites and characterize the dynamics of the protein. Our study indicates that proteins involved in HHV-1 DNA packaging and cleavage are amongst the most conserved gene products of HHVs. Since the packaging protein pUL15 is the most conserved among all HHV-1 gene products, the virus will have a lower chance of developing resistance to small molecules targeting pUL15. A subsequent analysis of the structure of pUL15 revealed distinct ATP and DNA binding domains and the elastic network model identifies a functionally important hinge region between the two domains of pUL15. The atomic information on the active and allosteric sites in the ATP- and DNA-bound model of pUL15 presented in this study can inform the structure-based drug discovery of a new class of drugs to treat a wide range of HHVs."
    ],
    "affiliation": [
      "Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. lthalj1@lsu.edu."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article",
          "Research Support, N.I.H., Extramural"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "R35 GM119524"
            ],
            "agency": [
              "NIGMS NIH HHS"
            ],
            "acronym": [
              "GM"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Herpes simplex virus 1",
          "Herpesviruses",
          "Dna Packaging Motor",
          "Hhv-1",
          "Pul15",
          "Dna Packaging Terminase"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/biom9100603"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6843332"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6843332?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen",
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2019-10-17"
    ],
    "firstIndexDate": [
      "2019-10-23"
    ],
    "fullTextReceivedDate": [
      "2019-11-27"
    ],
    "dateOfRevision": [
      "2020-05-05"
    ],
    "electronicPublicationDate": [
      "2019-10-12"
    ],
    "firstPublicationDate": [
      "2019-10-12"
    ]
  },
  {
    "id": [
      "31466307"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31466307"
    ],
    "pmcid": [
      "PMC6780377"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6780377"
        ]
      }
    ],
    "doi": [
      "10.3390/microorganisms7090296"
    ],
    "title": [
      "Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches."
    ],
    "authorString": [
      "Ahammad F, Tengku Abd Rashid TR, Mohamed M, Tanbin S, Ahmad Fuad FA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ahammad F"
            ],
            "firstName": [
              "Foysal"
            ],
            "lastName": [
              "Ahammad"
            ],
            "initials": [
              "F"
            ],
            "authorId": [
              {
                "_": "0000-0001-7313-4729",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biotechnology Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tengku Abd Rashid TR"
            ],
            "firstName": [
              "Tengku Rogayah"
            ],
            "lastName": [
              "Tengku Abd Rashid"
            ],
            "initials": [
              "TR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Virology Unit, Institute for Medical Research, Jalan Pahang, Kuala Lumpur 50588, Malaysia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mohamed M"
            ],
            "firstName": [
              "Maizan"
            ],
            "lastName": [
              "Mohamed"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0001-7783-8950",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, Locked Bag 36, Pengkalan Chepa, Kota Bharu 16100, Kelantan, Malaysia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tanbin S"
            ],
            "firstName": [
              "Suriyea"
            ],
            "lastName": [
              "Tanbin"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biotechnology Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ahmad Fuad FA"
            ],
            "firstName": [
              "Fazia Adyani"
            ],
            "lastName": [
              "Ahmad Fuad"
            ],
            "initials": [
              "FA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biotechnology Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia. fazia_adyani@iium.edu.my."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7313-4729",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-7783-8950",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "9"
        ],
        "volume": [
          "7"
        ],
        "journalIssueId": [
          "2850769"
        ],
        "dateOfPublication": [
          "2019 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-08-01"
        ],
        "journal": [
          {
            "title": [
              "Microorganisms"
            ],
            "ISOAbbreviation": [
              "Microorganisms"
            ],
            "medlineAbbreviation": [
              "Microorganisms"
            ],
            "NLMid": [
              "101625893"
            ],
            "ISSN": [
              "2076-2607"
            ],
            "ESSN": [
              "2076-2607"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "abstractText": [
      "Dengue virus (DENV) is an arboviral human pathogen transmitted through mosquito bite that infects an estimated ~400 million humans (~5% of the global population) annually. To date, no specific therapeutics have been developed that can prevent or treat infections resulting from this pathogen. DENV utilizes numerous host molecules and factors for transcribing the single-stranded ~11 kb positive-sense RNA genome. For example, the glycosylation machinery of the host is required for viral particles to assemble in the endoplasmic reticulum. Since a variety of host factors seem to be utilized by the pathogens, targeting these factors may result in DENV inhibitors, and will play an important role in attenuating the rapid emergence of other flaviviruses. Many experimental studies have yielded findings indicating that host factors facilitate infection, indicating that the focus should be given to targeting the processes contributing to pathogenesis along with many other immune responses. Here, we provide an extensive literature review in order to elucidate the progress made in the development of host-based approaches for DENV viral infections, focusing on host cellular mechanisms and factors responsible for viral replication, aiming to aid the potential development of host-dependent antiviral therapeutics."
    ],
    "affiliation": [
      "Department of Biotechnology Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "FRGS/1/2016/STG04/UIAM/02/1"
            ],
            "agency": [
              "Ministry of Education Malaysia"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral drugs",
          "drug targets",
          "Dengue Virus (Denv)",
          "Arthropod-borne Viruses",
          "Host Metabolism",
          "Denv Inhibitors",
          "Denv Host Factors"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/microorganisms7090296"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6780377"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6780377?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen"
        ]
      }
    ],
    "dateOfCreation": [
      "2019-08-31"
    ],
    "firstIndexDate": [
      "2019-08-30"
    ],
    "fullTextReceivedDate": [
      "2019-11-06"
    ],
    "dateOfRevision": [
      "2019-11-01"
    ],
    "electronicPublicationDate": [
      "2019-08-28"
    ],
    "firstPublicationDate": [
      "2019-08-28"
    ]
  },
  {
    "id": [
      "31595827"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31595827"
    ],
    "pmcid": [
      "PMC6792045"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6792045"
        ]
      }
    ],
    "doi": [
      "10.1080/22221751.2019.1673135"
    ],
    "title": [
      "A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs."
    ],
    "authorString": [
      "Zhang Z, Zhang X, Carr MJ, Zhou H, Li J, Liu S, Liu T, Xing W, Shi W."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhang Z"
            ],
            "firstName": [
              "Zhenjie"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang X"
            ],
            "firstName": [
              "Xingcheng"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China.",
                  "School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Carr MJ"
            ],
            "firstName": [
              "Michael J"
            ],
            "lastName": [
              "Carr"
            ],
            "initials": [
              "MJ"
            ],
            "authorId": [
              {
                "_": "0000-0003-0011-6209",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Virus Reference Laboratory, School of Medicine, University College Dublin , Dublin , Ireland.",
                  "Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University , Sapporo , Japan."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhou H"
            ],
            "firstName": [
              "Hong"
            ],
            "lastName": [
              "Zhou"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Li J"
            ],
            "firstName": [
              "Juan"
            ],
            "lastName": [
              "Li"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu S"
            ],
            "firstName": [
              "Shaoqiong"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu T"
            ],
            "firstName": [
              "Tao"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Obstetrics and Gynecology, Central Hospital of Taian , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xing W"
            ],
            "firstName": [
              "Weijia"
            ],
            "lastName": [
              "Xing"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shi W"
            ],
            "firstName": [
              "Weifeng"
            ],
            "lastName": [
              "Shi"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-0011-6209",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2783040"
        ],
        "dateOfPublication": [
          "2019 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-01-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging microbes & infections"
            ],
            "ISOAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "medlineAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "NLMid": [
              "101594885"
            ],
            "ISSN": [
              "2222-1751"
            ],
            "ESSN": [
              "2222-1751"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "1445-1455"
    ],
    "abstractText": [
      "Coxsackievirus A4 (CVA4) infection can cause hand, foot and mouth disease (HFMD), an epidemic illness affecting neonatal and paediatric cohorts, which can develop to severe neurological disease with high mortality. In this study, we established the first ICR mouse model of CVA4 infection for the evaluation of inactivated vaccines and antiviral drug screening. The CVA4 YT226R strain was selected to infect the neonatal mice and three infectious factors were optimized to establish the infection model. The 3-day-old neonatal mice exhibited clinical symptoms such as hind limb paralysis and death. The severe inflammatory reactions were closely related to the abnormal expression of the acute phase response proinflammatory cytokine IL-6 and an imbalance in the IFN-γ/IL-4 ratio. Importantly, the inactivated CVA4 whole-virus vaccine induced humoral immune responses in adult females and the maternal antibodies afforded mice complete protection against lethal dose challenges of homologous or heterologous CVA4 strains. Both IFN-α2a and antiserum inhibited the replication of CVA4 and increased the survival rates of neonatal mice during the early stages of infection. This neonatal murine model of CVA4 infection will be useful for the development of prophylactic and therapeutic vaccines and for screening of antiviral drugs targeting CVA4 to decrease morbidity and mortality."
    ],
    "affiliation": [
      "Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences , Taian , People's Republic of China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mice, Inbred ICR"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals, Newborn"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mice"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enterovirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hand, Foot and Mouth Disease"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Disease Models, Animal"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Vaccines, Inactivated"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Vaccines"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antibodies, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "BL"
                    ],
                    "qualifierName": [
                      "blood"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Immunization, Passive"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Load"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Evaluation, Preclinical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Female"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunity, Humoral"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antibodies, Neutralizing"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "BL"
                    ],
                    "qualifierName": [
                      "blood"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Inactivated vaccine",
          "Murine model",
          "Antiviral drugs",
          "Hfmd",
          "Coxsackievirus A4"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Viral Vaccines"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antibodies, Viral"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Vaccines, Inactivated"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antibodies, Neutralizing"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/22221751.2019.1673135"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6792045"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6792045?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-02-19"
    ],
    "dateOfCreation": [
      "2019-10-10"
    ],
    "firstIndexDate": [
      "2019-10-11"
    ],
    "fullTextReceivedDate": [
      "2019-11-02"
    ],
    "dateOfRevision": [
      "2020-02-19"
    ],
    "firstPublicationDate": [
      "2019-01-01"
    ]
  },
  {
    "id": [
      "32226028"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32226028"
    ],
    "pmcid": [
      "PMC7145266"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7145266"
        ]
      }
    ],
    "doi": [
      "10.1371/journal.pntd.0008156"
    ],
    "title": [
      "Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: Development of recombinant NS1-based serology and sensitivity to antiviral drugs."
    ],
    "authorString": [
      "Caracciolo I, Mora-Cardenas E, Aloise C, Carletti T, Segat L, Burali MS, Chiarvesio A, Totis V, Avšič-Županc T, Mastrangelo E, Manfroni G, D'Agaro P, Marcello A."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Caracciolo I"
            ],
            "firstName": [
              "Ilaria"
            ],
            "lastName": [
              "Caracciolo"
            ],
            "initials": [
              "I"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Regional Reference Centre for Arbovirus Infections, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mora-Cardenas E"
            ],
            "firstName": [
              "Erick"
            ],
            "lastName": [
              "Mora-Cardenas"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Aloise C"
            ],
            "firstName": [
              "Chiara"
            ],
            "lastName": [
              "Aloise"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Carletti T"
            ],
            "firstName": [
              "Tea"
            ],
            "lastName": [
              "Carletti"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Segat L"
            ],
            "firstName": [
              "Ludovica"
            ],
            "lastName": [
              "Segat"
            ],
            "initials": [
              "L"
            ],
            "authorId": [
              {
                "_": "0000-0002-6024-1485",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Regional Reference Centre for Arbovirus Infections, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.",
                  "Azienda Sanitaria Universitaria Integrata di Trieste, UCO Igiene e Sanità Pubblica, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Burali MS"
            ],
            "firstName": [
              "Maria Sole"
            ],
            "lastName": [
              "Burali"
            ],
            "initials": [
              "MS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Dipartimento di Scienze Farmaceutiche, Università degli Studi di Perugia, Perugia, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Chiarvesio A"
            ],
            "firstName": [
              "Alexsia"
            ],
            "lastName": [
              "Chiarvesio"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro Unico Regionale Produzione Emocomponenti C.U.R.P.E. P.O. Palmanova A.A.S.2 Bassa Friulana Isontina, Palmanova, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Totis V"
            ],
            "firstName": [
              "Vivianna"
            ],
            "lastName": [
              "Totis"
            ],
            "initials": [
              "V"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centro Unico Regionale Produzione Emocomponenti C.U.R.P.E. P.O. Palmanova A.A.S.2 Bassa Friulana Isontina, Palmanova, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Avšič-Županc T"
            ],
            "firstName": [
              "Tatjana"
            ],
            "lastName": [
              "Avšič-Županc"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Diagnostics of Zoonoses and WHO Centre, Institute of Microbiology and Immunology, University of Ljubljana, Ljubljana, Slovenia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mastrangelo E"
            ],
            "firstName": [
              "Eloise"
            ],
            "lastName": [
              "Mastrangelo"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "CNR-Biophysics Institute, University of Milan, Milano, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Manfroni G"
            ],
            "firstName": [
              "Giuseppe"
            ],
            "lastName": [
              "Manfroni"
            ],
            "initials": [
              "G"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Dipartimento di Scienze Farmaceutiche, Università degli Studi di Perugia, Perugia, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "D'Agaro P"
            ],
            "firstName": [
              "Pierlanfranco"
            ],
            "lastName": [
              "D'Agaro"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Regional Reference Centre for Arbovirus Infections, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.",
                  "Azienda Sanitaria Universitaria Integrata di Trieste, UCO Igiene e Sanità Pubblica, Trieste, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Marcello A"
            ],
            "firstName": [
              "Alessandro"
            ],
            "lastName": [
              "Marcello"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0002-8903-8202",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Padriciano, Trieste, Italy."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-6024-1485",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8903-8202",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "14"
        ],
        "journalIssueId": [
          "2918446"
        ],
        "dateOfPublication": [
          "2020 Mar"
        ],
        "monthOfPublication": [
          "3"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-03-01"
        ],
        "journal": [
          {
            "title": [
              "PLoS neglected tropical diseases"
            ],
            "ISOAbbreviation": [
              "PLoS Negl Trop Dis"
            ],
            "medlineAbbreviation": [
              "PLoS Negl Trop Dis"
            ],
            "NLMid": [
              "101291488"
            ],
            "ISSN": [
              "1935-2727"
            ],
            "ESSN": [
              "1935-2735"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "e0008156"
    ],
    "abstractText": [
      "Surveillance of Usutu virus is crucial to prevent future outbreaks both in Europe and in other countries currently naïve to the infection, such as the Americas. This goal remains difficult to achieve, notably because of the lack of large-scale cohort studies and the absence of commercially available diagnostic reagents for USUV. This work started with the first identification of USUV in a blood donor in the Friuli Venezia Giulia (FVG) Region in Northern-Eastern Italy, which is endemic for West Nile virus. Considering that only one IgG ELISA is commercially available, but none for IgM, a novel NS1 antigen based IgG/M ELISA has been developed. This assay tested successfully for the detection of Usutu virus in blood donors with the identification of a second case of transmission and high levels of exposure. Furthermore, two pan-flavivirus antiviral drugs, that we previously characterized to be inhibitors of other flavivirus infectivity, were successfully tested for inhibition of Usutu virus with inhibitory concentrations in the low micromolar range. To conclude, this work identifies North-Eastern Italy as endemic for Usutu virus with implications for the screening of transfusion blood. A novel NS1-based ELISA test has been implemented for the detection of IgM/G that will be of importance as a tool for the diagnosis and surveillance of Usutu virus infection. Finally, Usutu virus is shown to be sensitive to a class of promising pan-flavivirus drugs."
    ],
    "affiliation": [
      "Regional Reference Centre for Arbovirus Infections, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Blood"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Flavivirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IP"
                    ],
                    "qualifierName": [
                      "isolation & purification"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Flavivirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DI"
                    ],
                    "qualifierName": [
                      "diagnosis"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunoglobulin G"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "BL"
                    ],
                    "qualifierName": [
                      "blood"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunoglobulin M"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "BL"
                    ],
                    "qualifierName": [
                      "blood"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Nonstructural Proteins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antibodies, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "BL"
                    ],
                    "qualifierName": [
                      "blood"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enzyme-Linked Immunosorbent Assay"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Serologic Tests"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Neutralization Tests"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Microbial Sensitivity Tests"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Blood Donors"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Italy"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Female"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "NS1 protein, Flavivirus"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antibodies, Viral"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Immunoglobulin G"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Immunoglobulin M"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Viral Nonstructural Proteins"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1371/journal.pntd.0008156"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7145266"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7145266?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen",
          "doi"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-05-13"
    ],
    "dateOfCreation": [
      "2020-04-01"
    ],
    "firstIndexDate": [
      "2020-04-01"
    ],
    "fullTextReceivedDate": [
      "2020-04-23"
    ],
    "dateOfRevision": [
      "2020-05-13"
    ],
    "electronicPublicationDate": [
      "2020-03-30"
    ],
    "firstPublicationDate": [
      "2020-03-30"
    ]
  },
  {
    "id": [
      "29523062"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29523062"
    ],
    "pmcid": [
      "PMC7087576"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7087576"
        ]
      }
    ],
    "doi": [
      "10.1134/s0006297917130041"
    ],
    "title": [
      "Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs."
    ],
    "authorString": [
      "Nikonov OS, Chernykh ES, Garber MB, Nikonova EY."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Nikonov OS"
            ],
            "firstName": [
              "O S"
            ],
            "lastName": [
              "Nikonov"
            ],
            "initials": [
              "OS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia. katya_nik@vega.protres.ru."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Chernykh ES"
            ],
            "firstName": [
              "E S"
            ],
            "lastName": [
              "Chernykh"
            ],
            "initials": [
              "ES"
            ]
          },
          {
            "fullName": [
              "Garber MB"
            ],
            "firstName": [
              "M B"
            ],
            "lastName": [
              "Garber"
            ],
            "initials": [
              "MB"
            ]
          },
          {
            "fullName": [
              "Nikonova EY"
            ],
            "firstName": [
              "E Yu"
            ],
            "lastName": [
              "Nikonova"
            ],
            "initials": [
              "EY"
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "13"
        ],
        "volume": [
          "82"
        ],
        "journalIssueId": [
          "2660329"
        ],
        "dateOfPublication": [
          "2017 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-12-01"
        ],
        "journal": [
          {
            "title": [
              "Biochemistry. Biokhimiia"
            ],
            "ISOAbbreviation": [
              "Biochemistry Mosc."
            ],
            "medlineAbbreviation": [
              "Biochemistry (Mosc)"
            ],
            "NLMid": [
              "0376536"
            ],
            "ISSN": [
              "0006-2979"
            ],
            "ESSN": [
              "1608-3040"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "1615-1631"
    ],
    "abstractText": [
      "The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenicity motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical manifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined."
    ],
    "affiliation": [
      "Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region, 142290, Russia. katya_nik@vega.protres.ru."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enterovirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "CL"
                    ],
                    "qualifierName": [
                      "classification"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PY"
                    ],
                    "qualifierName": [
                      "pathogenicity"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enterovirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DI"
                    ],
                    "qualifierName": [
                      "diagnosis"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Internal Ribosome Entry Sites"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Internal Ribosome Entry Sites"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1134/S0006297917130041"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7087576"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7087576?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "3"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2018-03-23"
    ],
    "dateOfCreation": [
      "2018-03-11"
    ],
    "firstIndexDate": [
      "2018-03-11"
    ],
    "fullTextReceivedDate": [
      "2020-03-26"
    ],
    "dateOfRevision": [
      "2020-03-25"
    ],
    "firstPublicationDate": [
      "2017-12-01"
    ]
  },
  {
    "id": [
      "29292156"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29292156"
    ],
    "pmcid": [
      "PMC7127693"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7127693"
        ]
      }
    ],
    "doi": [
      "10.1016/j.biotechadv.2017.12.016"
    ],
    "title": [
      "In vitro methods for testing antiviral drugs."
    ],
    "authorString": [
      "Rumlová M, Ruml T."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Rumlová M"
            ],
            "firstName": [
              "Michaela"
            ],
            "lastName": [
              "Rumlová"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biotechnology, University of Chemistry and Technology, Prague 166 28, Czech Republic. Electronic address: michaela.rumlova@vscht.cz."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ruml T"
            ],
            "firstName": [
              "Tomáš"
            ],
            "lastName": [
              "Ruml"
            ],
            "initials": [
              "T"
            ],
            "authorId": [
              {
                "_": "0000-0002-5698-4366",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague 166 28, Czech Republic. Electronic address: tomas.ruml@vscht.cz."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-5698-4366",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "36"
        ],
        "journalIssueId": [
          "2683549"
        ],
        "dateOfPublication": [
          "2018 May - Jun"
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-05-01"
        ],
        "journal": [
          {
            "title": [
              "Biotechnology advances"
            ],
            "ISOAbbreviation": [
              "Biotechnol. Adv."
            ],
            "medlineAbbreviation": [
              "Biotechnol Adv"
            ],
            "NLMid": [
              "8403708"
            ],
            "ISSN": [
              "0734-9750"
            ],
            "ESSN": [
              "1873-1899"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "pageInfo": [
      "557-576"
    ],
    "abstractText": [
      "Despite successful vaccination programs and effective treatments for some viral infections, humans are still losing the battle with viruses. Persisting human pandemics, emerging and re-emerging viruses, and evolution of drug-resistant strains impose continuous search for new antiviral drugs. A combination of detailed information about the molecular organization of viruses and progress in molecular biology and computer technologies has enabled rational antivirals design. Initial step in establishing efficacy of new antivirals is based on simple methods assessing inhibition of the intended target. We provide here an overview of biochemical and cell-based assays evaluating the activity of inhibitors of clinically important viruses."
    ],
    "affiliation": [
      "Department of Biotechnology, University of Chemistry and Technology, Prague 166 28, Czech Republic. Electronic address: michaela.rumlova@vscht.cz."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Capsid"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enzyme Inhibitors"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Evaluation, Preclinical"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Internalization"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Host-Pathogen Interactions"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Physiological Phenomena"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "High-Throughput Screening Assays"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "In vitro",
          "Assembly",
          "Virus",
          "Inhibitor",
          "Method",
          "Assay",
          "Replication",
          "High-throughput screening",
          "Entry",
          "Cell-based"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Enzyme Inhibitors"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.biotechadv.2017.12.016"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7127693"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7127693?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "4"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2019-02-21"
    ],
    "dateOfCreation": [
      "2018-01-03"
    ],
    "firstIndexDate": [
      "2018-01-03"
    ],
    "fullTextReceivedDate": [
      "2020-04-12"
    ],
    "dateOfRevision": [
      "2020-04-09"
    ],
    "electronicPublicationDate": [
      "2017-12-29"
    ],
    "firstPublicationDate": [
      "2017-12-29"
    ]
  },
  {
    "id": [
      "29587409"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29587409"
    ],
    "pmcid": [
      "PMC6027266"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6027266"
        ]
      }
    ],
    "doi": [
      "10.3390/pharmaceutics10020039"
    ],
    "title": [
      "Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?"
    ],
    "authorString": [
      "Dalpiaz A, Pavan B."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Dalpiaz A"
            ],
            "firstName": [
              "Alessandro"
            ],
            "lastName": [
              "Dalpiaz"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical and Pharmaceutical Sciences, University of Ferrara, 44121 Ferrara, Italy. dla@unife.it."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Pavan B"
            ],
            "firstName": [
              "Barbara"
            ],
            "lastName": [
              "Pavan"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biomedical and Specialist Surgical Sciences, University of Ferrara, 44121 Ferrara, Italy. pvnbbr@unife.it."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "2"
        ],
        "volume": [
          "10"
        ],
        "journalIssueId": [
          "2663654"
        ],
        "dateOfPublication": [
          "2018 Mar"
        ],
        "monthOfPublication": [
          "3"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-03-01"
        ],
        "journal": [
          {
            "title": [
              "Pharmaceutics"
            ],
            "ISOAbbreviation": [
              "Pharmaceutics"
            ],
            "medlineAbbreviation": [
              "Pharmaceutics"
            ],
            "NLMid": [
              "101534003"
            ],
            "ISSN": [
              "1999-4923"
            ],
            "ESSN": [
              "1999-4923"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "abstractText": [
      "Although several viruses can easily infect the central nervous system (CNS), antiviral drugs often show dramatic difficulties in penetrating the brain from the bloodstream since they are substrates of active efflux transporters (AETs). These transporters, located in the physiological barriers between blood and the CNS and in macrophage membranes, are able to recognize their substrates and actively efflux them into the bloodstream. The active transporters currently known to efflux antiviral drugs are P-glycoprotein (ABCB1 or P-gp or MDR1), multidrug resistance-associated proteins (ABCC1 or MRP1, ABCC4 or MRP4, ABCC5 or MRP5), and breast cancer resistance protein (ABCG2 or BCRP). Inhibitors of AETs may be considered, but their co-administration causes serious unwanted effects. Nasal administration of antiviral drugs is therefore proposed in order to overcome the aforementioned problems, but innovative devices, formulations (thermoreversible gels, polymeric micro- and nano-particles, solid lipid microparticles, nanoemulsions), absorption enhancers (chitosan, papaverine), and mucoadhesive agents (chitosan, polyvinilpyrrolidone) are required in order to selectively target the antiviral drugs and, possibly, the AET inhibitors in the CNS. Moreover, several prodrugs of antiretroviral agents can inhibit or elude the AET systems, appearing as interesting substrates for innovative nasal formulations able to target anti-Human Immunodeficiency Virus (HIV) agents into macrophages of the CNS, which are one of the most important HIV Sanctuaries of the body."
    ],
    "affiliation": [
      "Department of Chemical and Pharmaceutical Sciences, University of Ferrara, 44121 Ferrara, Italy. dla@unife.it."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Virus",
          "Antiretroviral Drug",
          "Polymeric Nanoparticles",
          "Nano-emulsion",
          "Solid Lipid Microparticles",
          "Active Efflux Transporter",
          "Thermoreversible Gel",
          "Polymeric Microparticles",
          "Hiv Sanctuaries",
          "Nasal Formulation"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/pharmaceutics10020039"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6027266"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6027266?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "2"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2018-03-29"
    ],
    "firstIndexDate": [
      "2018-03-28"
    ],
    "fullTextReceivedDate": [
      "2018-07-15"
    ],
    "dateOfRevision": [
      "2018-07-15"
    ],
    "electronicPublicationDate": [
      "2018-03-26"
    ],
    "firstPublicationDate": [
      "2018-03-26"
    ]
  },
  {
    "id": [
      "30932009"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "30932009"
    ],
    "pmcid": [
      "PMC6444013"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6444013"
        ]
      }
    ],
    "doi": [
      "10.1038/s41598-019-41998-1"
    ],
    "title": [
      "Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs."
    ],
    "authorString": [
      "Sáez-Álvarez Y, Arias A, Del Águila C, Agudo R."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Sáez-Álvarez Y"
            ],
            "firstName": [
              "Yanira"
            ],
            "lastName": [
              "Sáez-Álvarez"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, 28668, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Arias A"
            ],
            "firstName": [
              "Armando"
            ],
            "lastName": [
              "Arias"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0002-4138-4608",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Life Science & Bioengineering Building, Technical University of Denmark, 2800, Kongens Lyngby, Denmark."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Del Águila C"
            ],
            "firstName": [
              "Carmen"
            ],
            "lastName": [
              "Del Águila"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, 28668, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Agudo R"
            ],
            "firstName": [
              "Rubén"
            ],
            "lastName": [
              "Agudo"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, 28668, Spain. ruben.agudotorres@ceu.es."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-4138-4608",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2799475"
        ],
        "dateOfPublication": [
          "2019 Apr"
        ],
        "monthOfPublication": [
          "4"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-04-01"
        ],
        "journal": [
          {
            "title": [
              "Scientific reports"
            ],
            "ISOAbbreviation": [
              "Sci Rep"
            ],
            "medlineAbbreviation": [
              "Sci Rep"
            ],
            "NLMid": [
              "101563288"
            ],
            "ISSN": [
              "2045-2322"
            ],
            "ESSN": [
              "2045-2322"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "5397"
    ],
    "abstractText": [
      "Zika virus (ZIKV) is an emerging pathogen that has been associated with large numbers of cases of severe neurologic disease, including Guillain-Barré syndrome and microcephaly. Despite its recent establishment as a serious global public health concern there are no licensed therapeutics to control this virus. Accordingly, there is an urgent need to develop methods for the high-throughput screening of antiviral agents. We describe here a fluorescence-based method to monitor the real-time polymerization activity of Zika virus RNA-dependent RNA polymerase (RdRp). By using homopolymeric RNA template molecules, de novo RNA synthesis can be detected with a fluorescent dye, which permits the specific quantification and kinetics of double-strand RNA formation. ZIKV RdRp activity detected using this fluorescence-based assay positively correlated with traditional assays measuring the incorporation of radiolabeled nucleotides. We also validated this method as a suitable assay for the identification of ZIKV inhibitors targeting the viral polymerase using known broad-spectrum inhibitors. The assay was also successfully adapted to detect RNA polymerization activity by different RdRps, illustrated here using purified RdRps from hepatitis C virus and foot-and-mouth disease virus. The potential of fluorescence-based approaches for the enzymatic characterization of viral polymerases, as well as for high-throughput screening of antiviral drugs, are discussed."
    ],
    "affiliation": [
      "Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, 28668, Spain."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1038/s41598-019-41998-1"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6444013"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6444013?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2019-04-02"
    ],
    "firstIndexDate": [
      "2019-04-02"
    ],
    "fullTextReceivedDate": [
      "2019-04-08"
    ],
    "dateOfRevision": [
      "2020-04-01"
    ],
    "electronicPublicationDate": [
      "2019-04-01"
    ],
    "firstPublicationDate": [
      "2019-04-01"
    ]
  },
  {
    "id": [
      "PMC7149606"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7149606"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7149606"
        ]
      }
    ],
    "title": [
      "Antiviral Drugs for Acute Infections."
    ],
    "authorString": [
      "Powell KL, Thomas E, Cockerill GS."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Powell KL"
            ],
            "firstName": [
              "K.L."
            ],
            "lastName": [
              "Powell"
            ],
            "initials": [
              "KL"
            ]
          },
          {
            "fullName": [
              "Thomas E"
            ],
            "firstName": [
              "E."
            ],
            "lastName": [
              "Thomas"
            ],
            "initials": [
              "E"
            ]
          },
          {
            "fullName": [
              "Cockerill GS"
            ],
            "firstName": [
              "G.S."
            ],
            "lastName": [
              "Cockerill"
            ],
            "initials": [
              "GS"
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2941873"
        ],
        "dateOfPublication": [
          "2017 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-01-01"
        ],
        "journal": [
          {
            "title": [
              "Comprehensive Medicinal Chemistry III"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "665-681"
    ],
    "abstractText": [
      "After the great success of the research and development of antiviral drugs to treat chronic infections like HIV and hepatitis C, attention is turning to treatment of acute viral infections. In this article, we illustrate the potential for developing antiviral drugs to treat such infections. Four distinct clinical problems caused by four different viruses allow exploration of the problems associated with each disease. Targets for each virus are evaluated, and the progress made to date in identifying suitable clinical candidates is discussed. Finally, we consider the problem of emerging acute virus infections and improving rapidity of responses to them."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "chapter-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Protease",
          "Drug design",
          "Paramyxoviruses",
          "RNA polymerase",
          "Neuraminidase",
          "Adenovirus",
          "DNA polymerase",
          "Influenza Virus",
          "Rhinovirus",
          "Capsid Binding",
          "Infant Respiratory Infections",
          "Virus-induced Fusion",
          "Emerging Virus Infection",
          "Virus Challenge Studies"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149606/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7149606"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-04-16"
    ],
    "firstIndexDate": [
      "2020-04-16"
    ],
    "fullTextReceivedDate": [
      "2020-04-15"
    ],
    "dateOfRevision": [
      "2020-04-16"
    ],
    "electronicPublicationDate": [
      "2017-06-13"
    ],
    "firstPublicationDate": [
      "2017-06-13"
    ]
  },
  {
    "id": [
      "31908501"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31908501"
    ],
    "pmcid": [
      "PMC6925545"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6925545"
        ]
      }
    ],
    "doi": [
      "10.2147/idr.s224291"
    ],
    "title": [
      "Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein-Barr Virus Reactivation."
    ],
    "authorString": [
      "Czyzewski K, Dziedzic M, Salamonowicz M, Fraczkiewicz J, Zajac-Spychala O, Zaucha-Prazmo A, Gozdzik J, Galazka P, Bartoszewicz N, Demidowicz E, Styczynski J."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Czyzewski K"
            ],
            "firstName": [
              "Krzysztof"
            ],
            "lastName": [
              "Czyzewski"
            ],
            "initials": [
              "K"
            ],
            "authorId": [
              {
                "_": "0000-0001-7704-7518",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dziedzic M"
            ],
            "firstName": [
              "Magdalena"
            ],
            "lastName": [
              "Dziedzic"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Salamonowicz M"
            ],
            "firstName": [
              "Malgorzata"
            ],
            "lastName": [
              "Salamonowicz"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Transplantation, Oncology and Hematology, Medical University, Wroclaw, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Fraczkiewicz J"
            ],
            "firstName": [
              "Jowita"
            ],
            "lastName": [
              "Fraczkiewicz"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0002-8467-8788",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Transplantation, Oncology and Hematology, Medical University, Wroclaw, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zajac-Spychala O"
            ],
            "firstName": [
              "Olga"
            ],
            "lastName": [
              "Zajac-Spychala"
            ],
            "initials": [
              "O"
            ],
            "authorId": [
              {
                "_": "0000-0002-8836-8605",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zaucha-Prazmo A"
            ],
            "firstName": [
              "Agnieszka"
            ],
            "lastName": [
              "Zaucha-Prazmo"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical University, Lublin, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gozdzik J"
            ],
            "firstName": [
              "Jolanta"
            ],
            "lastName": [
              "Gozdzik"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Stem Cell Transplant Center, University Children's Hospital, Department of Clinical Immunology and Transplantology, Jagiellonian University Collegium Medicum, Krakow, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Galazka P"
            ],
            "firstName": [
              "Przemyslaw"
            ],
            "lastName": [
              "Galazka"
            ],
            "initials": [
              "P"
            ],
            "authorId": [
              {
                "_": "0000-0002-8227-8350",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of General and Oncological Surgery for Children and Adolescents, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bartoszewicz N"
            ],
            "firstName": [
              "Natalia"
            ],
            "lastName": [
              "Bartoszewicz"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Demidowicz E"
            ],
            "firstName": [
              "Ewa"
            ],
            "lastName": [
              "Demidowicz"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Styczynski J"
            ],
            "firstName": [
              "Jan"
            ],
            "lastName": [
              "Styczynski"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0002-3158-119X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7704-7518",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8467-8788",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8836-8605",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8227-8350",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-3158-119X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2762066"
        ],
        "dateOfPublication": [
          "2019 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-01-01"
        ],
        "journal": [
          {
            "title": [
              "Infection and drug resistance"
            ],
            "ISOAbbreviation": [
              "Infect Drug Resist"
            ],
            "medlineAbbreviation": [
              "Infect Drug Resist"
            ],
            "NLMid": [
              "101550216"
            ],
            "ISSN": [
              "1178-6973"
            ],
            "ESSN": [
              "1178-6973"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "3893-3902"
    ],
    "abstractText": [
      "Objective:The analysis of epidemiology, risk factors and outcome of viral infections in children and adolescents after hematopoietic cell transplantation (HCT). Methods:In this multicenter nationwide study a total of 971 HCT procedures (741 allo-HCT; 230 auto-HCT) over a period of 6 years were analyzed. Results:During this period 801 episodes of viral infections were diagnosed in 442 patients. The incidence of viral infections was 57.9% in allo-HCT and 4.8% in auto-HCT patients. The most frequent infections after allo-HCT were caused by cytomegalovirus (CMV), polyoma BK virus (BKV) and Epstein-Barr virus (EBV). The majority of infections occurred within the first 4 months after allo-HCT and over 80% required pharmacotherapy or symptomatic therapy. The median time of treatment of specific viral infection ranged from 7 (for EBV) to 24 (for CMV) days. The highest mortality was observed in case of CMV infection. The risk factors for viral infections were allo-HCT, acute leukemia, acute and chronic graft versus host disease (a/cGVHD), and matched unrelated donor (MUD)/mismatched unrelated donor (MMUD)-HCT. The risk factor for death from viral infection were CMV-IgG seropositivity in acute lymphoblastic leukemia recipient, and MUD/MMUD-HCT. The incidence of EBV infection requiring pre-emptive treatment with rituximab in allo-HCT children was 19.3%. In 30.8% cases of EBV infection, these episodes were preceded by other viral infection and treated with antivirals, which did not prevent development of EBV-DNA-emia with need of rituximab treatment in 81.5% cases. In 47.7% of these cases, GVHD was a factor enabling development of significant EBV-DNA-emia during antiviral therapy of other infection. Conclusion:We have shown that antiviral drugs do not prevent EBV reactivation in allo-HCT pediatric patients."
    ],
    "affiliation": [
      "Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Children",
          "EBV",
          "Viral Infections",
          "Infectious Complications",
          "Hct",
          "Risk Factors Analysis"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.2147/IDR.S224291"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6925545"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6925545?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-01-08"
    ],
    "firstIndexDate": [
      "2020-01-16"
    ],
    "fullTextReceivedDate": [
      "2020-07-11"
    ],
    "dateOfRevision": [
      "2020-01-09"
    ],
    "electronicPublicationDate": [
      "2019-12-17"
    ],
    "firstPublicationDate": [
      "2019-12-17"
    ]
  },
  {
    "id": [
      "30976183"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "30976183"
    ],
    "pmcid": [
      "PMC6439212"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6439212"
        ]
      }
    ],
    "doi": [
      "10.1016/j.jsps.2018.12.008"
    ],
    "title": [
      "Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study."
    ],
    "authorString": [
      "Parvez MK, Tabish Rehman M, Alam P, Al-Dosari MS, Alqasoumi SI, Alajmi MF."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Parvez MK"
            ],
            "firstName": [
              "Mohammad K"
            ],
            "lastName": [
              "Parvez"
            ],
            "initials": [
              "MK"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tabish Rehman M"
            ],
            "firstName": [
              "Md"
            ],
            "lastName": [
              "Tabish Rehman"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alam P"
            ],
            "firstName": [
              "Perwez"
            ],
            "lastName": [
              "Alam"
            ],
            "initials": [
              "P"
            ],
            "authorId": [
              {
                "_": "0000-0003-0668-2236",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Al-Dosari MS"
            ],
            "firstName": [
              "Mohammed S"
            ],
            "lastName": [
              "Al-Dosari"
            ],
            "initials": [
              "MS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alqasoumi SI"
            ],
            "firstName": [
              "Saleh I"
            ],
            "lastName": [
              "Alqasoumi"
            ],
            "initials": [
              "SI"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alajmi MF"
            ],
            "firstName": [
              "Mohammed F"
            ],
            "lastName": [
              "Alajmi"
            ],
            "initials": [
              "MF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-0668-2236",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "27"
        ],
        "journalIssueId": [
          "2805548"
        ],
        "dateOfPublication": [
          "2019 Mar"
        ],
        "monthOfPublication": [
          "3"
        ],
        "yearOfPublication": [
          "2019"
        ],
        "printPublicationDate": [
          "2019-03-01"
        ],
        "journal": [
          {
            "title": [
              "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society"
            ],
            "ISOAbbreviation": [
              "Saudi Pharm J"
            ],
            "medlineAbbreviation": [
              "Saudi Pharm J"
            ],
            "NLMid": [
              "9705695"
            ],
            "ISSN": [
              "1319-0164"
            ],
            "ESSN": [
              "2213-7475"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2019"
    ],
    "pageInfo": [
      "389-400"
    ],
    "abstractText": [
      "Despite high anti-HBV efficacies, while the nucleoside analogs (e.g., lamivudine) lead to the emergence of drug-resistance, interferons (e.g., IFN-α causes adverse side-effects. Comparatively, various natural or plant products have shown similar or even better efficacy. Hence, new antiviral strategies must focus not only on synthetic molecules but also on potential natural compounds. In this report, we have combined the in vitro cell culture and in silico molecular docking methods to assess the novel anti-HBV activity and delineate the inhibitory mechanism of selected plant-derived pure compounds of different classes. Of the tested (2.5-50 μg/ml) twelve non-cytotoxic compounds, ten (10 μg/ml) were found to maximally inhibit HBsAg production at day 5. Compared to quercetin (73%), baccatin III (71%), psoralen (67%), embelin (65%), menisdaurin (64%) and azadirachtin (62%) that showed high inhibition of HBeAg synthesis, lupeol (52%), rutin (47%), β-sitosterol (43%) and hesperidin (41%) had moderate efficacies against HBV replication. Further assessment of quercetin in combination with the highly active compounds, enhanced its anti-HBV activity up to 10%. Being the most important drug target, a 3-D structure of HBV polymerase (Pol/RT) was modeled and docked with the active compounds, including lamivudine as standard. Docking of lamivudine indicated strong interaction with the modeled HBV Pol active-site residues that formed stable complex (∆G = -5.2 kcal/mol). Similarly, all the docked antiviral compounds formed very stable complexes with HBV Pol (∆G = -6.1 to -9.3 kcal/mol). Taken together, our data suggest the anti-HBV potential of the tested natural compounds as novel viral Pol/RT inhibitors."
    ],
    "affiliation": [
      "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Hepatitis B virus",
          "Molecular docking",
          "Antiviral",
          "Keywords",
          "Natural Compounds",
          "Hbv Polymerase",
          "Pol/rt Inhibitors"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.jsps.2018.12.008"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6439212"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6439212?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "4"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc-nd"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen",
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2019-04-13"
    ],
    "firstIndexDate": [
      "2019-04-13"
    ],
    "fullTextReceivedDate": [
      "2019-04-14"
    ],
    "dateOfRevision": [
      "2019-04-14"
    ],
    "electronicPublicationDate": [
      "2018-12-26"
    ],
    "firstPublicationDate": [
      "2018-12-26"
    ]
  },
  {
    "id": [
      "PMC7149618"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7149618"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7149618"
        ]
      }
    ],
    "title": [
      "Antiviral Drugs"
    ],
    "authorString": [
      "Vardanyan R, Hruby V."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Vardanyan R"
            ],
            "firstName": [
              "Ruben"
            ],
            "lastName": [
              "Vardanyan"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hruby V"
            ],
            "firstName": [
              "Victor"
            ],
            "lastName": [
              "Hruby"
            ],
            "initials": [
              "V"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3023674"
        ],
        "dateOfPublication": [
          "2016 Jan"
        ],
        "monthOfPublication": [
          "1"
        ],
        "yearOfPublication": [
          "2016"
        ],
        "printPublicationDate": [
          "2016-01-01"
        ],
        "journal": [
          {
            "title": [
              "Synthesis of Best-Seller Drugs"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2016"
    ],
    "pageInfo": [
      "687-736"
    ],
    "abstractText": [
      "Viruses are major pathogenic agents causing a variety of serious diseases in humans, other animals, and plants. Drugs that combat viral infections are called antiviral drugs. There are no effective antiviral drugs for many viral infections. However, there are several drugs for influenza, a couple of drugs for herpesviruses, and some new antiviral drugs for treatment of HIV and hepatitis C infections. The arsenal of antivirals is complex. As of March 2014, it consists of approximately 50 drugs approved by the FDA, approximately half of which are directed against HIV. Antiviral drug creation strategies are focused on two different approaches: targeting the viruses themselves or targeting host cell factors. Direct virus-targeting antiviral drugs include attachment inhibitors, entry inhibitors, uncoating inhibitors, protease inhibitors, polymerase inhibitors, nucleoside and nucleotide reverse transcriptase inhibitors, nonnucleoside reverse-transcriptase inhibitors, and integrase inhibitors. Protease inhibitors (darunavir, atazanavir, and ritonavir), viral DNA polymerase inhibitors (acyclovir, valacyclovir, valganciclovir, and tenofovir), and an integrase inhibitor (raltegravir) are included in the list of Top 200 Drugs by sales for the 2010s."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "chapter-article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Protease inhibitors",
          "Integrase Inhibitors",
          "Nonnucleoside Reverse-transcriptase Inhibitors",
          "Polymerase Inhibitors",
          "Entry Inhibitors",
          "Attachment Inhibitors",
          "Nucleoside And Nucleotide Reverse-transcriptase Inhibitors",
          "Uncoating Inhibitors"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149618/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149618/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7149618"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7149618?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-07-11"
    ],
    "firstIndexDate": [
      "2020-04-16"
    ],
    "fullTextReceivedDate": [
      "2020-07-11"
    ],
    "dateOfRevision": [
      "2020-09-30"
    ],
    "electronicPublicationDate": [
      "2016-01-01"
    ],
    "firstPublicationDate": [
      "2016-01-01"
    ]
  },
  {
    "id": [
      "29018267"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29018267"
    ],
    "pmcid": [
      "PMC7091927"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7091927"
        ]
      }
    ],
    "doi": [
      "10.1038/ja.2017.115"
    ],
    "title": [
      "Current landscape and future prospects of antiviral drugs derived from microbial products."
    ],
    "authorString": [
      "Takizawa N, Yamasaki M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Takizawa N"
            ],
            "firstName": [
              "Naoki"
            ],
            "lastName": [
              "Takizawa"
            ],
            "initials": [
              "N"
            ],
            "authorId": [
              {
                "_": "0000-0002-3714-2219",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Virology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yamasaki M"
            ],
            "firstName": [
              "Manabu"
            ],
            "lastName": [
              "Yamasaki"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Virology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-3714-2219",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2606908"
        ],
        "dateOfPublication": [
          "2017 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-10-01"
        ],
        "journal": [
          {
            "title": [
              "The Journal of antibiotics"
            ],
            "ISOAbbreviation": [
              "J. Antibiot."
            ],
            "medlineAbbreviation": [
              "J Antibiot (Tokyo)"
            ],
            "NLMid": [
              "0151115"
            ],
            "ISSN": [
              "0021-8820"
            ],
            "ESSN": [
              "1881-1469"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "abstractText": [
      "Viral infections are a major global health threat. Over the last 50 years, significant efforts have been devoted to the development of antiviral drugs and great success has been achieved for some viruses. However, other virus infections, such as epidemic influenza, still spread globally and new threats continue to arise from emerging and re-emerging viruses and drug-resistant viruses. In this review, the contributions of microbial products isolated in Institute of Microbial Chemistry for antiviral research are summarized. In addition, the current state of development of antiviral drugs that target influenza virus and hepatitis B virus, and the future prospects for antivirals from natural products are described and discussed.The Journal of Antibiotics advance online publication, 11 October 2017; doi:10.1038/ja.2017.115."
    ],
    "affiliation": [
      "Laboratory of Virology, Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1038/ja.2017.115"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7091927"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7091927?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "3"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2017-10-12"
    ],
    "firstIndexDate": [
      "2017-10-12"
    ],
    "fullTextReceivedDate": [
      "2020-03-26"
    ],
    "dateOfRevision": [
      "2020-03-25"
    ],
    "electronicPublicationDate": [
      "2017-10-11"
    ],
    "firstPublicationDate": [
      "2017-10-11"
    ]
  },
  {
    "id": [
      "29677162"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29677162"
    ],
    "pmcid": [
      "PMC5923505"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5923505"
        ]
      }
    ],
    "doi": [
      "10.3390/v10040211"
    ],
    "title": [
      "Gemcitabine and Nucleos(t)ide Synthesis Inhibitors Are Broad-Spectrum Antiviral Drugs that Activate Innate Immunity."
    ],
    "authorString": [
      "Shin HJ, Kim C, Cho S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Shin HJ"
            ],
            "firstName": [
              "Hye Jin"
            ],
            "lastName": [
              "Shin"
            ],
            "initials": [
              "HJ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon-si 34114, Korea. shinhy@krict.re.kr."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kim C"
            ],
            "firstName": [
              "Chonsaeng"
            ],
            "lastName": [
              "Kim"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon-si 34114, Korea. chonskim@krict.re.kr."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Cho S"
            ],
            "firstName": [
              "Sungchan"
            ],
            "lastName": [
              "Cho"
            ],
            "initials": [
              "S"
            ],
            "authorId": [
              {
                "_": "0000-0001-7627-978X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Anticancer Agent Research Center, Korea Research Institute of Bioscience & Biotechnology, 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungbuk 28116, Korea. sungchan@kribb.re.kr.",
                  "Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon-si 34113, Korea. sungchan@kribb.re.kr."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7627-978X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "4"
        ],
        "volume": [
          "10"
        ],
        "journalIssueId": [
          "2668122"
        ],
        "dateOfPublication": [
          "2018 Apr"
        ],
        "monthOfPublication": [
          "4"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-04-01"
        ],
        "journal": [
          {
            "title": [
              "Viruses"
            ],
            "ISOAbbreviation": [
              "Viruses"
            ],
            "medlineAbbreviation": [
              "Viruses"
            ],
            "NLMid": [
              "101509722"
            ],
            "ISSN": [
              "1999-4915"
            ],
            "ESSN": [
              "1999-4915"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "abstractText": [
      "Nucleoside analogs have been frequently identified as antiviral agents. In recent years, gemcitabine, a cytidine analog in clinical use for the treatment of many solid tumors, was also shown to have antiviral activity against a broad range of viruses. Nucleoside analogs generally interfere with cellular nucleos(t)ide synthesis pathways, resulting in the depletion or imbalance of (d)NTP pools. Intriguingly, a few recent reports have shown that some nucleoside analogs, including gemcitabine, activated innate immunity, inducing the expression of interferon-stimulated genes, through nucleos(t)ide synthesis inhibition. The precise crosstalk between these two independent processes remains to be determined. Nonetheless, we summarize the current knowledge of nucleos(t)ide synthesis inhibition-related innate immunity and propose it as a newly emerging antiviral mechanism of nucleoside analogs."
    ],
    "affiliation": [
      "Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon-si 34114, Korea. shinhy@krict.re.kr."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Nucleosides"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AI"
                    ],
                    "qualifierName": [
                      "antagonists & inhibitors"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Nucleotides"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AI"
                    ],
                    "qualifierName": [
                      "antagonists & inhibitors"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Deoxycytidine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Gene Expression"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interferon Regulatory Factors"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Metabolic Networks and Pathways"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunity, Innate"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral drugs",
          "innate immunity",
          "Nucleoside Analog",
          "gemcitabine",
          "Interferon-stimulated Gene",
          "Nucleos(t)ide Synthesis"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Nucleosides"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Nucleotides"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Interferon Regulatory Factors"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "gemcitabine"
            ],
            "registryNumber": [
              "B76N6SBZ8R"
            ]
          },
          {
            "name": [
              "Deoxycytidine"
            ],
            "registryNumber": [
              "0W860991D6"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/v10040211"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5923505"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5923505?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2018-10-02"
    ],
    "dateOfCreation": [
      "2018-04-21"
    ],
    "firstIndexDate": [
      "2018-04-21"
    ],
    "fullTextReceivedDate": [
      "2018-05-11"
    ],
    "dateOfRevision": [
      "2018-10-04"
    ],
    "electronicPublicationDate": [
      "2018-04-20"
    ],
    "firstPublicationDate": [
      "2018-04-20"
    ]
  },
  {
    "id": [
      "29475447"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29475447"
    ],
    "pmcid": [
      "PMC6389205"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC6389205"
        ]
      }
    ],
    "doi": [
      "10.1186/s12918-018-0536-3"
    ],
    "title": [
      "Correction to: dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs."
    ],
    "authorString": [
      "Shahen M, Guo Z, Shar AH, Ebaid R, Tao Q, Zhang W, Wu Z, Bai Y, Fu Y, Zheng C, Wang H, Shar PA, Liu J, Wang Z, Xiao W, Wang Y."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Shahen M"
            ],
            "firstName": [
              "Mohamed"
            ],
            "lastName": [
              "Shahen"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Zoology Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Guo Z"
            ],
            "firstName": [
              "Zihu"
            ],
            "lastName": [
              "Guo"
            ],
            "initials": [
              "Z"
            ],
            "authorId": [
              {
                "_": "0000-0003-3975-3141",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shar AH"
            ],
            "firstName": [
              "Akhtar Hussain"
            ],
            "lastName": [
              "Shar"
            ],
            "initials": [
              "AH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ebaid R"
            ],
            "firstName": [
              "Reham"
            ],
            "lastName": [
              "Ebaid"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "School of Environment and Safety Engineering, Jiangsu University, Zhenjiang, Jiangsu, 212013, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tao Q"
            ],
            "firstName": [
              "Qin"
            ],
            "lastName": [
              "Tao"
            ],
            "initials": [
              "Q"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang W"
            ],
            "firstName": [
              "Wenjuan"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wu Z"
            ],
            "firstName": [
              "Ziyin"
            ],
            "lastName": [
              "Wu"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bai Y"
            ],
            "firstName": [
              "Yaofei"
            ],
            "lastName": [
              "Bai"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Fu Y"
            ],
            "firstName": [
              "Yingxue"
            ],
            "lastName": [
              "Fu"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zheng C"
            ],
            "firstName": [
              "Chunli"
            ],
            "lastName": [
              "Zheng"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang H"
            ],
            "firstName": [
              "He"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shar PA"
            ],
            "firstName": [
              "Piar Ali"
            ],
            "lastName": [
              "Shar"
            ],
            "initials": [
              "PA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu J"
            ],
            "firstName": [
              "Jianling"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest University, Xi'an, Shaanxi, 710069, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang Z"
            ],
            "firstName": [
              "Zhenzhong"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Lianyungang, Jiangsu, 222001, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xiao W"
            ],
            "firstName": [
              "Wei"
            ],
            "lastName": [
              "Xiao"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Lianyungang, Jiangsu, 222001, China. moc.361@newnulnoi.nak."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang Y"
            ],
            "firstName": [
              "Yonghua"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China. yh_wang@nwafu.edu.cn.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China. yh_wang@nwafu.edu.cn."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-3975-3141",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2654313"
        ],
        "dateOfPublication": [
          "2018 Feb"
        ],
        "monthOfPublication": [
          "2"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-02-01"
        ],
        "journal": [
          {
            "title": [
              "BMC systems biology"
            ],
            "ISOAbbreviation": [
              "BMC Syst Biol"
            ],
            "medlineAbbreviation": [
              "BMC Syst Biol"
            ],
            "NLMid": [
              "101301827"
            ],
            "ISSN": [
              "1752-0509"
            ],
            "ESSN": [
              "1752-0509"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "pageInfo": [
      "21"
    ],
    "abstractText": [
      "After publication of the article [1], it has been brought to our attention that an author's name was spelt incorrectly in the original published article. Yonghua Wang was previously spelt \"Yonghua Wan\". This has now been corrected in the revised version of the article."
    ],
    "affiliation": [
      "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Published Erratum",
          "correction",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s12918-018-0536-3"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6389205"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC6389205?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "29301573"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "BMC Syst Biol. 2018 Jan 4;12 (1):2"
            ],
            "type": [
              "Erratum for"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2018-02-25"
    ],
    "firstIndexDate": [
      "2018-02-25"
    ],
    "fullTextReceivedDate": [
      "2019-03-23"
    ],
    "dateOfRevision": [
      "2020-05-11"
    ],
    "electronicPublicationDate": [
      "2018-02-23"
    ],
    "firstPublicationDate": [
      "2018-02-23"
    ]
  },
  {
    "id": [
      "29301573"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29301573"
    ],
    "pmcid": [
      "PMC5753465"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5753465"
        ]
      }
    ],
    "doi": [
      "10.1186/s12918-017-0518-x"
    ],
    "title": [
      "Dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs."
    ],
    "authorString": [
      "Shahen M, Guo Z, Shar AH, Ebaid R, Tao Q, Zhang W, Wu Z, Bai Y, Fu Y, Zheng C, Wang H, Shar PA, Liu J, Wang Z, Xiao W, Wang Y."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Shahen M"
            ],
            "firstName": [
              "Mohamed"
            ],
            "lastName": [
              "Shahen"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0003-3608-2581",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Zoology Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Guo Z"
            ],
            "firstName": [
              "Zihu"
            ],
            "lastName": [
              "Guo"
            ],
            "initials": [
              "Z"
            ],
            "authorId": [
              {
                "_": "0000-0003-3975-3141",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shar AH"
            ],
            "firstName": [
              "Akhtar Hussain"
            ],
            "lastName": [
              "Shar"
            ],
            "initials": [
              "AH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ebaid R"
            ],
            "firstName": [
              "Reham"
            ],
            "lastName": [
              "Ebaid"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "School of Environment and Safety Engineering, Jiangsu University, Jiangsu, 212013, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tao Q"
            ],
            "firstName": [
              "Qin"
            ],
            "lastName": [
              "Tao"
            ],
            "initials": [
              "Q"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang W"
            ],
            "firstName": [
              "Wenjuan"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wu Z"
            ],
            "firstName": [
              "Ziyin"
            ],
            "lastName": [
              "Wu"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bai Y"
            ],
            "firstName": [
              "Yaofei"
            ],
            "lastName": [
              "Bai"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Fu Y"
            ],
            "firstName": [
              "Yingxue"
            ],
            "lastName": [
              "Fu"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zheng C"
            ],
            "firstName": [
              "Chunli"
            ],
            "lastName": [
              "Zheng"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang H"
            ],
            "firstName": [
              "He"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shar PA"
            ],
            "firstName": [
              "Piar Ali"
            ],
            "lastName": [
              "Shar"
            ],
            "initials": [
              "PA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu J"
            ],
            "firstName": [
              "Jianling"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest University, Xi'an, Shaanxi, 710069, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang Z"
            ],
            "firstName": [
              "Zhenzhong"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Lianyungang, Jiangsu, 222001, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xiao W"
            ],
            "firstName": [
              "Wei"
            ],
            "lastName": [
              "Xiao"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Lianyungang, Jiangsu, 222001, China. kanionlunwen@163.com."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang Y"
            ],
            "firstName": [
              "Yonghua"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China. yh_wang@nwsuaf.edu.cn.",
                  "Center of Bioinformatics, Northwest A & F University, Yangling, Shaanxi, 712100, China. yh_wang@nwsuaf.edu.cn."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-3608-2581",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-3975-3141",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2633659"
        ],
        "dateOfPublication": [
          "2018 Jan"
        ],
        "monthOfPublication": [
          "1"
        ],
        "yearOfPublication": [
          "2018"
        ],
        "printPublicationDate": [
          "2018-01-01"
        ],
        "journal": [
          {
            "title": [
              "BMC systems biology"
            ],
            "ISOAbbreviation": [
              "BMC Syst Biol"
            ],
            "medlineAbbreviation": [
              "BMC Syst Biol"
            ],
            "NLMid": [
              "101301827"
            ],
            "ISSN": [
              "1752-0509"
            ],
            "ESSN": [
              "1752-0509"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2018"
    ],
    "pageInfo": [
      "2"
    ],
    "abstractText": [
      "BACKGROUND:Dengue virus (DENV) is an increasing global health threat and associated with induction of both a long-lived protective immune response and immune-suppression. So far, the potency of treatment of DENV via antiviral drugs is still under investigation. Recently, increasing evidences suggest the potential role of microRNAs (miRNAs) in regulating DENV. The present study focused on the function of miRNAs in innate insusceptible reactions and organization of various types of immune cells and inflammatory responses for DENV. Three drugs were tested including antiviral herbal medicine ReDuNing (RDN), Loratadine (LRD) and Acetaminophen. RESULTS:By the microarray expression of miRNAs in 165 Patients. Results showed that 89 active miRNAs interacted with 499 potential target genes, during antiviral treatment throughout the critical stage of DENV. Interestingly, reduction of the illness threats using RDN combined with LRD treatment showed better results than Acetaminophen alone. The inhibitions of DENV was confirmed by decrease concentrations of cytokines and interleukin parameters; like TNF-α, IFN-γ, TGF-β1, IL-4, IL-6, IL-12, and IL-17; after treatment and some coagulants factors increased. CONCLUSIONS:This study showed a preliminary support to suggest that the herbal medicine RDN combined with LRD can reduce both susceptibility and the severity of DENV."
    ],
    "affiliation": [
      "College of Life Science, Northwest A & F University, Yangling, Shaanxi, 712100, China."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Dengue Virus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Dengue"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Inflammation"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Blood Coagulation Factors"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "MicroRNAs"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Gene Regulatory Networks"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Transcriptome"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Dengue virus",
          "Immunity",
          "Microarray",
          "Mosquito",
          "Mirnas Expression"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Blood Coagulation Factors"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "MicroRNAs"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s12918-017-0518-x"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5753465"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5753465?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "29475447"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "BMC Syst Biol. 2018 Feb 23;12 (1):21"
            ],
            "type": [
              "Erratum in"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "3"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2019-05-29"
    ],
    "dateOfCreation": [
      "2018-01-06"
    ],
    "firstIndexDate": [
      "2018-01-06"
    ],
    "fullTextReceivedDate": [
      "2018-01-07"
    ],
    "dateOfRevision": [
      "2019-05-29"
    ],
    "electronicPublicationDate": [
      "2018-01-04"
    ],
    "firstPublicationDate": [
      "2018-01-04"
    ]
  },
  {
    "id": [
      "29061953"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "29061953"
    ],
    "pmcid": [
      "PMC5644647"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5644647"
        ]
      }
    ],
    "doi": [
      "10.3390/vetsci2040456"
    ],
    "title": [
      "Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus."
    ],
    "authorString": [
      "Hartmann K, Wooding A, Bergmann M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Hartmann K"
            ],
            "firstName": [
              "Katrin"
            ],
            "lastName": [
              "Hartmann"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinic of Small Animal Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany. hartmann@uni-muenchen.de."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wooding A"
            ],
            "firstName": [
              "Anita"
            ],
            "lastName": [
              "Wooding"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinic of Small Animal Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany. anitaschwartz@hotmail.com."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bergmann M"
            ],
            "firstName": [
              "Michèle"
            ],
            "lastName": [
              "Bergmann"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinic of Small Animal Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany. n.bergmann@medizinische-kleintierklinik.de."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "4"
        ],
        "volume": [
          "2"
        ],
        "journalIssueId": [
          "2482087"
        ],
        "dateOfPublication": [
          "2015 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-12-01"
        ],
        "journal": [
          {
            "title": [
              "Veterinary sciences"
            ],
            "ISOAbbreviation": [
              "Vet Sci"
            ],
            "medlineAbbreviation": [
              "Vet Sci"
            ],
            "NLMid": [
              "101680127"
            ],
            "ISSN": [
              "2306-7381"
            ],
            "ESSN": [
              "2306-7381"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "456-476"
    ],
    "abstractText": [
      "Feline immunodeficiency virus (FIV) is one of the most common infectious agents affecting cats worldwide .FIV and human immunodeficiency virus (HIV) share many properties: both are lifelong persistent lentiviruses that are similar genetically and morphologically and both viruses propagate in T-lymphocytes, macrophages, and neural cells. Experimentally infected cats have measurable immune suppression, which sometimes progresses to an acquired immunodeficiency syndrome. A transient initial state of infection is followed by a long latent stage with low virus replication and absence of clinical signs. In the terminal stage, both viruses can cause severe immunosuppression. Thus, FIV infection in cats has become an important natural model for studying HIV infection in humans, especially for evaluation of antiviral compounds. Of particular importance for chemotherapeutic studies is the close similarity between the reverse transcriptase (RT) of FIV and HIV, which results in high in vitro susceptibility of FIV to many RT-targeted antiviral compounds used in the treatment of HIV-infected patients. Thus, the aim of this article is to provide an up-to-date review of studies on antiviral treatment of FIV, focusing on commercially available compounds for human or animal use."
    ],
    "affiliation": [
      "Clinic of Small Animal Medicine, LMU Munich, Veterinaerstrasse 13, 80539 Munich, Germany. hartmann@uni-muenchen.de."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Therapy",
          "Treatment",
          "Fiv",
          "Antiviral Compounds"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/vetsci2040456"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5644647"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5644647?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "2"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2017-10-25"
    ],
    "firstIndexDate": [
      "2017-10-24"
    ],
    "fullTextReceivedDate": [
      "2017-10-24"
    ],
    "dateOfRevision": [
      "2017-12-19"
    ],
    "electronicPublicationDate": [
      "2015-12-18"
    ],
    "firstPublicationDate": [
      "2015-12-18"
    ]
  },
  {
    "id": [
      "32104366"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32104366"
    ],
    "pmcid": [
      "PMC7032198"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7032198"
        ]
      }
    ],
    "doi": [
      "10.1016/j.ajps.2017.07.002"
    ],
    "title": [
      "Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices."
    ],
    "authorString": [
      "Mazumder S, Dewangan AK, Pavurala N."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Mazumder S"
            ],
            "firstName": [
              "Sonal"
            ],
            "lastName": [
              "Mazumder"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Engineering, Birla Institute of Science and Technology, Pilani, Rajasthan 333031, India."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dewangan AK"
            ],
            "firstName": [
              "Ashish Kumar"
            ],
            "lastName": [
              "Dewangan"
            ],
            "initials": [
              "AK"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemical Engineering, Birla Institute of Science and Technology, Pilani, Rajasthan 333031, India."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Pavurala N"
            ],
            "firstName": [
              "Naresh"
            ],
            "lastName": [
              "Pavurala"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Oak Ridge Associated Universities, Food and Drug Administration, Silver Spring, MD, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "6"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2916924"
        ],
        "dateOfPublication": [
          "2017 Nov"
        ],
        "monthOfPublication": [
          "11"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-11-01"
        ],
        "journal": [
          {
            "title": [
              "Asian journal of pharmaceutical sciences"
            ],
            "ISOAbbreviation": [
              "Asian J Pharm Sci"
            ],
            "medlineAbbreviation": [
              "Asian J Pharm Sci"
            ],
            "NLMid": [
              "101535338"
            ],
            "ISSN": [
              "1818-0876"
            ],
            "ESSN": [
              "2221-285X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "532-541"
    ],
    "abstractText": [
      "Polysaccharide-based polymers were used to produce nanoparticles of poorly soluble antiviral drugs using a rapid precipitation process. The structure-property relationships of four novel cellulose acetate-based polymers were studied for their solubility enhancement of poorly soluble drugs. Particles were purified by dialysis, and dried powders were recovered after freeze-drying. The particle diameters were 150-200 nm. The target drug loading in the particles was 25 wt%, and the drug loading efficiencies were 80-96%. The effects of the formulation process and nanoparticle properties on drug solubility were investigated. All nanoparticles afforded increased solubility and faster release compared to pure drugs. Drug release was a function of the relative hydrophobicity (or solubility parameters) of the polymers."
    ],
    "affiliation": [
      "Department of Chemical Engineering, Birla Institute of Science and Technology, Pilani, Rajasthan 333031, India."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Precipitation",
          "Solubility",
          "Nanoparticles",
          "Solid dispersions",
          "Ritonavir",
          "Efavirenz"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.ajps.2017.07.002"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7032198"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7032198?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc-nd"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-02-28"
    ],
    "firstIndexDate": [
      "2020-02-28"
    ],
    "fullTextReceivedDate": [
      "2020-02-28"
    ],
    "dateOfRevision": [
      "2020-03-01"
    ],
    "electronicPublicationDate": [
      "2017-07-08"
    ],
    "firstPublicationDate": [
      "2017-07-08"
    ]
  },
  {
    "id": [
      "28608847"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "28608847"
    ],
    "pmcid": [
      "PMC5490823"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5490823"
        ]
      }
    ],
    "doi": [
      "10.3390/v9060147"
    ],
    "title": [
      "HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model."
    ],
    "authorString": [
      "Toth K, Spencer JF, Ying B, Tollefson AE, Wold WSM."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Toth K"
            ],
            "firstName": [
              "Karoly"
            ],
            "lastName": [
              "Toth"
            ],
            "initials": [
              "K"
            ],
            "authorId": [
              {
                "_": "0000-0001-6624-9683",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. toth@slu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Spencer JF"
            ],
            "firstName": [
              "Jacqueline F"
            ],
            "lastName": [
              "Spencer"
            ],
            "initials": [
              "JF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. spencejf@slu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ying B"
            ],
            "firstName": [
              "Baoling"
            ],
            "lastName": [
              "Ying"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. yingb@slu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tollefson AE"
            ],
            "firstName": [
              "Ann E"
            ],
            "lastName": [
              "Tollefson"
            ],
            "initials": [
              "AE"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. tollefae@slu.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wold WSM"
            ],
            "firstName": [
              "William S M"
            ],
            "lastName": [
              "Wold"
            ],
            "initials": [
              "WSM"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. woldws@slu.edu."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-6624-9683",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "6"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2563145"
        ],
        "dateOfPublication": [
          "2017 Jun"
        ],
        "monthOfPublication": [
          "6"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-06-01"
        ],
        "journal": [
          {
            "title": [
              "Viruses"
            ],
            "ISOAbbreviation": [
              "Viruses"
            ],
            "medlineAbbreviation": [
              "Viruses"
            ],
            "NLMid": [
              "101509722"
            ],
            "ISSN": [
              "1999-4915"
            ],
            "ESSN": [
              "1999-4915"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "abstractText": [
      "Adenovirus infections of immunocompromised patients can cause a severe multi-organ disease that often results in the patients' death. Presently, there are no drugs specifically approved to treat adenovirus infections, and clinicians resort to the off-label use of antivirals that are approved to treat other DNA virus infections, most frequently cidofovir (CDV). CDV, however, has considerable nephrotoxicity, thus it is recommended only for the most severe cases of adenovirus infections. To facilitate the development of effective, non-toxic antivirals against adenovirus, we have developed a permissive animal model based on the Syrian hamster that can be used to test the efficacy of antiviral compounds. Here, we show that in the hamster model, HAdV-C6 is a more useful challenge virus than the previously described HAdV-C5, because it is filtered out by tissue macrophages to a lesser extent. HAdV-C6 has a 10-fold lower LD50 in hamsters than HAdV-C5 and the pathology is caused by virus replication to a larger extent. We show that valganciclovir (VGCV), a drug that was shown to be active against intravenous HAdV-C5 infection previously, is efficacious against HAdV-C6 when administered either prophylactically or therapeutically. Further, we show for the first time that VGCV, and to a lesser extent CDV, can be used to treat respiratory adenovirus infections in the hamster model. These results extend the utility of the hamster model, and demonstrate the efficacy of two drugs available for clinicians to treat adenovirus infections."
    ],
    "affiliation": [
      "Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, MO 63104, USA. toth@slu.edu."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article",
          "Research Support, N.I.H., Extramural"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "HHSN272201000021I"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "HHSN272201000021C"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Liver"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cell Line"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adenoviruses, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adenoviridae Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adenovirus Infections, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Disease Models, Animal"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cytosine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ganciclovir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunosuppression"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Load"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cricetinae"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Male"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Organophosphonates"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "A549 Cells"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Adenovirus",
          "Animal model",
          "Antiviral",
          "hamster"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Organophosphonates"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "cidofovir"
            ],
            "registryNumber": [
              "JIL713Q00N"
            ]
          },
          {
            "name": [
              "Cytosine"
            ],
            "registryNumber": [
              "8J337D1HZY"
            ]
          },
          {
            "name": [
              "Ganciclovir"
            ],
            "registryNumber": [
              "P9G3CKZ4P5"
            ]
          },
          {
            "name": [
              "valganciclovir"
            ],
            "registryNumber": [
              "GCU97FKN3R"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/v9060147"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5490823"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5490823?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2018-02-28"
    ],
    "dateOfCreation": [
      "2017-06-14"
    ],
    "firstIndexDate": [
      "2017-06-13"
    ],
    "fullTextReceivedDate": [
      "2017-07-05"
    ],
    "dateOfRevision": [
      "2018-03-27"
    ],
    "electronicPublicationDate": [
      "2017-06-13"
    ],
    "firstPublicationDate": [
      "2017-06-13"
    ]
  },
  {
    "id": [
      "28828170"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "28828170"
    ],
    "pmcid": [
      "PMC5549007"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5549007"
        ]
      }
    ],
    "title": [
      "HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs."
    ],
    "authorString": [
      "Fernandes AR, Laranjinha IJ, Birne R, Matias P, Jorge C, Adragão T, Bruges M, Weigert A, Machado D."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Fernandes AR"
            ],
            "firstName": [
              "A R"
            ],
            "lastName": [
              "Fernandes"
            ],
            "initials": [
              "AR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital São Bernardo, Setúbal, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Laranjinha IJ"
            ],
            "firstName": [
              "I J"
            ],
            "lastName": [
              "Laranjinha"
            ],
            "initials": [
              "IJ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Birne R"
            ],
            "firstName": [
              "R"
            ],
            "lastName": [
              "Birne"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Matias P"
            ],
            "firstName": [
              "P"
            ],
            "lastName": [
              "Matias"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jorge C"
            ],
            "firstName": [
              "C"
            ],
            "lastName": [
              "Jorge"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Adragão T"
            ],
            "firstName": [
              "T"
            ],
            "lastName": [
              "Adragão"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bruges M"
            ],
            "firstName": [
              "M"
            ],
            "lastName": [
              "Bruges"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Weigert A"
            ],
            "firstName": [
              "A"
            ],
            "lastName": [
              "Weigert"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Machado D"
            ],
            "firstName": [
              "D"
            ],
            "lastName": [
              "Machado"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Nephrology, Hospital Santa Cruz, Carnaxide, Portugal."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "2"
        ],
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2588909"
        ],
        "dateOfPublication": [
          "2017 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-01-01"
        ],
        "journal": [
          {
            "title": [
              "International journal of organ transplantation medicine"
            ],
            "ISOAbbreviation": [
              "Int J Organ Transplant Med"
            ],
            "medlineAbbreviation": [
              "Int J Organ Transplant Med"
            ],
            "NLMid": [
              "101535773"
            ],
            "ISSN": [
              "2008-6482"
            ],
            "ESSN": [
              "2008-6490"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "104-109"
    ],
    "abstractText": [
      "Natural history of HCV-infected renal transplant recipients is about to change with the invention of new drugs available for the treatment of HCV.To analyze the evolution of renal transplant recipients infected with HCV in 30 years of activity of a Renal Transplantation Unit.We studied 1334 patients who underwent renal transplantation between 1985 and 2015.189 (14.2%) of these 1334 were found HCV seropositive. 60 were HCV RNA-positive for >6 months. 5 died with a functioning graft; 19 lost their graft and resumed dialysis. Most of the rejections occurred within the first year of the transplantation and none resulted in immediate loss of the graft. In post-transplantation period, 14 patients developed clinical hepatic disease, 10 manifested new-onset diabetes after transplantation, and 4 had de novo neoplasia, none of them had hepatocellular carcinoma. The outcomes of the different variables analyzed were similar between patients with HCV-infection and those with HCV and HBV co-infection. The median survival time was 13.4 (95% CI: 10.7-16.1) years; the median survival time of patients without HCV infection was 14.6 (95% CI: 13.8-15.4) years (p=0.23).In the era before the availability of new anti-HCV drugs, our experience with HCV-infected renal transplant recipients revealed similar post-transplantation complications, graft and patient survival as those not infected with HCV."
    ],
    "affiliation": [
      "Department of Nephrology, Hospital São Bernardo, Setúbal, Portugal."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Survival rate",
          "Graft rejection",
          "Kidney transplantation",
          "Postoperative complications",
          "hepatitis C",
          "Transplant Recipients"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5549007"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5549007?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2017-08-22"
    ],
    "firstIndexDate": [
      "2017-08-23"
    ],
    "fullTextReceivedDate": [
      "2017-08-25"
    ],
    "dateOfRevision": [
      "2017-08-25"
    ],
    "electronicPublicationDate": [
      "2017-05-01"
    ],
    "firstPublicationDate": [
      "2017-05-01"
    ]
  },
  {
    "id": [
      "31305661"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31305661"
    ],
    "pmcid": [
      "PMC5440157"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5440157"
        ]
      }
    ],
    "doi": [
      "10.1097/md.0000000000006958"
    ],
    "title": [
      "Erratum: Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs: Erratum."
    ],
    "journalInfo": [
      {
        "issue": [
          "20"
        ],
        "volume": [
          "96"
        ],
        "journalIssueId": [
          "2558481"
        ],
        "dateOfPublication": [
          "2017 May"
        ],
        "monthOfPublication": [
          "5"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-05-01"
        ],
        "journal": [
          {
            "title": [
              "Medicine"
            ],
            "ISOAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "medlineAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "NLMid": [
              "2985248R"
            ],
            "ISSN": [
              "0304-5412"
            ],
            "ESSN": [
              "1536-5964"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "e6958"
    ],
    "abstractText": [
      "[This corrects the article DOI: 10.1097/MD.0000000000005321.]."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Published Erratum",
          "correction"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1097/MD.0000000000006958"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5440157"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5440157?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "28072684"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "Medicine (Baltimore). 2017 Jan;96(1):e5321"
            ],
            "type": [
              "Erratum for"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2019-07-16"
    ],
    "firstIndexDate": [
      "2019-07-16"
    ],
    "fullTextReceivedDate": [
      "2017-05-27"
    ],
    "dateOfRevision": [
      "2019-07-23"
    ],
    "electronicPublicationDate": [
      "2017-05-19"
    ],
    "firstPublicationDate": [
      "2017-05-19"
    ]
  },
  {
    "id": [
      "25625858"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "25625858"
    ],
    "pmcid": [
      "PMC4313645"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4313645"
        ]
      }
    ],
    "doi": [
      "10.3201/eid2102.141024"
    ],
    "title": [
      "Optimizing distribution of pandemic influenza antiviral drugs."
    ],
    "authorString": [
      "Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Singh B"
            ],
            "firstName": [
              "Bismark"
            ],
            "lastName": [
              "Singh"
            ],
            "initials": [
              "B"
            ],
            "authorId": [
              {
                "_": "0000-0002-6943-657X",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          },
          {
            "fullName": [
              "Huang HC"
            ],
            "firstName": [
              "Hsin-Chan"
            ],
            "lastName": [
              "Huang"
            ],
            "initials": [
              "HC"
            ]
          },
          {
            "fullName": [
              "Morton DP"
            ],
            "firstName": [
              "David P"
            ],
            "lastName": [
              "Morton"
            ],
            "initials": [
              "DP"
            ],
            "authorId": [
              {
                "_": "0000-0001-6001-9078",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          },
          {
            "fullName": [
              "Johnson GP"
            ],
            "firstName": [
              "Gregory P"
            ],
            "lastName": [
              "Johnson"
            ],
            "initials": [
              "GP"
            ]
          },
          {
            "fullName": [
              "Gutfraind A"
            ],
            "firstName": [
              "Alexander"
            ],
            "lastName": [
              "Gutfraind"
            ],
            "initials": [
              "A"
            ]
          },
          {
            "fullName": [
              "Galvani AP"
            ],
            "firstName": [
              "Alison P"
            ],
            "lastName": [
              "Galvani"
            ],
            "initials": [
              "AP"
            ]
          },
          {
            "fullName": [
              "Clements B"
            ],
            "firstName": [
              "Bruce"
            ],
            "lastName": [
              "Clements"
            ],
            "initials": [
              "B"
            ]
          },
          {
            "fullName": [
              "Meyers LA"
            ],
            "firstName": [
              "Lauren A"
            ],
            "lastName": [
              "Meyers"
            ],
            "initials": [
              "LA"
            ],
            "authorId": [
              {
                "_": "0000-0002-5828-8874",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-6943-657X",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-6001-9078",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-5828-8874",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "2"
        ],
        "volume": [
          "21"
        ],
        "journalIssueId": [
          "2246892"
        ],
        "dateOfPublication": [
          "2015 Feb"
        ],
        "monthOfPublication": [
          "2"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-02-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging infectious diseases"
            ],
            "ISOAbbreviation": [
              "Emerging Infect. Dis."
            ],
            "medlineAbbreviation": [
              "Emerg Infect Dis"
            ],
            "NLMid": [
              "9508155"
            ],
            "ISSN": [
              "1080-6059"
            ],
            "ESSN": [
              "1080-6059"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "251-258"
    ],
    "abstractText": [
      "We provide a data-driven method for optimizing pharmacy-based distribution of antiviral drugs during an influenza pandemic in terms of overall access for a target population and apply it to the state of Texas, USA. We found that during the 2009 influenza pandemic, the Texas Department of State Health Services achieved an estimated statewide access of 88% (proportion of population willing to travel to the nearest dispensing point). However, access reached only 34.5% of US postal code (ZIP code) areas containing <1,000 underinsured persons. Optimized distribution networks increased expected access to 91% overall and 60% in hard-to-reach regions, and 2 or 3 major pharmacy chains achieved near maximal coverage in well-populated areas. Independent pharmacies were essential for reaching ZIP code areas containing <1,000 underinsured persons. This model was developed during a collaboration between academic researchers and public health officials and is available as a decision support tool for Texas Department of State Health Services at a Web-based interface."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article",
          "Research Support, N.I.H., Extramural"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "U01 GM087719-01"
            ],
            "agency": [
              "NIGMS NIH HHS"
            ],
            "acronym": [
              "GM"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "U01 GM087719"
            ],
            "agency": [
              "NIGMS NIH HHS"
            ],
            "acronym": [
              "GM"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "SD"
                    ],
                    "qualifierName": [
                      "supply & distribution"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Geography"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Algorithms"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Decision Support Techniques"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Models, Theoretical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pharmacies"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Texas"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3201/eid2102.141024"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4313645"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4313645?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "2"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-10-09"
    ],
    "dateOfCreation": [
      "2015-01-28"
    ],
    "firstIndexDate": [
      "2015-01-28"
    ],
    "fullTextReceivedDate": [
      "2015-02-07"
    ],
    "dateOfRevision": [
      "2016-10-19"
    ],
    "firstPublicationDate": [
      "2015-02-01"
    ]
  },
  {
    "id": [
      "31305738"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "31305738"
    ],
    "pmcid": [
      "PMC5319548"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5319548"
        ]
      }
    ],
    "doi": [
      "10.1097/md.0000000000006193"
    ],
    "title": [
      "Erratum: Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs: Erratum."
    ],
    "journalInfo": [
      {
        "issue": [
          "7"
        ],
        "volume": [
          "96"
        ],
        "journalIssueId": [
          "2525488"
        ],
        "dateOfPublication": [
          "2017 Feb"
        ],
        "monthOfPublication": [
          "2"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-02-01"
        ],
        "journal": [
          {
            "title": [
              "Medicine"
            ],
            "ISOAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "medlineAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "NLMid": [
              "2985248R"
            ],
            "ISSN": [
              "0304-5412"
            ],
            "ESSN": [
              "1536-5964"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "e6193"
    ],
    "abstractText": [
      "[This corrects the article DOI: 10.1097/MD.0000000000005321.]."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Published Erratum",
          "correction"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1097/MD.0000000000006193"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5319548"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5319548?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "28072684"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "Medicine (Baltimore). 2017 Jan;96(1):e5321"
            ],
            "type": [
              "Erratum for"
            ],
            "orderIn": [
              "1"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2019-07-16"
    ],
    "firstIndexDate": [
      "2019-07-16"
    ],
    "fullTextReceivedDate": [
      "2017-03-05"
    ],
    "dateOfRevision": [
      "2019-07-23"
    ],
    "electronicPublicationDate": [
      "2017-02-17"
    ],
    "firstPublicationDate": [
      "2017-02-17"
    ]
  },
  {
    "id": [
      "26576812"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26576812"
    ],
    "pmcid": [
      "PMC4654359"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4654359"
        ]
      }
    ],
    "doi": [
      "10.1136/bmjopen-2015-009333"
    ],
    "title": [
      "Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study."
    ],
    "authorString": [
      "Ward DJ, Hammond E, Linden-Phillips L, Stevens AJ."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ward DJ"
            ],
            "firstName": [
              "Derek J"
            ],
            "lastName": [
              "Ward"
            ],
            "initials": [
              "DJ"
            ],
            "authorId": [
              {
                "_": "0000-0003-0740-9741",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "NIHR Horizon Scanning Research & Intelligence Centre, School of Health and Population Sciences, University of Birmingham, Birmingham, UK."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hammond E"
            ],
            "firstName": [
              "Edward"
            ],
            "lastName": [
              "Hammond"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "NIHR Horizon Scanning Research & Intelligence Centre, School of Health and Population Sciences, University of Birmingham, Birmingham, UK."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Linden-Phillips L"
            ],
            "firstName": [
              "Luan"
            ],
            "lastName": [
              "Linden-Phillips"
            ],
            "initials": [
              "L"
            ],
            "authorId": [
              {
                "_": "0000-0003-3711-0222",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "NIHR Horizon Scanning Research & Intelligence Centre, School of Health and Population Sciences, University of Birmingham, Birmingham, UK."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Stevens AJ"
            ],
            "firstName": [
              "Andrew J"
            ],
            "lastName": [
              "Stevens"
            ],
            "initials": [
              "AJ"
            ],
            "authorId": [
              {
                "_": "0000-0003-2079-3397",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Public Health, Epidemiology and Biostatistics, School of Health and Population Sciences, University of Birmingham, Birmingham, UK."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-0740-9741",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-3711-0222",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-2079-3397",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "11"
        ],
        "volume": [
          "5"
        ],
        "journalIssueId": [
          "2476819"
        ],
        "dateOfPublication": [
          "2015 Nov"
        ],
        "monthOfPublication": [
          "11"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-11-01"
        ],
        "journal": [
          {
            "title": [
              "BMJ open"
            ],
            "ISOAbbreviation": [
              "BMJ Open"
            ],
            "medlineAbbreviation": [
              "BMJ Open"
            ],
            "NLMid": [
              "101552874"
            ],
            "ISSN": [
              "2044-6055"
            ],
            "ESSN": [
              "2044-6055"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "e009333"
    ],
    "abstractText": [
      "OBJECTIVES:Recent decades have witnessed the development of highly innovative new antiviral drug therapies. However, there are concerns that rising costs and lengthening development times could have implications for future patient access to innovative new drugs. We sought to establish whether the time taken for the clinical development of new antiviral drugs launched in the UK had increased since the 1980s. DESIGN AND SETTING:Retrospective observational study of all new antiviral drugs licensed for use in the UK. PRIMARY AND SECONDARY OUTCOME MEASURES:Duration of clinical development (from initiation of studies in humans to receipt of Marketing Authorisation), subdivided into clinical trial and regulatory approval periods by the date of Marketing Authorisation Application. RESULTS:48 new antiviral drugs were licensed for use in the UK between 1981 and 2014 (inclusive), over half (54%) initially for HIV infection. The overall mean duration of clinical development was 77.2 months, of which 64.6 months was spent in clinical trials before regulatory submission. The total time in clinical development increased from 41.7 months for drugs licensed 1981-1992 to 91.7 months for drugs licensed 2004-2014. This increase was accounted for by an increase in the clinical trials period and not the regulatory approval period, for which there was no observable trend. Drugs initially licensed to treat hepatitis C had a longer duration of clinical development than those indicated for other viral infections. However, the, initially shorter clinical development durations of drugs indicated for HIV infection increased more rapidly across the study period than those indicated for other viral infections. CONCLUSIONS:The time spent by antiviral drugs in clinical development has increased markedly in recent decades despite many initiatives to speed access to innovative new drugs. However, this represents only one part of the translational research pathway, and a complete picture of development timeframes is lacking."
    ],
    "affiliation": [
      "NIHR Horizon Scanning Research & Intelligence Centre, School of Health and Population Sciences, University of Birmingham, Birmingham, UK."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Diseases"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis C"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HIV Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Retrospective Studies"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Approval"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "United Kingdom"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Viral infection",
          "United Kingdom",
          "Drug Licensing",
          "Drug Development Timeframes"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1136/bmjopen-2015-009333"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4654359"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4654359?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2016-08-22"
    ],
    "dateOfCreation": [
      "2015-11-19"
    ],
    "firstIndexDate": [
      "2015-11-18"
    ],
    "fullTextReceivedDate": [
      "2015-12-04"
    ],
    "dateOfRevision": [
      "2019-02-02"
    ],
    "electronicPublicationDate": [
      "2015-11-16"
    ],
    "firstPublicationDate": [
      "2015-11-16"
    ]
  },
  {
    "id": [
      "PMC7152365"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7152365"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7152365"
        ]
      }
    ],
    "title": [
      "Antiviral Drugs for Influenza and Other Respiratory Virus Infections."
    ],
    "authorString": [
      "Aoki FY."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Aoki FY"
            ],
            "firstName": [
              "Fred Y."
            ],
            "lastName": [
              "Aoki"
            ],
            "initials": [
              "FY"
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2935850"
        ],
        "dateOfPublication": [
          "2015 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "531-545.e5"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "chapter-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Resistance",
          "Pharmacokinetics",
          "Influenza",
          "Chemotherapy",
          "Respiratory syncytial virus",
          "Ribavirin",
          "Oseltamivir",
          "Chemoprophylaxis",
          "Amantadine",
          "Zanamivir",
          "Seasonal",
          "Peramivir",
          "Inhaled",
          "Postexposure",
          "Laninamivir",
          "Rimantadine",
          "Das181 (Fludase)",
          "Outbreak (Control)",
          "Rsv604"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152365/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7152365"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-04-16"
    ],
    "firstIndexDate": [
      "2020-04-16"
    ],
    "fullTextReceivedDate": [
      "2020-04-15"
    ],
    "dateOfRevision": [
      "2020-04-16"
    ],
    "electronicPublicationDate": [
      "2014-10-31"
    ],
    "firstPublicationDate": [
      "2014-10-31"
    ]
  },
  {
    "id": [
      "28072684"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "28072684"
    ],
    "pmcid": [
      "PMC5228644"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5228644"
        ]
      }
    ],
    "doi": [
      "10.1097/md.0000000000005321"
    ],
    "title": [
      "Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs."
    ],
    "authorString": [
      "Lee SH, Jin YJ, Shin JY, Lee JW."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Lee SH"
            ],
            "firstName": [
              "Seung Ho"
            ],
            "lastName": [
              "Lee"
            ],
            "initials": [
              "SH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jin YJ"
            ],
            "firstName": [
              "Young-Joo"
            ],
            "lastName": [
              "Jin"
            ],
            "initials": [
              "YJ"
            ]
          },
          {
            "fullName": [
              "Shin JY"
            ],
            "firstName": [
              "Jun Young"
            ],
            "lastName": [
              "Shin"
            ],
            "initials": [
              "JY"
            ]
          },
          {
            "fullName": [
              "Lee JW"
            ],
            "firstName": [
              "Jin-Woo"
            ],
            "lastName": [
              "Lee"
            ],
            "initials": [
              "JW"
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "96"
        ],
        "journalIssueId": [
          "2514143"
        ],
        "dateOfPublication": [
          "2017 Jan"
        ],
        "monthOfPublication": [
          "1"
        ],
        "yearOfPublication": [
          "2017"
        ],
        "printPublicationDate": [
          "2017-01-01"
        ],
        "journal": [
          {
            "title": [
              "Medicine"
            ],
            "ISOAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "medlineAbbreviation": [
              "Medicine (Baltimore)"
            ],
            "NLMid": [
              "2985248R"
            ],
            "ISSN": [
              "0304-5412"
            ],
            "ESSN": [
              "1536-5964"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2017"
    ],
    "pageInfo": [
      "e5321"
    ],
    "abstractText": [
      "In this new era of highly effective oral antiviral drugs for chronic hepatitis C virus (HCV), indications for antiviral treatment may be extendable. This study undertaken to identify suitable candidates for peg-interferon plus ribavirin (PEG-IFN/RBV) treatment by evaluating hepatocellular carcinoma (HCC) risk in patients with chronic HCV treated or not with PEG-IFN/RBV.This large-scale retrospective study was conducted on 1176 patients with chronic HCV without a history of HCC (treatment group [n = 489] and no-treatment group [n = 687]). In the treatment group, patients treated with PEG-IFN/RBV were dichotomized based on the achievement of sustained virologic response (SVR) into SVR (+) and SVR (-) groups.Median follow-up for all study subjects was 31 months (range 6-144 months). Three-year cumulative HCC development rates in the SVR (+) (1.1%) and SVR (-) (8.6%) subgroups were significantly lower than in the no-treatment group (13.5%) (P < 0.01 and P < 0.01, respectively). In all study subjects, presence of cirrhosis (hazard ratio [HR], 9.92, P < 0.01), age (HR 1.03, P < 0.01), SVR (-) (HR 7.02, P < 0.01), and no-treatment (HR 6.76, P < 0.01) were found to be independent risk factors of HCC development. In the treatment group, age, the presence of cirrhosis, and SVR (-) were predictors of HCC development. In the no-treatment group, age, male, and the presence of cirrhosis were independent predictors for HCC development.HCC risk increased in patients with chronic HCV with older age, cirrhosis, SVR (-) after PEG-IFN/RBV treatment, and no PEG-IFN/RBV treatment. Active antiviral therapy based on highly effective oral drugs needs to be considered in these patients."
    ],
    "affiliation": [
      "Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Hepacivirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IP"
                    ],
                    "qualifierName": [
                      "isolation & purification"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Hepatitis C, Chronic"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Carcinoma, Hepatocellular"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DI"
                    ],
                    "qualifierName": [
                      "diagnosis"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Liver Neoplasms"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DI"
                    ],
                    "qualifierName": [
                      "diagnosis"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Liver Cirrhosis"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Polyethylene Glycols"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interferon-alpha"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Recombinant Proteins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ribavirin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Prognosis"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Risk Assessment"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Risk Factors"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Retrospective Studies"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Age Factors"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adult"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Middle Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Female"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Male"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Republic of Korea"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interferon alpha-2"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Interferon-alpha"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Recombinant Proteins"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Ribavirin"
            ],
            "registryNumber": [
              "49717AWG6K"
            ]
          },
          {
            "name": [
              "peginterferon alfa-2b"
            ],
            "registryNumber": [
              "G8RGG88B68"
            ]
          },
          {
            "name": [
              "Polyethylene Glycols"
            ],
            "registryNumber": [
              "3WJQ0SDW1A"
            ]
          },
          {
            "name": [
              "Interferon alpha-2"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "AIM"
            ],
            "name": [
              "Core clinical journals"
            ]
          },
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1097/MD.0000000000005321"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5228644"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5228644?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "31305661"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "Medicine (Baltimore). 2017 May 19;96(20):e6958"
            ],
            "type": [
              "Erratum in"
            ],
            "orderIn": [
              "1"
            ]
          },
          {
            "id": [
              "31305738"
            ],
            "source": [
              "MED"
            ],
            "reference": [
              "Medicine (Baltimore). 2017 Feb 17;96(7):e6193"
            ],
            "type": [
              "Erratum in"
            ],
            "orderIn": [
              "2"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "4"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc-nd"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2017-02-16"
    ],
    "dateOfCreation": [
      "2017-01-11"
    ],
    "firstIndexDate": [
      "2017-01-13"
    ],
    "fullTextReceivedDate": [
      "2017-01-31"
    ],
    "dateOfRevision": [
      "2018-12-02"
    ],
    "firstPublicationDate": [
      "2017-01-01"
    ]
  },
  {
    "id": [
      "27177310"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "27177310"
    ],
    "pmcid": [
      "PMC4865845"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4865845"
        ]
      }
    ],
    "doi": [
      "10.1038/ncomms11320"
    ],
    "title": [
      "A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs."
    ],
    "authorString": [
      "Karlas A, Berre S, Couderc T, Varjak M, Braun P, Meyer M, Gangneux N, Karo-Astover L, Weege F, Raftery M, Schönrich G, Klemm U, Wurzlbauer A, Bracher F, Merits A, Meyer TF, Lecuit M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Karlas A"
            ],
            "firstName": [
              "Alexander"
            ],
            "lastName": [
              "Karlas"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0002-2187-2057",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Max Planck Institute for Infection Biology, Department of Molecular Biology, Charitéplatz 1, 10117 Berlin, Germany.",
                  "Steinbeis Innovation gGmbH, Center for Systems Biomedicine, Haydnallee 21, 14612 Falkensee, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Berre S"
            ],
            "firstName": [
              "Stefano"
            ],
            "lastName": [
              "Berre"
            ],
            "initials": [
              "S"
            ],
            "authorId": [
              {
                "_": "0000-0001-8427-759X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institut Pasteur, Biology of Infection Unit, 28 rue du Dr. Roux, 75015 Paris, France.",
                  "Inserm U1117, 28 rue du Dr. Roux, 75015 Paris, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Couderc T"
            ],
            "firstName": [
              "Thérèse"
            ],
            "lastName": [
              "Couderc"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institut Pasteur, Biology of Infection Unit, 28 rue du Dr. Roux, 75015 Paris, France.",
                  "Inserm U1117, 28 rue du Dr. Roux, 75015 Paris, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Varjak M"
            ],
            "firstName": [
              "Margus"
            ],
            "lastName": [
              "Varjak"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0003-2608-5148",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Braun P"
            ],
            "firstName": [
              "Peter"
            ],
            "lastName": [
              "Braun"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Max Planck Institute for Infection Biology, Department of Molecular Biology, Charitéplatz 1, 10117 Berlin, Germany.",
                  "Steinbeis Innovation gGmbH, Center for Systems Biomedicine, Haydnallee 21, 14612 Falkensee, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Meyer M"
            ],
            "firstName": [
              "Michael"
            ],
            "lastName": [
              "Meyer"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Steinbeis Innovation gGmbH, Center for Systems Biomedicine, Haydnallee 21, 14612 Falkensee, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gangneux N"
            ],
            "firstName": [
              "Nicolas"
            ],
            "lastName": [
              "Gangneux"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institut Pasteur, Biology of Infection Unit, 28 rue du Dr. Roux, 75015 Paris, France.",
                  "Inserm U1117, 28 rue du Dr. Roux, 75015 Paris, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Karo-Astover L"
            ],
            "firstName": [
              "Liis"
            ],
            "lastName": [
              "Karo-Astover"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Weege F"
            ],
            "firstName": [
              "Friderike"
            ],
            "lastName": [
              "Weege"
            ],
            "initials": [
              "F"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Max Planck Institute for Infection Biology, Department of Molecular Biology, Charitéplatz 1, 10117 Berlin, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Raftery M"
            ],
            "firstName": [
              "Martin"
            ],
            "lastName": [
              "Raftery"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Virology, Charité University Medicine, Charitéplatz 1, 10117 Berlin, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Schönrich G"
            ],
            "firstName": [
              "Günther"
            ],
            "lastName": [
              "Schönrich"
            ],
            "initials": [
              "G"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Virology, Charité University Medicine, Charitéplatz 1, 10117 Berlin, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Klemm U"
            ],
            "firstName": [
              "Uwe"
            ],
            "lastName": [
              "Klemm"
            ],
            "initials": [
              "U"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Max Planck Institute for Infection Biology, Core Facility Experimental Animals, Charitéplatz 1, 10117 Berlin, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wurzlbauer A"
            ],
            "firstName": [
              "Anne"
            ],
            "lastName": [
              "Wurzlbauer"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Ludwig-Maximilians-University, Department of Pharmacy-Center for Drug Research, Butenandtstraße 5-13, 81377 Munich, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bracher F"
            ],
            "firstName": [
              "Franz"
            ],
            "lastName": [
              "Bracher"
            ],
            "initials": [
              "F"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Ludwig-Maximilians-University, Department of Pharmacy-Center for Drug Research, Butenandtstraße 5-13, 81377 Munich, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Merits A"
            ],
            "firstName": [
              "Andres"
            ],
            "lastName": [
              "Merits"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0001-8193-0071",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Meyer TF"
            ],
            "firstName": [
              "Thomas F"
            ],
            "lastName": [
              "Meyer"
            ],
            "initials": [
              "TF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Max Planck Institute for Infection Biology, Department of Molecular Biology, Charitéplatz 1, 10117 Berlin, Germany.",
                  "Steinbeis Innovation gGmbH, Center for Systems Biomedicine, Haydnallee 21, 14612 Falkensee, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lecuit M"
            ],
            "firstName": [
              "Marc"
            ],
            "lastName": [
              "Lecuit"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0002-4491-1063",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institut Pasteur, Biology of Infection Unit, 28 rue du Dr. Roux, 75015 Paris, France.",
                  "Inserm U1117, 28 rue du Dr. Roux, 75015 Paris, France.",
                  "Paris Descartes University, Sorbonne Paris Cité, Division of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, Institut Imagine, 149, rue de Sèvres 75743 Paris, France."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-2187-2057",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-8427-759X",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-2608-5148",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-8193-0071",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-4491-1063",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "recommended_reviews",
          "full_text",
          "related_data",
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "7"
        ],
        "journalIssueId": [
          "2477570"
        ],
        "dateOfPublication": [
          "2016 May"
        ],
        "monthOfPublication": [
          "5"
        ],
        "yearOfPublication": [
          "2016"
        ],
        "printPublicationDate": [
          "2016-05-01"
        ],
        "journal": [
          {
            "title": [
              "Nature communications"
            ],
            "ISOAbbreviation": [
              "Nat Commun"
            ],
            "medlineAbbreviation": [
              "Nat Commun"
            ],
            "NLMid": [
              "101528555"
            ],
            "ISSN": [
              "2041-1723"
            ],
            "ESSN": [
              "2041-1723"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2016"
    ],
    "pageInfo": [
      "11320"
    ],
    "abstractText": [
      "Chikungunya virus (CHIKV) is a globally spreading alphavirus against which there is no commercially available vaccine or therapy. Here we use a genome-wide siRNA screen to identify 156 proviral and 41 antiviral host factors affecting CHIKV replication. We analyse the cellular pathways in which human proviral genes are involved and identify druggable targets. Twenty-one small-molecule inhibitors, some of which are FDA approved, targeting six proviral factors or pathways, have high antiviral activity in vitro, with low toxicity. Three identified inhibitors have prophylactic antiviral effects in mouse models of chikungunya infection. Two of them, the calmodulin inhibitor pimozide and the fatty acid synthesis inhibitor TOFA, have a therapeutic effect in vivo when combined. These results demonstrate the value of loss-of-function screening and pathway analysis for the rational identification of small molecules with therapeutic potential and pave the way for the development of new, host-directed, antiviral agents."
    ],
    "affiliation": [
      "Max Planck Institute for Infection Biology, Department of Molecular Biology, Charitéplatz 1, 10117 Berlin, Germany."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mice"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chikungunya virus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Furans"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pimozide"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "RNA, Small Interfering"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Gene Expression Profiling"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Genome, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Small Molecule Libraries"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Host-Pathogen Interactions"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HEK293 Cells"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chikungunya Fever"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "5-(tetradecyloxy)-2-furancarboxylic acid"
            ],
            "registryNumber": [
              "54857-86-2"
            ]
          },
          {
            "name": [
              "Furans"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "RNA, Small Interfering"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Small Molecule Libraries"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Pimozide"
            ],
            "registryNumber": [
              "1HIZ4DL86F"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1038/ncomms11320"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4865845"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4865845?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "23"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "geo"
        ]
      }
    ],
    "dateOfCompletion": [
      "2018-06-26"
    ],
    "dateOfCreation": [
      "2016-05-14"
    ],
    "firstIndexDate": [
      "2016-05-14"
    ],
    "fullTextReceivedDate": [
      "2016-05-26"
    ],
    "dateOfRevision": [
      "2018-06-26"
    ],
    "electronicPublicationDate": [
      "2016-05-12"
    ],
    "firstPublicationDate": [
      "2016-05-12"
    ]
  },
  {
    "id": [
      "24997250"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "24997250"
    ],
    "pmcid": [
      "PMC4195804"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4195804"
        ]
      }
    ],
    "doi": [
      "10.1016/j.coviro.2014.06.002"
    ],
    "title": [
      "Antiviral drugs specific for coronaviruses in preclinical development."
    ],
    "authorString": [
      "Adedeji AO, Sarafianos SG."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Adedeji AO"
            ],
            "firstName": [
              "Adeyemi O"
            ],
            "lastName": [
              "Adedeji"
            ],
            "initials": [
              "AO"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616, United States. Electronic address: aoadedeji@ucdavis.edu."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sarafianos SG"
            ],
            "firstName": [
              "Stefan G"
            ],
            "lastName": [
              "Sarafianos"
            ],
            "initials": [
              "SG"
            ],
            "authorId": [
              {
                "_": "0000-0002-5840-154X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Christopher Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, United States; Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine, Columbia, MO 65211, United States; Department of Biochemistry, University of Missouri, Columbia, MO 65211, United States. Electronic address: sarafianoss@missouri.edu."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-5840-154X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2211399"
        ],
        "dateOfPublication": [
          "2014 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2014"
        ],
        "printPublicationDate": [
          "2014-10-01"
        ],
        "journal": [
          {
            "title": [
              "Current opinion in virology"
            ],
            "ISOAbbreviation": [
              "Curr Opin Virol"
            ],
            "medlineAbbreviation": [
              "Curr Opin Virol"
            ],
            "NLMid": [
              "101560941"
            ],
            "ISSN": [
              "1879-6257"
            ],
            "ESSN": [
              "1879-6265"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2014"
    ],
    "pageInfo": [
      "45-53"
    ],
    "abstractText": [
      "Coronaviruses are positive stranded RNA viruses that cause respiratory, enteric and central nervous system diseases in many species, including humans. Until recently, the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics. However, the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV), and more recently, Middle East respiratory syndrome coronavirus (MERS-CoV), has impelled the development of such drugs. This review focuses on some newly identified SARS-CoV inhibitors, with known mechanisms of action and their potential to inhibit the novel MERS-CoV. The clinical development of optimized versions of such compounds could be beneficial for the treatment and control of SARS-CoV, the current MERS-CoV and other future SARS-like epidemics."
    ],
    "affiliation": [
      "Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616, United States. Electronic address: aoadedeji@ucdavis.edu."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Review",
          "Journal Article",
          "Research Support, N.I.H., Extramural"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "P50 GM103368"
            ],
            "agency": [
              "NIGMS NIH HHS"
            ],
            "acronym": [
              "GM"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "AI100890"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "R01 AI076119"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "R21 AI112417"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "AI112417"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "R01 AI100890"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "R37 AI076119"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "AI076119"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "GM103368"
            ],
            "agency": [
              "NIGMS NIH HHS"
            ],
            "acronym": [
              "GM"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "AI099284"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "R01 AI099284"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "SARS Virus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IP"
                    ],
                    "qualifierName": [
                      "isolation & purification"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Evaluation, Preclinical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Discovery"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TD"
                    ],
                    "qualifierName": [
                      "trends"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Middle East Respiratory Syndrome Coronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.coviro.2014.06.002"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4195804"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4195804?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "25"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "Y"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "Y"
    ],
    "manuscriptId": [
      "NIHMS606468"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCompletion": [
      "2015-06-09"
    ],
    "dateOfCreation": [
      "2014-07-06"
    ],
    "firstIndexDate": [
      "2014-07-06"
    ],
    "fullTextReceivedDate": [
      "2020-07-12"
    ],
    "dateOfRevision": [
      "2020-06-11"
    ],
    "electronicPublicationDate": [
      "2014-07-02"
    ],
    "firstPublicationDate": [
      "2014-07-02"
    ]
  },
  {
    "id": [
      "27741230"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "27741230"
    ],
    "pmcid": [
      "PMC5065164"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC5065164"
        ]
      }
    ],
    "doi": [
      "10.1371/journal.pone.0163945"
    ],
    "title": [
      "Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C."
    ],
    "authorString": [
      "Davitkov P, Chandar AK, Hirsch A, Compan A, Silveira MG, Anthony DD, Smith S, Gideon C, Bonomo RA, Falck-Ytter Y."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Davitkov P"
            ],
            "firstName": [
              "Perica"
            ],
            "lastName": [
              "Davitkov"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Case Western Reserve University, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Chandar AK"
            ],
            "firstName": [
              "Apoorva Krishna"
            ],
            "lastName": [
              "Chandar"
            ],
            "initials": [
              "AK"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Case Western Reserve University, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hirsch A"
            ],
            "firstName": [
              "Amy"
            ],
            "lastName": [
              "Hirsch"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Compan A"
            ],
            "firstName": [
              "Anita"
            ],
            "lastName": [
              "Compan"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Silveira MG"
            ],
            "firstName": [
              "Marina G"
            ],
            "lastName": [
              "Silveira"
            ],
            "initials": [
              "MG"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Case Western Reserve University, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Anthony DD"
            ],
            "firstName": [
              "Donald D"
            ],
            "lastName": [
              "Anthony"
            ],
            "initials": [
              "DD"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Case Western Reserve University, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Smith S"
            ],
            "firstName": [
              "Suzanne"
            ],
            "lastName": [
              "Smith"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gideon C"
            ],
            "firstName": [
              "Clare"
            ],
            "lastName": [
              "Gideon"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bonomo RA"
            ],
            "firstName": [
              "Robert A"
            ],
            "lastName": [
              "Bonomo"
            ],
            "initials": [
              "RA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Falck-Ytter Y"
            ],
            "firstName": [
              "Yngve"
            ],
            "lastName": [
              "Falck-Ytter"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States of America."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "10"
        ],
        "volume": [
          "11"
        ],
        "journalIssueId": [
          "2457476"
        ],
        "dateOfPublication": [
          "2016 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2016"
        ],
        "printPublicationDate": [
          "2016-01-01"
        ],
        "journal": [
          {
            "title": [
              "PloS one"
            ],
            "ISOAbbreviation": [
              "PLoS ONE"
            ],
            "medlineAbbreviation": [
              "PLoS One"
            ],
            "NLMid": [
              "101285081"
            ],
            "ISSN": [
              "1932-6203"
            ],
            "ESSN": [
              "1932-6203"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2016"
    ],
    "pageInfo": [
      "e0163945"
    ],
    "abstractText": [
      "Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir and telaprevir as uncertainty existed regarding the drug of choice between these two seemingly equally Hepatitis-C treatment options.We randomly assigned 50 patients in an open-label, pragmatic randomized controlled trial (RCT) at a VA Medical Center to either boceprevir or telaprevir in combination with peginterferon and ribavirin, stratified by the presence of cirrhosis and prior treatment experience. Tolerability was assessed at each visit and reasons for discontinuation of treatment and severity of adverse events due to PI treatment were adjudicated using a blinded adjudication committee. The primary outcome was difference in tolerability between boceprevir vs. telaprevir. Secondary outcomes included viral response rates and cost-per cure achieved.Higher rates of treatment discontinuations and/or severe DAA associated adverse events were seen in 10/25 (40%) patients randomized to telaprevir compared to 2/25 (8%) patients randomized to boceprevir (RR: 5; 95% CI: 1.2, 20; p<0.01). Cure rates did not appear to be significantly different between groups (telaprevir vs. boceprevir: RR 1.23; 95% CI: 0.76, 1.99; p = 0.39). On an intention-to-treat basis, total cost per cure was $44,329 for boceprevir vs. $57,115 for telaprevir. The significant side effect profile of telaprevir combined with the availability of highly efficacious second generation DAAs led to the early discontinuation of the trial.Telaprevir is associated with a significantly higher rate of severe adverse events leading to treatment discontinuations, hospitalizations or severe anemia and a substantially higher cost per SVR when compared to boceprevir. Real-time, point of care, pragmatic randomized controlled trials are necessary for guidance beyond just acquisition costs and to make evidence-based formulary selections when multiple effective treatments are available. (Clinicaltrials.gov registration: NCT02113631)."
    ],
    "affiliation": [
      "Case Western Reserve University, Cleveland, Ohio, United States of America."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Randomized Controlled Trial",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "P30 AI036219"
            ],
            "agency": [
              "NIAID NIH HHS"
            ],
            "acronym": [
              "AI"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "I01 CX001104"
            ],
            "agency": [
              "CSRD VA"
            ],
            "acronym": [
              "CX"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis C"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EC"
                    ],
                    "qualifierName": [
                      "economics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Anemia"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ET"
                    ],
                    "qualifierName": [
                      "etiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Proline"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Oligopeptides"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interferon-alpha"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ribavirin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Treatment Outcome"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Therapy, Combination"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hospitalization"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Severity of Illness Index"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mood Disorders"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ET"
                    ],
                    "qualifierName": [
                      "etiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Tolerance"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Middle Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Cost-Benefit Analysis"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Female"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Male"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Oligopeptides"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Interferon-alpha"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Proline"
            ],
            "registryNumber": [
              "9DLQ4CIU6V"
            ]
          },
          {
            "name": [
              "Ribavirin"
            ],
            "registryNumber": [
              "49717AWG6K"
            ]
          },
          {
            "name": [
              "telaprevir"
            ],
            "registryNumber": [
              "655M5O3W0U"
            ]
          },
          {
            "name": [
              "N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide"
            ],
            "registryNumber": [
              "89BT58KELH"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1371/journal.pone.0163945"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5065164"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC5065164?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "1"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCompletion": [
      "2017-06-13"
    ],
    "dateOfCreation": [
      "2016-10-15"
    ],
    "firstIndexDate": [
      "2016-10-15"
    ],
    "fullTextReceivedDate": [
      "2016-10-30"
    ],
    "dateOfRevision": [
      "2017-12-18"
    ],
    "electronicPublicationDate": [
      "2016-10-14"
    ],
    "firstPublicationDate": [
      "2016-10-14"
    ]
  },
  {
    "id": [
      "24458263"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "24458263"
    ],
    "pmcid": [
      "PMC7171712"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7171712"
        ]
      }
    ],
    "doi": [
      "10.1055/s-0033-1360277"
    ],
    "title": [
      "Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus."
    ],
    "authorString": [
      "Schwarz S, Sauter D, Wang K, Zhang R, Sun B, Karioti A, Bilia AR, Efferth T, Schwarz W."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Schwarz S"
            ],
            "firstName": [
              "Silvia"
            ],
            "lastName": [
              "Schwarz"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shanghai Research Center for Acupuncture & Meridians, Shanghai, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sauter D"
            ],
            "firstName": [
              "Daniel"
            ],
            "lastName": [
              "Sauter"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shanghai Research Center for Acupuncture & Meridians, Shanghai, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang K"
            ],
            "firstName": [
              "Kai"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "K"
            ],
            "authorId": [
              {
                "_": "0000-0002-0137-1247",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Shanghai Chinese Academy of Sciences, Shanghai, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang R"
            ],
            "firstName": [
              "Ronghua"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Shanghai Chinese Academy of Sciences, Shanghai, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sun B"
            ],
            "firstName": [
              "Bing"
            ],
            "lastName": [
              "Sun"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Shanghai Chinese Academy of Sciences, Shanghai, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Karioti A"
            ],
            "firstName": [
              "Anastasia"
            ],
            "lastName": [
              "Karioti"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0002-5249-6808",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bilia AR"
            ],
            "firstName": [
              "Anna Rita"
            ],
            "lastName": [
              "Bilia"
            ],
            "initials": [
              "AR"
            ],
            "authorId": [
              {
                "_": "0000-0001-8772-1895",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Chemistry, Building of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino (FI), Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Efferth T"
            ],
            "firstName": [
              "Thomas"
            ],
            "lastName": [
              "Efferth"
            ],
            "initials": [
              "T"
            ],
            "authorId": [
              {
                "_": "0000-0002-3096-3292",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Pharmacology and Biochemistry, J-Gutenberg University, Mainz, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Schwarz W"
            ],
            "firstName": [
              "Wolfgang"
            ],
            "lastName": [
              "Schwarz"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Shanghai Research Center for Acupuncture & Meridians, Shanghai, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-0137-1247",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-5249-6808",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-8772-1895",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-3096-3292",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "2-3"
        ],
        "volume": [
          "80"
        ],
        "journalIssueId": [
          "2130354"
        ],
        "dateOfPublication": [
          "2014 Feb"
        ],
        "monthOfPublication": [
          "2"
        ],
        "yearOfPublication": [
          "2014"
        ],
        "printPublicationDate": [
          "2014-02-01"
        ],
        "journal": [
          {
            "title": [
              "Planta medica"
            ],
            "ISOAbbreviation": [
              "Planta Med."
            ],
            "medlineAbbreviation": [
              "Planta Med"
            ],
            "NLMid": [
              "0066751"
            ],
            "ISSN": [
              "0032-0943"
            ],
            "ESSN": [
              "1439-0221"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2014"
    ],
    "pageInfo": [
      "177-182"
    ],
    "abstractText": [
      "The protein coded by the open-reading-frame 3a of SARS coronavirus has been demonstrated to form a cation-selective channel that may become expressed in the infected cell. The activity of the channel is involved in the mechanism of virus release. Drugs that inhibit the ion channel can, therefore, inhibit virus release, and they could be a source for development of novel therapeutic antiviral agents. Various drugs found in Chinese herbs that are well known as anticancer agents also have an antiviral potency. Here we tested the flavonols kaempferol, kaempferol glycosides, and acylated kaempferol glucoside derivatives with respect to their potency to block the 3a channel. We used the Xenopus oocyte with a heterologously expressed 3a protein as a model system to test the efficacy of the flavonols. Some of these drugs turned out to be potent inhibitors of the 3a channel. The most effective one was the glycoside juglanin (carrying an arabinose residue) with an IC50 value of 2.3 µM for inhibition of the 3a-mediated current. Kaempferol derivatives with rhamnose residue also seem to be quite effective. We suggest that viral ion channels, in general, may be a good target for the development of antiviral agents, and that, in particular, kaempferol glycosides are good candidates for 3a channel proteins of coronaviruses."
    ],
    "affiliation": [
      "Shanghai Research Center for Acupuncture & Meridians, Shanghai, China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Xenopus"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "SARS Virus"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Kaempferols"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Proteins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AI"
                    ],
                    "qualifierName": [
                      "antagonists & inhibitors"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Patch-Clamp Techniques"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "3a protein, severe acute respiratory syndrome coronavirus"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Viral Proteins"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Kaempferols"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1055/s-0033-1360277"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7171712"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7171712?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "11"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2014-11-07"
    ],
    "dateOfCreation": [
      "2014-01-25"
    ],
    "firstIndexDate": [
      "2014-01-25"
    ],
    "fullTextReceivedDate": [
      "2020-04-24"
    ],
    "dateOfRevision": [
      "2020-04-23"
    ],
    "electronicPublicationDate": [
      "2014-01-23"
    ],
    "firstPublicationDate": [
      "2014-01-23"
    ]
  },
  {
    "id": [
      "25798159"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "25798159"
    ],
    "pmcid": [
      "PMC4353274"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4353274"
        ]
      }
    ],
    "doi": [
      "10.1155/2015/371840"
    ],
    "title": [
      "Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014-2015."
    ],
    "authorString": [
      "Stiver HG, Evans GA, Aoki FY, Allen UD, Laverdière M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Stiver HG"
            ],
            "firstName": [
              "H Grant"
            ],
            "lastName": [
              "Stiver"
            ],
            "initials": [
              "HG"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor Emeritus of Medicine, Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Evans GA"
            ],
            "firstName": [
              "Gerald A"
            ],
            "lastName": [
              "Evans"
            ],
            "initials": [
              "GA"
            ],
            "authorId": [
              {
                "_": "0000-0003-2557-0897",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine; Chair, Division of Infectious Diseases, Department of Medicine, Kingston General Hospital, Queen's University, Kingston, Ontario;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Aoki FY"
            ],
            "firstName": [
              "Fred Y"
            ],
            "lastName": [
              "Aoki"
            ],
            "initials": [
              "FY"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor of Medicine, Medical Microbiology and Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Allen UD"
            ],
            "firstName": [
              "Upton D"
            ],
            "lastName": [
              "Allen"
            ],
            "initials": [
              "UD"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor, Department of Pediatrics & Institute of Health Policy, Management and Evaluation; Senior Associate Scientist, Research Institute; Chief, Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Laverdière M"
            ],
            "firstName": [
              "Michel"
            ],
            "lastName": [
              "Laverdière"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology-Infectious Disease, Hopital Maisonneuve-Rosemont, Montreal, Quebec."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-2557-0897",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "26"
        ],
        "journalIssueId": [
          "2265937"
        ],
        "dateOfPublication": [
          "2015 Jan-Feb"
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale"
            ],
            "ISOAbbreviation": [
              "Can J Infect Dis Med Microbiol"
            ],
            "medlineAbbreviation": [
              "Can J Infect Dis Med Microbiol"
            ],
            "NLMid": [
              "101226876"
            ],
            "ISSN": [
              "1712-9532"
            ],
            "ESSN": [
              "1918-1493"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "e5-8"
    ],
    "abstractText": [
      "This article represents the second update to the AMMI Canada Guidelines document on the use of antiviral drugs for influenza. The article aims to inform health care professionals of the increased risk for influenza in long-term care facilities due to a documented mismatch between the components chosen for this season's vaccine and currently circulating influenza strains. Adjusted recommendations for the use of antiviral drugs for influenza in the acute care setting for this season are provided."
    ],
    "affiliation": [
      "Professor Emeritus of Medicine, Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia;"
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1155/2015/371840"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4353274"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4353274?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "2"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-03-23"
    ],
    "dateOfCreation": [
      "2015-03-24"
    ],
    "firstIndexDate": [
      "2015-03-24"
    ],
    "fullTextReceivedDate": [
      "2015-03-23"
    ],
    "dateOfRevision": [
      "2019-06-09"
    ],
    "firstPublicationDate": [
      "2015-01-01"
    ]
  },
  {
    "id": [
      "PMC7173598"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7173598"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7173598"
        ]
      }
    ],
    "title": [
      "Antiviral drugs–: history and obstacles."
    ],
    "authorString": [
      "Korsman SNJ, van Zyl GU, Nutt L, Andersson MI, Preiser W."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Korsman SNJ"
            ],
            "firstName": [
              "Stephen N.J."
            ],
            "lastName": [
              "Korsman"
            ],
            "initials": [
              "SNJ"
            ]
          },
          {
            "fullName": [
              "van Zyl GU"
            ],
            "firstName": [
              "Gert U."
            ],
            "lastName": [
              "van Zyl"
            ],
            "initials": [
              "GU"
            ]
          },
          {
            "fullName": [
              "Nutt L"
            ],
            "firstName": [
              "Louise"
            ],
            "lastName": [
              "Nutt"
            ],
            "initials": [
              "L"
            ]
          },
          {
            "fullName": [
              "Andersson MI"
            ],
            "firstName": [
              "Monique I."
            ],
            "lastName": [
              "Andersson"
            ],
            "initials": [
              "MI"
            ]
          },
          {
            "fullName": [
              "Preiser W"
            ],
            "firstName": [
              "Wolfgang"
            ],
            "lastName": [
              "Preiser"
            ],
            "initials": [
              "W"
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2940796"
        ],
        "dateOfPublication": [
          "2012 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2012"
        ],
        "printPublicationDate": [
          "2012-01-01"
        ],
        "journal": [
          {
            "title": [
              "Virology"
            ],
            "ISOAbbreviation": [
              "Virology"
            ],
            "medlineAbbreviation": [
              "Virology"
            ],
            "NLMid": [
              "0110674"
            ],
            "ISSN": [
              "0042-6822"
            ],
            "ESSN": [
              "1096-0341"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2012"
    ],
    "pageInfo": [
      "36-41"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "chapter-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173598/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7173598"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-04-24"
    ],
    "firstIndexDate": [
      "2020-04-24"
    ],
    "fullTextReceivedDate": [
      "2020-04-24"
    ],
    "dateOfRevision": [
      "2020-04-24"
    ],
    "electronicPublicationDate": [
      "2016-10-14"
    ],
    "firstPublicationDate": [
      "2012-01-01"
    ]
  },
  {
    "id": [
      "26260344"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26260344"
    ],
    "pmcid": [
      "PMC4542094"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4542094"
        ]
      }
    ],
    "doi": [
      "10.1186/s13046-015-0199-5"
    ],
    "title": [
      "Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements."
    ],
    "authorString": [
      "Díaz-Carballo D, Acikelli AH, Klein J, Jastrow H, Dammann P, Wyganowski T, Guemues C, Gustmann S, Bardenheuer W, Malak S, Tefett NS, Khosrawipour V, Giger-Pabst U, Tannapfel A, Strumberg D."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Díaz-Carballo D"
            ],
            "firstName": [
              "David"
            ],
            "lastName": [
              "Díaz-Carballo"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany. david.diaz-carballo@marienhospital-herne.de."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Acikelli AH"
            ],
            "firstName": [
              "Ali Haydar"
            ],
            "lastName": [
              "Acikelli"
            ],
            "initials": [
              "AH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Klein J"
            ],
            "firstName": [
              "Jacqueline"
            ],
            "lastName": [
              "Klein"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jastrow H"
            ],
            "firstName": [
              "Holger"
            ],
            "lastName": [
              "Jastrow"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Anatomy and Experimental Morphology, University of Duisburg-Essen, Medical School, Essen, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dammann P"
            ],
            "firstName": [
              "Philipp"
            ],
            "lastName": [
              "Dammann"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Central Animal Laboratory, University of Duisburg-Essen, Medical School, Essen, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wyganowski T"
            ],
            "firstName": [
              "Thomas"
            ],
            "lastName": [
              "Wyganowski"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Guemues C"
            ],
            "firstName": [
              "Cihan"
            ],
            "lastName": [
              "Guemues"
            ],
            "initials": [
              "C"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gustmann S"
            ],
            "firstName": [
              "Sebastian"
            ],
            "lastName": [
              "Gustmann"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bardenheuer W"
            ],
            "firstName": [
              "Walter"
            ],
            "lastName": [
              "Bardenheuer"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Malak S"
            ],
            "firstName": [
              "Sascha"
            ],
            "lastName": [
              "Malak"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tefett NS"
            ],
            "firstName": [
              "Nora Sophia"
            ],
            "lastName": [
              "Tefett"
            ],
            "initials": [
              "NS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Khosrawipour V"
            ],
            "firstName": [
              "Veria"
            ],
            "lastName": [
              "Khosrawipour"
            ],
            "initials": [
              "V"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Visceral Surgery, Marienhospital Herne, Ruhr University of Bochum, Medical School, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Giger-Pabst U"
            ],
            "firstName": [
              "Urs"
            ],
            "lastName": [
              "Giger-Pabst"
            ],
            "initials": [
              "U"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Visceral Surgery, Marienhospital Herne, Ruhr University of Bochum, Medical School, Herne, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tannapfel A"
            ],
            "firstName": [
              "Andrea"
            ],
            "lastName": [
              "Tannapfel"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute of Pathology, Ruhr-University of Bochum, Medical School, Bochum, Germany."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Strumberg D"
            ],
            "firstName": [
              "Dirk"
            ],
            "lastName": [
              "Strumberg"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "34"
        ],
        "journalIssueId": [
          "2267244"
        ],
        "dateOfPublication": [
          "2015 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of experimental & clinical cancer research : CR"
            ],
            "ISOAbbreviation": [
              "J. Exp. Clin. Cancer Res."
            ],
            "medlineAbbreviation": [
              "J Exp Clin Cancer Res"
            ],
            "NLMid": [
              "8308647"
            ],
            "ISSN": [
              "0392-9078"
            ],
            "ESSN": [
              "1756-9966"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "81"
    ],
    "abstractText": [
      "Endoretroviruses account for circa 8 % of all transposable elements found in the genome of humans and other animals. They represent a genetic footprint of ancestral germ-cell infections of exoviruses that is transmittable to the progeny by Mendelian segregation. Traces of human endogenous retroviruses are physiologically expressed in ovarial, testicular and placental tissues as well as in stem cells. In addition, a number of these fossil viral elements have also been related to carcinogenesis. However, a relation between endoretroviruses expression and chemoresistance has not been reported yet.Twenty colorectal carcinoma patient samples were scrutinized for HERV-WE1 and HERV-FRD1 endoretroviruses using immunohistochemical approaches. In order to search for differential expression of these elements in chemotherapy refractory cells, a resistant HCT8 colon carcinoma subline was developed by serial etoposide exposure. Endoretroviral elements were detected by immunocytochemical staining, qPCR and ELISA. IC50-values of antiviral and cytostatic drugs in HCT8 cells were determined by MTT proliferation assay. The antivirals-cytostatics interaction was evaluated by the isobologram method.In this work, we show for the first time that HERV-WE1, HERV-FRD1, HERV-31, and HERV-V1 are a) simultaneously expressed in treatment-naïve colon carcinoma cells and b) upregulated after cytostatic exposure, suggesting that these retroviral elements are intimately related to chemotherapy resistance. We found a number of antiviral drugs to have cytotoxic activity and the ability to force the downregulation of HERV proteins in vitro. We also demonstrate that the use of different antiviral compounds alone or in combination with anticancer agents results in a synergistic antiproliferative effect and downregulation of different endoretroviral elements in highly chemotherapy-resistant colorectal tumor cells.Enhanced HERV-expression is associated with chemoresistance in colon carcinomas which can be overcome by antiviral drugs alone or in combination with anticancer drugs. Therefore, the introduction of antiviral compounds to the current chemotherapy regimens potentially improves patient outcomes."
    ],
    "affiliation": [
      "Institute for Molecular Oncology and Experimental Therapeutics, Division of Oncology and Hematology, Marienhospital Herne, Ruhr University of Bochum, Medical School, Marienhospital Herne, Duengelstr. 33, 44623, Herne, Germany. david.diaz-carballo@marienhospital-herne.de."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cell Line, Tumor"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Endogenous Retroviruses"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Colorectal Neoplasms"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Transcriptional Activation"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s13046-015-0199-5"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4542094"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4542094?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "5"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen"
        ]
      }
    ],
    "dateOfCompletion": [
      "2016-04-13"
    ],
    "dateOfCreation": [
      "2015-08-11"
    ],
    "firstIndexDate": [
      "2015-08-14"
    ],
    "fullTextReceivedDate": [
      "2015-08-28"
    ],
    "dateOfRevision": [
      "2015-08-21"
    ],
    "electronicPublicationDate": [
      "2015-08-12"
    ],
    "firstPublicationDate": [
      "2015-08-12"
    ]
  },
  {
    "id": [
      "26345608"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26345608"
    ],
    "pmcid": [
      "PMC4531042"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4531042"
        ]
      }
    ],
    "doi": [
      "10.2147/idr.s79131"
    ],
    "title": [
      "Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus."
    ],
    "authorString": [
      "Melendez DP, Razonable RR."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Melendez DP"
            ],
            "firstName": [
              "Dante P"
            ],
            "lastName": [
              "Melendez"
            ],
            "initials": [
              "DP"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA ; William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Razonable RR"
            ],
            "firstName": [
              "Raymund R"
            ],
            "lastName": [
              "Razonable"
            ],
            "initials": [
              "RR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA ; William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2305226"
        ],
        "dateOfPublication": [
          "2015"
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "Infection and drug resistance"
            ],
            "ISOAbbreviation": [
              "Infect Drug Resist"
            ],
            "medlineAbbreviation": [
              "Infect Drug Resist"
            ],
            "NLMid": [
              "101550216"
            ],
            "ISSN": [
              "1178-6973"
            ],
            "ESSN": [
              "1178-6973"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "269-277"
    ],
    "abstractText": [
      "Infection with cytomegalovirus is prevalent in immunosuppressed patients. In solid organ transplant and hematopoietic stem cell transplant recipients, cytomegalovirus infection is associated with high morbidity and preventable mortality. Prevention and treatment of cytomegalovirus with currently approved antiviral drugs is often associated with side effects that sometimes preclude their use. Moreover, cytomegalovirus has developed mutations that confer resistance to standard antiviral drugs. During the last decade, there have been calls to develop novel antiviral drugs that could provide better options for prevention and treatment of cytomegalovirus. Letermovir (AIC246) is a highly specific antiviral drug that is currently undergoing clinical development for the management of cytomegalovirus infection. It acts by inhibiting the viral terminase complex. Letermovir is highly potent in vitro and in vivo against cytomegalovirus. Because of a distinct mechanism of action, it does not exhibit cross-resistance with other antiviral drugs. It is predicted to be active against strains that are resistant to ganciclovir, foscarnet, and cidofovir. To date, early-phase clinical trials suggest a very low incidence of adverse effects. Herein, we present a comprehensive review on letermovir, from its postulated novel mechanism of action to the results of most recent clinical studies."
    ],
    "affiliation": [
      "Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA ; William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USA."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Transplantation",
          "Cytomegalovirus",
          "Antivirals",
          "Terminase",
          "Aic246",
          "Letermovir"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.2147/IDR.S79131"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4531042"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4531042?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "24"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-09-08"
    ],
    "dateOfCreation": [
      "2015-09-08"
    ],
    "firstIndexDate": [
      "2015-09-09"
    ],
    "fullTextReceivedDate": [
      "2015-09-06"
    ],
    "dateOfRevision": [
      "2015-09-10"
    ],
    "electronicPublicationDate": [
      "2015-08-05"
    ],
    "firstPublicationDate": [
      "2015-08-05"
    ]
  },
  {
    "id": [
      "26300933"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26300933"
    ],
    "pmcid": [
      "PMC4539848"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4539848"
        ]
      }
    ],
    "doi": [
      "10.5812/hepatmon.29052v2"
    ],
    "title": [
      "Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis."
    ],
    "authorString": [
      "Long LH, Xue CQ, Shi JF, Dong JN, Wang L."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Long LH"
            ],
            "firstName": [
              "Li-Hui"
            ],
            "lastName": [
              "Long"
            ],
            "initials": [
              "LH"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xue CQ"
            ],
            "firstName": [
              "Cai-Qin"
            ],
            "lastName": [
              "Xue"
            ],
            "initials": [
              "CQ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Shi JF"
            ],
            "firstName": [
              "Jun-Feng"
            ],
            "lastName": [
              "Shi"
            ],
            "initials": [
              "JF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dong JN"
            ],
            "firstName": [
              "Juan-Ni"
            ],
            "lastName": [
              "Dong"
            ],
            "initials": [
              "JN"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang L"
            ],
            "firstName": [
              "Li"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Research Division, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "7"
        ],
        "volume": [
          "15"
        ],
        "journalIssueId": [
          "2316442"
        ],
        "dateOfPublication": [
          "2015 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-07-01"
        ],
        "journal": [
          {
            "title": [
              "Hepatitis monthly"
            ],
            "ISOAbbreviation": [
              "Hepat Mon"
            ],
            "medlineAbbreviation": [
              "Hepat Mon"
            ],
            "NLMid": [
              "101277874"
            ],
            "ISSN": [
              "1735-143X"
            ],
            "ESSN": [
              "1735-3408"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "e29052"
    ],
    "abstractText": [
      "CONTEXT: To systematically evaluate the effects of hepatoprotective agents, when delivered either alone or in combination with other antiviral or non-antiviral drugs in patients with hepatitis B and hepatic fibrosis. OBJECTIVES: The current randomized controlled clinical trials aimed to evaluate the efficacy of combinations of antiviral and non-antiviral hepatoprotective agents on indexes of liver function and liver fibrosis in patients with hepatitis B. DATA SOURCES: Published literatures in Chinese and English on hepatoprotective treatment strategies for chronic hepatitis B and liver fibrosis were searched in three databases and randomized controlled clinical trials were selected. STUDY SELECTION: Data were extracted according to a variety of inclusion and exclusion criteria. Meta-analysis was employed to analyze the data. RESULTS: A total of 22 randomized controlled trials encompassing 1,714 cases were considered in the meta-analysis. The obtained results indicated that the combination of antiviral drug and hepatoprotective agent was better than antiviral drug alone to improve liver function. Similarly, regarding liver fibrosis, using two different hepatoprotective agents was better than using one agent. The normalization rates of Aminotransferase (ALT) and total Bilirubin (TBil) were improved 25.7% by two hepatoprotective agents compared to the single agent. Acetylcysteine was superior to ursodeoxycholic acid or silibinin to reduce ALT. Ursodeoxycholic acid was superior to acetylcysteine or silibinin to reduce TBIL. CONCLUSIONS: Hepatoprotective agents combined with antiviral drugs can significantly improve liver function and liver fibrosis parameters in patients with hepatitis B."
    ],
    "affiliation": [
      "Department of Pharmacy, the First Affiliated Hospital of Xi'an Medical College, Xi'an, Shaanxi 710077, China."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Hepatitis B",
          "Meta-analysis",
          "Liver cirrhosis",
          "acetylcysteine",
          "Silibinin",
          "Ursodeoxycholic Acid (Udca)"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.5812/hepatmon.29052v2"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4539848"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4539848?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-08-24"
    ],
    "dateOfCreation": [
      "2015-08-24"
    ],
    "firstIndexDate": [
      "2015-08-25"
    ],
    "fullTextReceivedDate": [
      "2015-08-28"
    ],
    "dateOfRevision": [
      "2015-08-26"
    ],
    "electronicPublicationDate": [
      "2015-07-22"
    ],
    "firstPublicationDate": [
      "2015-07-22"
    ]
  },
  {
    "id": [
      "26382043"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26382043"
    ],
    "pmcid": [
      "PMC4574619"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4574619"
        ]
      }
    ],
    "doi": [
      "10.1186/s12879-015-1115-5"
    ],
    "title": [
      "Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs."
    ],
    "authorString": [
      "Duintjer Tebbens RJ, Pallansch MA, Thompson KM."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Duintjer Tebbens RJ"
            ],
            "firstName": [
              "Radboud J"
            ],
            "lastName": [
              "Duintjer Tebbens"
            ],
            "initials": [
              "RJ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Kid Risk, Inc., 10524 Moss Park Rd., Ste. 204-364, Orlando, FL, 32832, USA. rdt@kidrisk.org."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Pallansch MA"
            ],
            "firstName": [
              "Mark A"
            ],
            "lastName": [
              "Pallansch"
            ],
            "initials": [
              "MA"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. map1@cdc.gov."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Thompson KM"
            ],
            "firstName": [
              "Kimberly M"
            ],
            "lastName": [
              "Thompson"
            ],
            "initials": [
              "KM"
            ],
            "authorId": [
              {
                "_": "0000-0002-0849-9147",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Kid Risk, Inc., 10524 Moss Park Rd., Ste. 204-364, Orlando, FL, 32832, USA. kimt@kidrisk.org."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-0849-9147",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "15"
        ],
        "journalIssueId": [
          "2476583"
        ],
        "dateOfPublication": [
          "2015 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-09-01"
        ],
        "journal": [
          {
            "title": [
              "BMC infectious diseases"
            ],
            "ISOAbbreviation": [
              "BMC Infect. Dis."
            ],
            "medlineAbbreviation": [
              "BMC Infect Dis"
            ],
            "NLMid": [
              "100968551"
            ],
            "ISSN": [
              "1471-2334"
            ],
            "ESSN": [
              "1471-2334"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "379"
    ],
    "abstractText": [
      "A small number of individuals with B-cell-related primary immunodeficiency diseases (PIDs) may exhibit long-term (prolonged or chronic) excretion of immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) following infection with oral poliovirus vaccine (OPV). These individuals pose a risk of live poliovirus reintroduction into the population after global wild poliovirus eradication and subsequent OPV cessation. Treatment with polio antiviral drugs may potentially stop excretion in some of these individuals and thus may reduce the future population risk.We developed a discrete event simulation model to characterize the global prevalence of long-term iVDPV excretors based on the best available evidence. We explored the impact of different assumptions about the effectiveness of polio antiviral drugs and the fraction of long-term excretors identified and treated.Due to the rarity of long-term iVDPV excretion and limited data on the survival of PID patients in developing countries, uncertainty remains about the current and future prevalence of long-term iVDPV excretors. While the model suggests only approximately 30 current excretors globally and a rapid decrease after OPV cessation, most of these excrete asymptomatically and remain undetected. The possibility that one or more PID patients may continue to excrete iVDPVs for several years after OPV cessation represents a risk for reintroduction of live polioviruses after OPV cessation, particularly for middle-income countries. With the effectiveness of a single polio antiviral drug possibly as low as 40% and no system in place to identify and treat asymptomatic excretors, the impact of passive use of a single polio antiviral drug to treat identified excretors appears limited. Higher drug effectiveness and active efforts to identify long-term excretors will dramatically increase the benefits of polio antiviral drugs.Efforts to develop a second polio antiviral compound to increase polio antiviral effectiveness and/or to maximize the identification and treatment of affected individuals represent important risk management opportunities for the polio endgame. Better data on the survival of PID patients in developing countries and more longitudinal data on their exposure to and recovery from OPV infections would improve our understanding of the risks associated with iVDPV excretors and the benefits of further investments in polio antiviral drugs."
    ],
    "affiliation": [
      "Kid Risk, Inc., 10524 Moss Park Rd., Ste. 204-364, Orlando, FL, 32832, USA. rdt@kidrisk.org."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, U.S. Gov't, P.H.S.",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "U66IP000519"
            ],
            "agency": [
              "NCIRD CDC HHS"
            ],
            "acronym": [
              "IP"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "U66 IP000519"
            ],
            "agency": [
              "NCIRD CDC HHS"
            ],
            "acronym": [
              "IP"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Poliovirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Poliomyelitis"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Immunologic Deficiency Syndromes"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "CO"
                    ],
                    "qualifierName": [
                      "complications"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "MO"
                    ],
                    "qualifierName": [
                      "mortality"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Poliovirus Vaccine, Oral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Prevalence"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Survival Analysis"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Models, Theoretical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Risk Management"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Poliovirus Vaccine, Oral"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s12879-015-1115-5"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4574619"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4574619?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "19"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2016-04-15"
    ],
    "dateOfCreation": [
      "2015-09-19"
    ],
    "firstIndexDate": [
      "2015-09-19"
    ],
    "fullTextReceivedDate": [
      "2015-09-20"
    ],
    "dateOfRevision": [
      "2016-10-19"
    ],
    "electronicPublicationDate": [
      "2015-09-17"
    ],
    "firstPublicationDate": [
      "2015-09-17"
    ]
  },
  {
    "id": [
      "24040153"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "24040153"
    ],
    "pmcid": [
      "PMC3764029"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3764029"
        ]
      }
    ],
    "doi": [
      "10.1371/journal.pone.0074027"
    ],
    "title": [
      "Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs."
    ],
    "authorString": [
      "Mihalik KB, Feigelstock DA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Mihalik KB"
            ],
            "firstName": [
              "Kathleen B"
            ],
            "lastName": [
              "Mihalik"
            ],
            "initials": [
              "KB"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Feigelstock DA"
            ],
            "firstName": [
              "Dino A"
            ],
            "lastName": [
              "Feigelstock"
            ],
            "initials": [
              "DA"
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "9"
        ],
        "volume": [
          "8"
        ],
        "journalIssueId": [
          "2074012"
        ],
        "dateOfPublication": [
          "2013 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2013"
        ],
        "printPublicationDate": [
          "2013-01-01"
        ],
        "journal": [
          {
            "title": [
              "PloS one"
            ],
            "ISOAbbreviation": [
              "PLoS ONE"
            ],
            "medlineAbbreviation": [
              "PLoS One"
            ],
            "NLMid": [
              "101285081"
            ],
            "ISSN": [
              "1932-6203"
            ],
            "ESSN": [
              "1932-6203"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2013"
    ],
    "pageInfo": [
      "e74027"
    ],
    "abstractText": [
      "BACKGROUND: While ribavirin mono-therapy regimens have minimal effect on patients with chronic hepatitis C virus (HCV) infections, they can be efficacious when combined with interferon. Clinical studies show that interferon-free combination therapies containing ribavirin are also efficacious, suggesting that an interferon-free therapy could be adopted in the near future. However, generation of drug resistant mutants and cross resistance to other drugs could impair the efficacy of the treatment. Therefore, understanding the mechanism of HCV resistance to ribavirin and cross resistance to other antiviral drugs could be of major importance. METHODS: We tested the ability of a J6/JFH1 derived HCV ribavirin resistant mutant to grow in tissue cultured Huh7D cells in the presence of the mutagen 5-Fluorouracil and the nucleoside analog 2'-C-Methylcytidine. Virus replication was assessed by detecting HCV antigens by immunofluorescence and by titrating virus present in the supernatants. Recovered viruses were amplified by RT-PCR and sequenced. RESULTS: The sensitivity of HCV-RR relative to parental J6/JFH1 to the tested drugs varied. HCV-RR was more resistant than J6/JFH1 to 5-Fluorouracil but was not more resistant than J6/JFH1 to 2'-C-Methylcytidine. Growth of HCV-RR in 5-Fluorouracil allowed the selection of an HCV-RR derived mutant resistant to 5-Fluorouracil (HCV-5FU). HCV-5FU grows to moderate levels in the presence of high concentrations of 5-Fluorouracil and to parental levels in the absence of the drug. Sequence of its genome shows that HCV-5FU accumulated multiple synonymous and non-synonymous mutations. CONCLUSIONS: These results indicate that determinants of resistance to ribavirin could also confer resistance to other anti-HCV drugs, shedding light toward understanding the mechanism of action of ribavirin and highlighting the importance of combination drug selection for HCV treatment. The results also show that it is possible to select a 5-Fluorouracil HCV resistant mutant that replicates to levels similar to parental virus when grown in the absence of 5-Fluorouracil."
    ],
    "affiliation": [
      "Division of Viral Products, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, United States of America."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic-eCollection"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, U.S. Gov't, P.H.S.",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cell Line"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepacivirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis C, Chronic"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Fluorouracil"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Viral Proteins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cytidine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ribavirin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Microbial Sensitivity Tests"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Amino Acid Substitution"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Resistance, Viral"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Kinetics"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Mutation"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Viral Proteins"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "2'-C-methylcytidine"
            ],
            "registryNumber": [
              "27FS20C1D8"
            ]
          },
          {
            "name": [
              "Fluorouracil"
            ],
            "registryNumber": [
              "U3P01618RT"
            ]
          },
          {
            "name": [
              "Ribavirin"
            ],
            "registryNumber": [
              "49717AWG6K"
            ]
          },
          {
            "name": [
              "Cytidine"
            ],
            "registryNumber": [
              "5CSZ8459RP"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24040153/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24040153/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1371/journal.pone.0074027"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3764029"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3764029?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "3"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "gen"
        ]
      }
    ],
    "dateOfCompletion": [
      "2014-06-15"
    ],
    "dateOfCreation": [
      "2013-09-16"
    ],
    "firstIndexDate": [
      "2013-09-17"
    ],
    "fullTextReceivedDate": [
      "2013-09-15"
    ],
    "electronicPublicationDate": [
      "2013-09-05"
    ],
    "firstPublicationDate": [
      "2013-09-05"
    ]
  },
  {
    "id": [
      "26507957"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "26507957"
    ],
    "pmcid": [
      "PMC4623666"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4623666"
        ]
      }
    ],
    "doi": [
      "10.1038/srep15411"
    ],
    "title": [
      "Sexual behavior, risk perception, and HIV transmission can respond to HIV antiviral drugs and vaccines through multiple pathways."
    ],
    "authorString": [
      "Tully S, Cojocaru M, Bauch CT."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Tully S"
            ],
            "firstName": [
              "Stephen"
            ],
            "lastName": [
              "Tully"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Mathematics and Statistics University of Guelph, 50 Stone Road East, Guelph, ON, N1G 2W1 Canada."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Cojocaru M"
            ],
            "firstName": [
              "Monica"
            ],
            "lastName": [
              "Cojocaru"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Mathematics and Statistics University of Guelph, 50 Stone Road East, Guelph, ON, N1G 2W1 Canada."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bauch CT"
            ],
            "firstName": [
              "Chris T"
            ],
            "lastName": [
              "Bauch"
            ],
            "initials": [
              "CT"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Applied Mathematics University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1 Canada."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "5"
        ],
        "journalIssueId": [
          "2243512"
        ],
        "dateOfPublication": [
          "2015"
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "Scientific reports"
            ],
            "ISOAbbreviation": [
              "Sci Rep"
            ],
            "medlineAbbreviation": [
              "Sci Rep"
            ],
            "NLMid": [
              "101563288"
            ],
            "ISSN": [
              "2045-2322"
            ],
            "ESSN": [
              "2045-2322"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "15411"
    ],
    "abstractText": [
      "There has been growing use of highly active antiretroviral treatment (HAART) for HIV and significant progress in developing prophylactic HIV vaccines. The simplest theories of counterproductive behavioral responses to such interventions tend to focus on single feedback mechanisms: for instance, HAART optimism makes infection less scary and thus promotes risky sexual behavior. Here, we develop an agent based, age-structured model of HIV transmission, risk perception, and partner selection in a core group to explore behavioral responses to interventions. We find that interventions can activate not one, but several feedback mechanisms that could potentially influence decision-making and HIV prevalence. In the model, HAART increases the attractiveness of unprotected sex, but it also increases perceived risk of infection and, on longer timescales, causes demographic impacts that partially counteract HAART optimism. Both HAART and vaccination usually lead to lower rates of unprotected sex on the whole, but intervention effectiveness depends strongly on whether individuals over- or under-estimate intervention coverage. Age-specific effects cause sexual behavior and HIV prevalence to change in opposite ways in old and young age groups. For complex infections like HIV-where interventions influence transmission, demography, sexual behavior and risk perception-we conclude that evaluations of behavioral responses should consider multiple feedback mechanisms."
    ],
    "affiliation": [
      "Department of Mathematics and Statistics University of Guelph, 50 Stone Road East, Guelph, ON, N1G 2W1 Canada."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HIV"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HIV Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PX"
                    ],
                    "qualifierName": [
                      "psychology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TM"
                    ],
                    "qualifierName": [
                      "transmission"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "AIDS Vaccines"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Anti-HIV Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Prevalence"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Risk-Taking"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Sexual Behavior"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PX"
                    ],
                    "qualifierName": [
                      "psychology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Models, Biological"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adolescent"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adult"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Middle Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Disease Transmission, Infectious"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Young Adult"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "AIDS Vaccines"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Anti-HIV Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1038/srep15411"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4623666"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4623666?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "6"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2016-08-17"
    ],
    "dateOfCreation": [
      "2015-10-28"
    ],
    "firstIndexDate": [
      "2015-10-29"
    ],
    "fullTextReceivedDate": [
      "2015-11-05"
    ],
    "dateOfRevision": [
      "2015-11-04"
    ],
    "electronicPublicationDate": [
      "2015-10-28"
    ],
    "firstPublicationDate": [
      "2015-10-28"
    ]
  },
  {
    "id": [
      "24433304"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "24433304"
    ],
    "pmcid": [
      "PMC3898391"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3898391"
        ]
      }
    ],
    "doi": [
      "10.1186/1471-2458-14-41"
    ],
    "title": [
      "Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?"
    ],
    "authorString": [
      "Duque J, McMorrow ML, Cohen AL."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Duque J"
            ],
            "firstName": [
              "Jazmin"
            ],
            "lastName": [
              "Duque"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0003-3484-276X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U,S, Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, Atlanta, GA 30333, USA. jduque@cdc.gov."
                ]
              }
            ]
          },
          {
            "fullName": [
              "McMorrow ML"
            ],
            "firstName": [
              "Meredith L"
            ],
            "lastName": [
              "McMorrow"
            ],
            "initials": [
              "ML"
            ]
          },
          {
            "fullName": [
              "Cohen AL"
            ],
            "firstName": [
              "Adam L"
            ],
            "lastName": [
              "Cohen"
            ],
            "initials": [
              "AL"
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-3484-276X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "14"
        ],
        "journalIssueId": [
          "2473258"
        ],
        "dateOfPublication": [
          "2014 Jan"
        ],
        "monthOfPublication": [
          "1"
        ],
        "yearOfPublication": [
          "2014"
        ],
        "printPublicationDate": [
          "2014-01-01"
        ],
        "journal": [
          {
            "title": [
              "BMC Public Health"
            ],
            "ISOAbbreviation": [
              "BMC Public Health"
            ],
            "medlineAbbreviation": [
              "BMC Public Health"
            ],
            "NLMid": [
              "100968562"
            ],
            "ISSN": [
              "1471-2458"
            ],
            "ESSN": [
              "1471-2458"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2014"
    ],
    "pageInfo": [
      "41"
    ],
    "abstractText": [
      "BACKGROUND:Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa. METHODS:A self-administered survey was distributed among key influenza experts in 40 African countries. RESULTS:Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population. CONCLUSIONS:Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely."
    ],
    "affiliation": [
      "International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U,S, Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, Atlanta, GA 30333, USA. jduque@cdc.gov."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza Vaccines"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "SD"
                    ],
                    "qualifierName": [
                      "supply & distribution"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "SD"
                    ],
                    "qualifierName": [
                      "supply & distribution"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Africa"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Guidelines as Topic"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Surveys and Questionnaires"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Influenza Vaccines"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24433304/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24433304/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/1471-2458-14-41"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3898391"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3898391?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "20"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-08-24"
    ],
    "dateOfCreation": [
      "2014-01-18"
    ],
    "firstIndexDate": [
      "2014-01-18"
    ],
    "fullTextReceivedDate": [
      "2014-01-25"
    ],
    "dateOfRevision": [
      "2019-03-18"
    ],
    "electronicPublicationDate": [
      "2014-01-16"
    ],
    "firstPublicationDate": [
      "2014-01-16"
    ]
  },
  {
    "id": [
      "25252828"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "25252828"
    ],
    "pmcid": [
      "PMC4247767"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4247767"
        ]
      }
    ],
    "doi": [
      "10.1186/1742-4682-11-41"
    ],
    "title": [
      "Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs."
    ],
    "authorString": [
      "Koizumi Y, Iwami S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Koizumi Y"
            ],
            "firstName": [
              "Yoshiki"
            ],
            "lastName": [
              "Koizumi"
            ],
            "initials": [
              "Y"
            ]
          },
          {
            "fullName": [
              "Iwami S"
            ],
            "firstName": [
              "Shingo"
            ],
            "lastName": [
              "Iwami"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Biology, Faculty of Sciences, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan. siwami@kyushu-u.org."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "11"
        ],
        "journalIssueId": [
          "2496185"
        ],
        "dateOfPublication": [
          "2014 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2014"
        ],
        "printPublicationDate": [
          "2014-09-01"
        ],
        "journal": [
          {
            "title": [
              "Theoretical biology & medical modelling"
            ],
            "ISOAbbreviation": [
              "Theor Biol Med Model"
            ],
            "medlineAbbreviation": [
              "Theor Biol Med Model"
            ],
            "NLMid": [
              "101224383"
            ],
            "ISSN": [
              "1742-4682"
            ],
            "ESSN": [
              "1742-4682"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2014"
    ],
    "pageInfo": [
      "41"
    ],
    "abstractText": [
      "In the current era of antiviral drug therapy, combining multiple drugs is a primary approach for improving antiviral effects, reducing the doses of individual drugs, relieving the side effects of strong antiviral drugs, and preventing the emergence of drug-resistant viruses. Although a variety of new drugs have been developed for HIV, HCV and influenza virus, the optimal combinations of multiple drugs are incompletely understood. To optimize the benefits of multi-drugs combinations, we must investigate the interactions between the combined drugs and their target viruses. Mathematical models of viral infection dynamics provide an ideal tool for this purpose. Additionally, whether drug combinations computed by these models are synergistic can be assessed by two prominent drug combination theories, Loewe additivity and Bliss independence. By combining the mathematical modeling of virus dynamics with drug combination theories, we could show the principles by which drug combinations yield a synergistic effect. Here, we describe the theoretical aspects of multi-drugs therapy and discuss their application to antiviral research."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HIV-1"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cytidine Deaminase"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Therapy, Combination"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Dose-Response Relationship, Drug"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mutation"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Models, Biological"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "APOBEC-3G Deaminase"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Cytidine Deaminase"
            ],
            "registryNumber": [
              "EC 3.5.4.5"
            ]
          },
          {
            "name": [
              "APOBEC3G protein, human"
            ],
            "registryNumber": [
              "EC 3.5.4.5"
            ]
          },
          {
            "name": [
              "APOBEC-3G Deaminase"
            ],
            "registryNumber": [
              "EC 3.5.4.5"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/1742-4682-11-41"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4247767"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4247767?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "7"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-03-30"
    ],
    "dateOfCreation": [
      "2014-10-21"
    ],
    "firstIndexDate": [
      "2014-09-26"
    ],
    "fullTextReceivedDate": [
      "2014-12-02"
    ],
    "dateOfRevision": [
      "2016-11-25"
    ],
    "electronicPublicationDate": [
      "2014-09-25"
    ],
    "firstPublicationDate": [
      "2014-09-25"
    ]
  },
  {
    "id": [
      "PMC7148789"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7148789"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7148789"
        ]
      }
    ],
    "title": [
      "Antiviral drugs."
    ],
    "authorString": [
      "Koch O, Sheehy S, Sargent C, Democratis J, Abbas S, Schiefermueller J, Angus BJ."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Koch O"
            ],
            "firstName": [
              "Oliver"
            ],
            "lastName": [
              "Koch"
            ],
            "initials": [
              "O"
            ]
          },
          {
            "fullName": [
              "Sheehy S"
            ],
            "firstName": [
              "Susanne"
            ],
            "lastName": [
              "Sheehy"
            ],
            "initials": [
              "S"
            ]
          },
          {
            "fullName": [
              "Sargent C"
            ],
            "firstName": [
              "Catherine"
            ],
            "lastName": [
              "Sargent"
            ],
            "initials": [
              "C"
            ]
          },
          {
            "fullName": [
              "Democratis J"
            ],
            "firstName": [
              "Jane"
            ],
            "lastName": [
              "Democratis"
            ],
            "initials": [
              "J"
            ]
          },
          {
            "fullName": [
              "Abbas S"
            ],
            "firstName": [
              "Sarah"
            ],
            "lastName": [
              "Abbas"
            ],
            "initials": [
              "S"
            ]
          },
          {
            "fullName": [
              "Schiefermueller J"
            ],
            "firstName": [
              "Jurgen"
            ],
            "lastName": [
              "Schiefermueller"
            ],
            "initials": [
              "J"
            ]
          },
          {
            "fullName": [
              "Angus BJ"
            ],
            "firstName": [
              "Brian J."
            ],
            "lastName": [
              "Angus"
            ],
            "initials": [
              "BJ"
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "32"
        ],
        "journalIssueId": [
          "2941475"
        ],
        "dateOfPublication": [
          "2010 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2010"
        ],
        "printPublicationDate": [
          "2010-01-01"
        ],
        "journal": [
          {
            "title": [
              "Side Effects of Drugs Annual"
            ],
            "ISSN": [
              "0378-6080"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2010"
    ],
    "pageInfo": [
      "529-553"
    ],
    "abstractText": [
      "Publisher SummaryThis chapter discusses the adverse effects of antiviral drugs used against cytomegalovirus, herpesviruses, hepatitis viruses, against HIV, and against influenza viruses. The cidofovir, drug active against cytomegalovirus, has been associated with bronchiolitis obliterans. Aciclovir and valaciclovir has been reported with renal insufficiency. Adefovir , a drug active against hepatitis viruses, is associated with the fall in creatinine clearance in patients with lamivudine-resistant HBe antigen (HBeAg)negative disease. Drugs active against HIV are comprehensively reviewed as in combination, nucleoside analogue reverse transcriptase inhibitors, nucleoside analogue reverse transcriptase inhibitors, and protease inhibitors. In a randomized controlled trial of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir in 656 patients, median total cholesterol increased by 0.5 mmol/l in the patients with the highest minimum drug plasma concentrations. In patients with AIDS-associated AIDS dementia complex taking optimal stable background antiretroviral therapy including either abacavir or placebo, there was significantly more nausea in those who took abacavir."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Other"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148789/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7148789"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-04-16"
    ],
    "firstIndexDate": [
      "2020-04-16"
    ],
    "fullTextReceivedDate": [
      "2020-04-15"
    ],
    "dateOfRevision": [
      "2020-04-16"
    ],
    "electronicPublicationDate": [
      "2010-10-27"
    ],
    "firstPublicationDate": [
      "2010-10-27"
    ]
  },
  {
    "id": [
      "22841701"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "22841701"
    ],
    "pmcid": [
      "PMC7114304"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7114304"
        ]
      }
    ],
    "doi": [
      "10.1016/j.antiviral.2012.07.007"
    ],
    "title": [
      "The viral RNA capping machinery as a target for antiviral drugs."
    ],
    "authorString": [
      "Ferron F, Decroly E, Selisko B, Canard B."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ferron F"
            ],
            "firstName": [
              "François"
            ],
            "lastName": [
              "Ferron"
            ],
            "initials": [
              "F"
            ],
            "authorId": [
              {
                "_": "0000-0002-8351-4992",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Centre National de la Recherche Scientifique and Aix-Marseille Université, UMR 7257, Architecture et Fonction des Macromolécules Biologiques, 163 Avenue de Luminy, 13288 Marseille Cedex 09, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Decroly E"
            ],
            "firstName": [
              "Etienne"
            ],
            "lastName": [
              "Decroly"
            ],
            "initials": [
              "E"
            ],
            "authorId": [
              {
                "_": "0000-0002-6046-024X",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          },
          {
            "fullName": [
              "Selisko B"
            ],
            "firstName": [
              "Barbara"
            ],
            "lastName": [
              "Selisko"
            ],
            "initials": [
              "B"
            ]
          },
          {
            "fullName": [
              "Canard B"
            ],
            "firstName": [
              "Bruno"
            ],
            "lastName": [
              "Canard"
            ],
            "initials": [
              "B"
            ],
            "authorId": [
              {
                "_": "0000-0003-4924-1991",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-8351-4992",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-6046-024X",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-4924-1991",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "96"
        ],
        "journalIssueId": [
          "1971828"
        ],
        "dateOfPublication": [
          "2012 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2012"
        ],
        "printPublicationDate": [
          "2012-10-01"
        ],
        "journal": [
          {
            "title": [
              "Antiviral research"
            ],
            "ISOAbbreviation": [
              "Antiviral Res."
            ],
            "medlineAbbreviation": [
              "Antiviral Res"
            ],
            "NLMid": [
              "8109699"
            ],
            "ISSN": [
              "0166-3542"
            ],
            "ESSN": [
              "1872-9096"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2012"
    ],
    "pageInfo": [
      "21-31"
    ],
    "abstractText": [
      "Most viruses modify their genomic and mRNA 5'-ends with the addition of an RNA cap, allowing efficient mRNA translation, limiting degradation by cellular 5'-3' exonucleases, and avoiding its recognition as foreign RNA by the host cell. Viral RNA caps can be synthesized or acquired through the use of a capping machinery which exhibits a significant diversity in organization, structure and mechanism relative to that of their cellular host. Therefore, viral RNA capping has emerged as an interesting field for antiviral drug design. Here, we review the different pathways and mechanisms used to produce viral mRNA 5'-caps, and present current structures, mechanisms, and inhibitors known to act on viral RNA capping."
    ],
    "affiliation": [
      "Centre National de la Recherche Scientifique and Aix-Marseille Université, UMR 7257, Architecture et Fonction des Macromolécules Biologiques, 163 Avenue de Luminy, 13288 Marseille Cedex 09, France."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Nucleotidyltransferases"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AI"
                    ],
                    "qualifierName": [
                      "antagonists & inhibitors"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "RNA Caps"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "RNA, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Enzyme Inhibitors"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Enzyme Inhibitors"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "RNA, Viral"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "RNA Caps"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Nucleotidyltransferases"
            ],
            "registryNumber": [
              "EC 2.7.7.-"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.antiviral.2012.07.007"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7114304"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7114304?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "27"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "pdb"
        ]
      }
    ],
    "dateOfCompletion": [
      "2013-02-22"
    ],
    "dateOfCreation": [
      "2012-07-31"
    ],
    "firstIndexDate": [
      "2012-07-31"
    ],
    "fullTextReceivedDate": [
      "2020-04-05"
    ],
    "dateOfRevision": [
      "2020-04-07"
    ],
    "electronicPublicationDate": [
      "2012-07-26"
    ],
    "firstPublicationDate": [
      "2012-07-26"
    ]
  },
  {
    "id": [
      "25798158"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "25798158"
    ],
    "pmcid": [
      "PMC4353273"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC4353273"
        ]
      }
    ],
    "doi": [
      "10.1155/2015/613068"
    ],
    "title": [
      "Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season."
    ],
    "authorString": [
      "Aoki FY, Allen UD, Stiver HG, Laverdière M, Skowronski D, Evans GA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Aoki FY"
            ],
            "firstName": [
              "Fred Y"
            ],
            "lastName": [
              "Aoki"
            ],
            "initials": [
              "FY"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor of Medicine, Medical Microbiology and Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Allen UD"
            ],
            "firstName": [
              "Upton D"
            ],
            "lastName": [
              "Allen"
            ],
            "initials": [
              "UD"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor, Department of Pediatrics & Institute of Health Policy, Management and Evaluation; Senior Associate Scientist, Research Institute; Chief, Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Stiver HG"
            ],
            "firstName": [
              "H Grant"
            ],
            "lastName": [
              "Stiver"
            ],
            "initials": [
              "HG"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor Emeritus of Medicine, Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Laverdière M"
            ],
            "firstName": [
              "Michel"
            ],
            "lastName": [
              "Laverdière"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Microbiology-Infectious Disease, Hopital Maisonneuve-Rosemont, Montreal, Quebec;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Skowronski D"
            ],
            "firstName": [
              "Danuta"
            ],
            "lastName": [
              "Skowronski"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Epidemiology Lead, Influenza & Emerging Respiratory Pathogens, BC Centre for Disease Control, Vancouver, British Columbia;"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Evans GA"
            ],
            "firstName": [
              "Gerald A"
            ],
            "lastName": [
              "Evans"
            ],
            "initials": [
              "GA"
            ],
            "authorId": [
              {
                "_": "0000-0003-2557-0897",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Professor of Medicine, Biomedical & Molecular Sciences and Pathology & Molecular Medicine; Chair, Division of Infectious Diseases, Department of Medicine, Kingston General Hospital, Queen's University, Kingston, Ontario."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-2557-0897",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "26"
        ],
        "journalIssueId": [
          "2265937"
        ],
        "dateOfPublication": [
          "2015 Jan-Feb"
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2015"
        ],
        "printPublicationDate": [
          "2015-01-01"
        ],
        "journal": [
          {
            "title": [
              "The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale"
            ],
            "ISOAbbreviation": [
              "Can J Infect Dis Med Microbiol"
            ],
            "medlineAbbreviation": [
              "Can J Infect Dis Med Microbiol"
            ],
            "NLMid": [
              "101226876"
            ],
            "ISSN": [
              "1712-9532"
            ],
            "ESSN": [
              "1918-1493"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2015"
    ],
    "pageInfo": [
      "e1-4"
    ],
    "abstractText": [
      "The AMMI Canada Guidelines document 'The use of antiviral drugs for influenza: A foundation document for practitioners', published in the Autumn 2013 issue of the Journal, outlines the recommendations for the use of antiviral drugs to treat influenza. This article, which represents the first of two updates to these guidelines published in the current issue of the Journal, aims to inform health care professionals of the increased risk for influenza in long-term care facilities due to a documented mismatch between the components chosen for this season's vaccine and currently circulating influenza strains. Adjusted recommendations for the use of antiviral drugs for influenza in long-term care facilities for this season are provided."
    ],
    "affiliation": [
      "Professor of Medicine, Medical Microbiology and Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba;"
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1155/2015/613068"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4353273"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC4353273?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "4"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2015-03-23"
    ],
    "dateOfCreation": [
      "2015-03-24"
    ],
    "firstIndexDate": [
      "2015-03-24"
    ],
    "fullTextReceivedDate": [
      "2015-03-23"
    ],
    "dateOfRevision": [
      "2019-06-09"
    ],
    "firstPublicationDate": [
      "2015-01-01"
    ]
  },
  {
    "id": [
      "21964179"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "21964179"
    ],
    "pmcid": [
      "PMC3184032"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3184032"
        ]
      }
    ],
    "doi": [
      "10.4065/mcp.2011.0309"
    ],
    "title": [
      "Antiviral drugs for viruses other than human immunodeficiency virus."
    ],
    "authorString": [
      "Razonable RR."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Razonable RR"
            ],
            "firstName": [
              "Raymund R"
            ],
            "lastName": [
              "Razonable"
            ],
            "initials": [
              "RR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA. razonable.raymund@mayo.edu"
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "wikipedia",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "10"
        ],
        "volume": [
          "86"
        ],
        "journalIssueId": [
          "1868267"
        ],
        "dateOfPublication": [
          "2011 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2011"
        ],
        "printPublicationDate": [
          "2011-10-01"
        ],
        "journal": [
          {
            "title": [
              "Mayo Clinic proceedings"
            ],
            "ISOAbbreviation": [
              "Mayo Clin. Proc."
            ],
            "medlineAbbreviation": [
              "Mayo Clin Proc"
            ],
            "NLMid": [
              "0405543"
            ],
            "ISSN": [
              "0025-6196"
            ],
            "ESSN": [
              "1942-5546"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2011"
    ],
    "pageInfo": [
      "1009-1026"
    ],
    "abstractText": [
      "Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy. The currently available antiviral drugs target 3 main groups of viruses: herpes, hepatitis, and influenza viruses. With the exception of the antisense molecule fomivirsen, all antiherpes drugs inhibit viral replication by serving as competitive substrates for viral DNA polymerase. Drugs for the treatment of influenza inhibit the ion channel M(2) protein or the enzyme neuraminidase. Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1. Chronic hepatitis B can be treated with interferon or a combination of nucleos(t)ide analogues. Notably, almost all the nucleos(t) ide analogues for the treatment of chronic hepatitis B possess anti-human immunodeficiency virus properties, and they inhibit replication of hepatitis B virus by serving as competitive substrates for its DNA polymerase. Some antiviral drugs possess multiple potential clinical applications, such as ribavirin for the treatment of chronic hepatitis C and respiratory syncytial virus and cidofovir for the treatment of cytomegalovirus and other DNA viruses. Drug resistance is an emerging threat to the clinical utility of antiviral drugs. The major mechanisms for drug resistance are mutations in the viral DNA polymerase gene or in genes that encode for the viral kinases required for the activation of certain drugs such as acyclovir and ganciclovir. Widespread antiviral resistance has limited the clinical utility of M(2) inhibitors for the prevention and treatment of influenza infections. This article provides an overview of clinically available antiviral drugs for the primary care physician, with a special focus on pharmacology, clinical uses, and adverse effects."
    ],
    "affiliation": [
      "Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA. razonable.raymund@mayo.edu"
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis B, Chronic"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Herpesviridae Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis C"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "HIV Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hepatitis"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Foscarnet"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Amantadine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pyrimidinones"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adenine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Guanine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Acyclovir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ganciclovir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Nucleosides"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Valine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Proline"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Oligopeptides"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interferons"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Lamivudine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Thymidine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ribavirin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Protease Inhibitors"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Therapy, Combination"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Comorbidity"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Zanamivir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Oseltamivir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Organophosphonates"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Valacyclovir"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Valganciclovir"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Telbivudine"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Nucleosides"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Pyrimidinones"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Protease Inhibitors"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Interferons"
            ],
            "registryNumber": [
              "9008-11-1"
            ]
          },
          {
            "name": [
              "Oligopeptides"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Organophosphonates"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "valacyclovir"
            ],
            "registryNumber": [
              "MZ1IW7Q79D"
            ]
          },
          {
            "name": [
              "adefovir"
            ],
            "registryNumber": [
              "6GQP90I798"
            ]
          },
          {
            "name": [
              "telbivudine"
            ],
            "registryNumber": [
              "2OC4HKD3SF"
            ]
          },
          {
            "name": [
              "Acyclovir"
            ],
            "registryNumber": [
              "X4HES1O11F"
            ]
          },
          {
            "name": [
              "Amantadine"
            ],
            "registryNumber": [
              "BF4C9Z1J53"
            ]
          },
          {
            "name": [
              "Lamivudine"
            ],
            "registryNumber": [
              "2T8Q726O95"
            ]
          },
          {
            "name": [
              "Adenine"
            ],
            "registryNumber": [
              "JAC85A2161"
            ]
          },
          {
            "name": [
              "Guanine"
            ],
            "registryNumber": [
              "5Z93L87A1R"
            ]
          },
          {
            "name": [
              "Foscarnet"
            ],
            "registryNumber": [
              "364P9RVW4X"
            ]
          },
          {
            "name": [
              "Oseltamivir"
            ],
            "registryNumber": [
              "20O93L6F9H"
            ]
          },
          {
            "name": [
              "Zanamivir"
            ],
            "registryNumber": [
              "L6O3XI777I"
            ]
          },
          {
            "name": [
              "Valine"
            ],
            "registryNumber": [
              "HG18B9YRS7"
            ]
          },
          {
            "name": [
              "Ganciclovir"
            ],
            "registryNumber": [
              "P9G3CKZ4P5"
            ]
          },
          {
            "name": [
              "Proline"
            ],
            "registryNumber": [
              "9DLQ4CIU6V"
            ]
          },
          {
            "name": [
              "Ribavirin"
            ],
            "registryNumber": [
              "49717AWG6K"
            ]
          },
          {
            "name": [
              "Thymidine"
            ],
            "registryNumber": [
              "VC2W18DGKR"
            ]
          },
          {
            "name": [
              "entecavir"
            ],
            "registryNumber": [
              "5968Y6H45M"
            ]
          },
          {
            "name": [
              "telaprevir"
            ],
            "registryNumber": [
              "655M5O3W0U"
            ]
          },
          {
            "name": [
              "N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide"
            ],
            "registryNumber": [
              "89BT58KELH"
            ]
          },
          {
            "name": [
              "valganciclovir"
            ],
            "registryNumber": [
              "GCU97FKN3R"
            ]
          },
          {
            "name": [
              "penciclovir"
            ],
            "registryNumber": [
              "359HUE8FJC"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "AIM"
            ],
            "name": [
              "Core clinical journals"
            ]
          },
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21964179/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21964179/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.4065/mcp.2011.0309"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3184032"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3184032?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "62"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2011-12-07"
    ],
    "dateOfCreation": [
      "2011-10-04"
    ],
    "firstIndexDate": [
      "2011-10-04"
    ],
    "fullTextReceivedDate": [
      "2020-07-08"
    ],
    "dateOfRevision": [
      "2020-04-07"
    ],
    "firstPublicationDate": [
      "2011-10-01"
    ]
  },
  {
    "id": [
      "32338155"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32338155"
    ],
    "pmcid": [
      "PMC7241459"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7241459"
        ]
      }
    ],
    "doi": [
      "10.1080/22221751.2020.1760145"
    ],
    "title": [
      "Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19."
    ],
    "authorString": [
      "Sun X, Ni Y, Zhang M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Sun X"
            ],
            "firstName": [
              "Xiaoxuan"
            ],
            "lastName": [
              "Sun"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ni Y"
            ],
            "firstName": [
              "Yicheng"
            ],
            "lastName": [
              "Ni"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Imaging & Pathology, Faculty of Medicine, KU Leuven, Belgium."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang M"
            ],
            "firstName": [
              "Miaojia"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2893331"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging microbes & infections"
            ],
            "ISOAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "medlineAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "NLMid": [
              "101594885"
            ],
            "ISSN": [
              "2222-1751"
            ],
            "ESSN": [
              "2222-1751"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "830-832"
    ],
    "abstractText": [
      "The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as promising candidate therapeutics that are now under either compassionate off-label use or clinical trials for the treatment of COVID-19 patients. However, there are public concerns and disputes about both the safety and efficacy of CQ and HCQ for this new application. Given the fact that for decades HCQ has been approved as an immunomodulatory drug for the long term treatment of chronic rheumatic diseases, as experienced rheumatologists, we would like to share our thoughts in this regard and trigger a brainstorm among clinical care providers for exchanging their diverse opinions on this urgent topic."
    ],
    "affiliation": [
      "Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Letter"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Hydroxychloroquine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Antirheumatic Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Antimalarials"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Interdisciplinary Communication"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Clinical Trials as Topic"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Rheumatologists"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Therapy",
          "Hydroxychloroquine (Hcq)",
          "Covid-19",
          "Sars-cov-2",
          "Chloroquine (Cq)"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antimalarials"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antirheumatic Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Hydroxychloroquine"
            ],
            "registryNumber": [
              "4QWG6N8QKH"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/22221751.2020.1760145"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7241459"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7241459?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-05-05"
    ],
    "dateOfCreation": [
      "2020-04-28"
    ],
    "firstIndexDate": [
      "2020-04-28"
    ],
    "fullTextReceivedDate": [
      "2020-06-03"
    ],
    "dateOfRevision": [
      "2020-06-02"
    ],
    "firstPublicationDate": [
      "2020-12-01"
    ]
  },
  {
    "id": [
      "32490731"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32490731"
    ],
    "pmcid": [
      "PMC7473106"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7473106"
        ]
      }
    ],
    "doi": [
      "10.1080/22221751.2020.1776161"
    ],
    "title": [
      "Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents."
    ],
    "authorString": [
      "Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Gelman R"
            ],
            "firstName": [
              "Ram"
            ],
            "lastName": [
              "Gelman"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Bayatra A"
            ],
            "firstName": [
              "Areej"
            ],
            "lastName": [
              "Bayatra"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kessler A"
            ],
            "firstName": [
              "Asa"
            ],
            "lastName": [
              "Kessler"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Schwartz A"
            ],
            "firstName": [
              "Asaf"
            ],
            "lastName": [
              "Schwartz"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ilan Y"
            ],
            "firstName": [
              "Yaron"
            ],
            "lastName": [
              "Ilan"
            ],
            "initials": [
              "Y"
            ],
            "authorId": [
              {
                "_": "0000-0003-0802-1220",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-0802-1220",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2893331"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging microbes & infections"
            ],
            "ISOAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "medlineAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "NLMid": [
              "101594885"
            ],
            "ISSN": [
              "2222-1751"
            ],
            "ESSN": [
              "2222-1751"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1397-1406"
    ],
    "abstractText": [
      "The ongoing severe acute respiratory syndrome pandemic caused by the novel coronavirus 2 (SARS-CoV-2) is associated with high morbidity and mortality rates, and it has created a pressing global need for effective antiviral therapies against it. COVID-19 disease pathogenesis is characterized by an initial virus-mediated phase, followed by inappropriate hyperactivation of the immune system leading to organ damage. Targeting of the SARS-CoV-2 viral receptors is being explored as a therapeutic option for these patients. In this paper, we summarize several potential receptors associated with the infectivity of SARS-CoV-2 and discuss their association with the immune-mediated inflammatory response. The potential for the development of resistance towards antiviral drugs is also presented. An algorithm-based platform to improve the efficacy of and overcome resistance to viral receptor blockers through the introduction of personalized variability is described. This method is designed to ensure sustained antiviral effectiveness when using SARS-CoV-2 receptor blockers."
    ],
    "affiliation": [
      "Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Receptors, Virus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AI"
                    ],
                    "qualifierName": [
                      "antagonists & inhibitors"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "IM"
                    ],
                    "qualifierName": [
                      "immunology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Resistance, Viral"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Algorithms"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Receptors",
          "Treatment",
          "Coronavirus",
          "ACE",
          "Dpp4",
          "Viral Resistance",
          "Sars-cov-2"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Receptors, Virus"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/22221751.2020.1776161"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7473106"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7473106?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-06-24"
    ],
    "dateOfCreation": [
      "2020-06-04"
    ],
    "firstIndexDate": [
      "2020-06-04"
    ],
    "fullTextReceivedDate": [
      "2020-09-17"
    ],
    "dateOfRevision": [
      "2020-09-16"
    ],
    "firstPublicationDate": [
      "2020-12-01"
    ]
  },
  {
    "id": [
      "21464934"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "21464934"
    ],
    "pmcid": [
      "PMC3065466"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3065466"
        ]
      }
    ],
    "doi": [
      "10.1371/journal.pone.0017764"
    ],
    "title": [
      "Can antiviral drugs contain pandemic influenza transmission?"
    ],
    "authorString": [
      "Becker NG, Wang D."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Becker NG"
            ],
            "firstName": [
              "Niels G"
            ],
            "lastName": [
              "Becker"
            ],
            "initials": [
              "NG"
            ]
          },
          {
            "fullName": [
              "Wang D"
            ],
            "firstName": [
              "Dingcheng"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "D"
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "6"
        ],
        "journalIssueId": [
          "1815255"
        ],
        "dateOfPublication": [
          "2011 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2011"
        ],
        "printPublicationDate": [
          "2011-01-01"
        ],
        "journal": [
          {
            "title": [
              "PloS one"
            ],
            "ISOAbbreviation": [
              "PLoS ONE"
            ],
            "medlineAbbreviation": [
              "PLoS One"
            ],
            "NLMid": [
              "101285081"
            ],
            "ISSN": [
              "1932-6203"
            ],
            "ESSN": [
              "1932-6203"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2011"
    ],
    "pageInfo": [
      "e17764"
    ],
    "abstractText": [
      "Antiviral drugs dispensed during the 2009 influenza pandemic generally failed to contain transmission. This poses the question of whether preparedness for a future pandemic should include plans to use antiviral drugs to mitigate transmission.Simulations using a standard transmission model that allows for infected arrivals and delayed vaccination show that attempts to contain transmission require relatively few antiviral doses. In contrast, persistent use of antiviral drugs when the reproduction number remains above 1 use very many doses and are unlikely to reduce the eventual attack rate appreciably unless the stockpile is very large. A second model, in which the community has a household structure, shows that the effectiveness of a strategy of dispensing antiviral drugs to infected households decreases rapidly with time delays in dispensing the antivirals. Using characteristics of past pandemics it is estimated that at least 80% of primary household cases must present upon show of symptoms to have a chance of containing transmission by dispensing antiviral drugs to households. To determine data needs, household outbreaks were simulated with 50% receiving antiviral drugs early and 50% receiving antiviral drugs late. A test to compare the size of household outbreaks indicates that at least 100-200 household outbreaks need to be monitored to find evidence that antiviral drugs can mitigate transmission of the newly emerged virus.Use of antiviral drugs in an early attempt to contain transmission should be part of preparedness plans for a future influenza pandemic. Data on the incidence of the first 350 cases and the eventual attack rates of the first 200 hundred household outbreaks should be used to estimate the initial reproduction number R and the effectiveness of antiviral drugs to mitigate transmission. Use of antiviral drugs to mitigate general transmission should cease if these estimates indicate that containment of transmission is unlikely."
    ],
    "affiliation": [
      "National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia. Niels.Becker@anu.edu.au"
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Treatment Outcome"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Models, Statistical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Family Characteristics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Dose-Response Relationship, Drug"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Models, Biological"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Basic Reproduction Number"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TM"
                    ],
                    "qualifierName": [
                      "transmission"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "SN"
                    ],
                    "qualifierName": [
                      "statistics & numerical data"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21464934/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21464934/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1371/journal.pone.0017764"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3065466"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3065466?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "8"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2011-07-18"
    ],
    "dateOfCreation": [
      "2011-04-05"
    ],
    "firstIndexDate": [
      "2011-04-06"
    ],
    "fullTextReceivedDate": [
      "2012-06-13"
    ],
    "dateOfRevision": [
      "2013-06-30"
    ],
    "electronicPublicationDate": [
      "2011-03-28"
    ],
    "firstPublicationDate": [
      "2011-03-28"
    ]
  },
  {
    "id": [
      "32963581"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32963581"
    ],
    "pmcid": [
      "PMC7498411"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7498411"
        ]
      }
    ],
    "doi": [
      "10.1016/j.nantod.2020.100976"
    ],
    "title": [
      "Antiviral nanoagents: More attention and effort needed?"
    ],
    "authorString": [
      "Chen Y, Ma J, Xu M, Liu S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Chen Y"
            ],
            "firstName": [
              "Yongjiu"
            ],
            "lastName": [
              "Chen"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.",
                  "University of Chinese Academy of Sciences, Beijing 100049, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ma J"
            ],
            "firstName": [
              "Juan"
            ],
            "lastName": [
              "Ma"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.",
                  "University of Chinese Academy of Sciences, Beijing 100049, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xu M"
            ],
            "firstName": [
              "Ming"
            ],
            "lastName": [
              "Xu"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.",
                  "School of Environment, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.",
                  "University of Chinese Academy of Sciences, Beijing 100049, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu S"
            ],
            "firstName": [
              "Sijin"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.",
                  "University of Chinese Academy of Sciences, Beijing 100049, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "35"
        ],
        "journalIssueId": [
          "2986466"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Nano today"
            ],
            "ISOAbbreviation": [
              "Nano Today"
            ],
            "medlineAbbreviation": [
              "Nano Today"
            ],
            "NLMid": [
              "101297352"
            ],
            "ISSN": [
              "1748-0132"
            ],
            "ESSN": [
              "1878-044X"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "100976"
    ],
    "abstractText": [
      "The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps."
    ],
    "affiliation": [
      "State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Mechanism",
          "Therapeutics",
          "antivirus",
          "Engineered Nanomaterials",
          "Nanoagents"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.nantod.2020.100976"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7498411"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7498411?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "N"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-23"
    ],
    "firstIndexDate": [
      "2020-09-24"
    ],
    "fullTextReceivedDate": [
      "2020-09-20"
    ],
    "dateOfRevision": [
      "2020-09-24"
    ],
    "electronicPublicationDate": [
      "2020-09-18"
    ],
    "firstPublicationDate": [
      "2020-09-18"
    ]
  },
  {
    "id": [
      "32623657"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32623657"
    ],
    "pmcid": [
      "PMC7335219"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7335219"
        ]
      }
    ],
    "doi": [
      "10.1007/s41669-020-00222-x"
    ],
    "title": [
      "The Cost Effectiveness of Stockpiling Drugs, Vaccines and Other Health Resources for Pandemic Preparedness."
    ],
    "authorString": [
      "Plans-Rubió P."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Plans-Rubió P"
            ],
            "firstName": [
              "Pedro"
            ],
            "lastName": [
              "Plans-Rubió"
            ],
            "initials": [
              "P"
            ],
            "authorId": [
              {
                "_": "0000-0002-4424-2971",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Health of Catalonia, Public Health Agency of Catalonia, Roc Boronat 83-95, 08005, Barcelona, Spain. pedro.plans@gencat.cat."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-4424-2971",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "4"
        ],
        "journalIssueId": [
          "2995233"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "PharmacoEconomics - open"
            ],
            "ISOAbbreviation": [
              "Pharmacoecon Open"
            ],
            "medlineAbbreviation": [
              "Pharmacoecon Open"
            ],
            "NLMid": [
              "101700780"
            ],
            "ISSN": [
              "2509-4262"
            ],
            "ESSN": [
              "2509-4254"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "393-395"
    ],
    "affiliation": [
      "Department of Health of Catalonia, Public Health Agency of Catalonia, Roc Boronat 83-95, 08005, Barcelona, Spain. pedro.plans@gencat.cat."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Editorial"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1007/s41669-020-00222-x"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7335219"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7335219?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-07-06"
    ],
    "firstIndexDate": [
      "2020-07-06"
    ],
    "fullTextReceivedDate": [
      "2020-08-21"
    ],
    "dateOfRevision": [
      "2020-09-21"
    ],
    "firstPublicationDate": [
      "2020-09-01"
    ]
  },
  {
    "id": [
      "32579067"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32579067"
    ],
    "pmcid": [
      "PMC7473320"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7473320"
        ]
      }
    ],
    "doi": [
      "10.1080/22221751.2020.1787108"
    ],
    "title": [
      "In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies."
    ],
    "authorString": [
      "Andrews CD, Huang Y, Ho DD, Liberatore RA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Andrews CD"
            ],
            "firstName": [
              "Chasity D"
            ],
            "lastName": [
              "Andrews"
            ],
            "initials": [
              "CD"
            ],
            "authorId": [
              {
                "_": "0000-0001-9675-172X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "RenBio, Inc., New York, NY, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Huang Y"
            ],
            "firstName": [
              "Yaoxing"
            ],
            "lastName": [
              "Huang"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Aaron Diamond AIDS Research Center, New York, NY, USA.",
                  "Columbia University Vagelos College of Physicans and Surgeons, New York, NY, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ho DD"
            ],
            "firstName": [
              "David D"
            ],
            "lastName": [
              "Ho"
            ],
            "initials": [
              "DD"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Aaron Diamond AIDS Research Center, New York, NY, USA.",
                  "Columbia University Vagelos College of Physicans and Surgeons, New York, NY, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liberatore RA"
            ],
            "firstName": [
              "Rachel A"
            ],
            "lastName": [
              "Liberatore"
            ],
            "initials": [
              "RA"
            ],
            "authorId": [
              {
                "_": "0000-0002-3861-5858",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "RenBio, Inc., New York, NY, USA."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-9675-172X",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-3861-5858",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2893331"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging microbes & infections"
            ],
            "ISOAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "medlineAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "NLMid": [
              "101594885"
            ],
            "ISSN": [
              "2222-1751"
            ],
            "ESSN": [
              "2222-1751"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1523-1533"
    ],
    "abstractText": [
      "With increasing frequency, humans are facing outbreaks of emerging infectious diseases (EIDs) with the potential to cause significant morbidity and mortality. In the most extreme instances, such outbreaks can become pandemics, as we are now witnessing with COVID-19. According to the World Health Organization, this new disease, caused by the novel coronavirus SARS-CoV-2, has already infected more than 10 million people worldwide and led to 499,913 deaths as of 29 June, 2020. How high these numbers will eventually go depends on many factors, including policies on travel and movement, availability of medical support, and, because there is no vaccine or highly effective treatment, the pace of biomedical research. Other than an approved antiviral drug that can be repurposed, monoclonal antibodies (mAbs) hold the most promise for providing a stopgap measure to lessen the impact of an outbreak while vaccines are in development. Technical advances in mAb identification, combined with the flexibility and clinical experience of mAbs in general, make them ideal candidates for rapid deployment. Furthermore, the development of mAb cocktails can provide a faster route to developing a robust medical intervention than searching for a single, outstanding mAb. In addition, mAbs are well-suited for integration into platform technologies for delivery, in which minimal components need to be changed in order to be redirected against a novel pathogen. In particular, utilizing the manufacturing and logistical benefits of DNA-based platform technologies in order to deliver one or more antiviral mAbs has the potential to revolutionize EID responses."
    ],
    "affiliation": [
      "RenBio, Inc., New York, NY, USA."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Mice"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Communicable Diseases, Emerging"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "DNA"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Biological Products"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antibodies, Monoclonal"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antibodies, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "GE"
                    ],
                    "qualifierName": [
                      "genetics"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Time Factors"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Discovery"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Post-Exposure Prophylaxis"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PC"
                    ],
                    "qualifierName": [
                      "prevention & control"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Gene transfer",
          "Antibody cocktail",
          "Electroporation",
          "Antivirals",
          "Emerging Infectious Disease",
          "Neutralizing Antibodies",
          "Dna Therapeutics"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "DNA"
            ],
            "registryNumber": [
              "9007-49-2"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antibodies, Viral"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Biological Products"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antibodies, Monoclonal"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/22221751.2020.1787108"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7473320"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7473320?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by-nc"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-07-13"
    ],
    "dateOfCreation": [
      "2020-06-25"
    ],
    "firstIndexDate": [
      "2020-06-25"
    ],
    "fullTextReceivedDate": [
      "2020-09-17"
    ],
    "dateOfRevision": [
      "2020-09-16"
    ],
    "firstPublicationDate": [
      "2020-12-01"
    ]
  },
  {
    "id": [
      "32375558"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32375558"
    ],
    "pmcid": [
      "PMC7219522"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7219522"
        ]
      }
    ],
    "doi": [
      "10.1080/21505594.2020.1760443"
    ],
    "title": [
      "Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages."
    ],
    "authorString": [
      "Aquaro S, Borrajo A, Pellegrino M, Svicher V."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Aquaro S"
            ],
            "firstName": [
              "Stefano"
            ],
            "lastName": [
              "Aquaro"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Borrajo A"
            ],
            "firstName": [
              "Ana"
            ],
            "lastName": [
              "Borrajo"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Experimental Medicine, University of Rome Tor Vergata, Roma, Italy.",
                  "Department of Microbiology and Parasitology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Pellegrino M"
            ],
            "firstName": [
              "Michele"
            ],
            "lastName": [
              "Pellegrino"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Svicher V"
            ],
            "firstName": [
              "Valentina"
            ],
            "lastName": [
              "Svicher"
            ],
            "initials": [
              "V"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Experimental Medicine, University of Rome Tor Vergata, Roma, Italy."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "11"
        ],
        "journalIssueId": [
          "2895107"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Virulence"
            ],
            "ISOAbbreviation": [
              "Virulence"
            ],
            "medlineAbbreviation": [
              "Virulence"
            ],
            "NLMid": [
              "101531386"
            ],
            "ISSN": [
              "2150-5594"
            ],
            "ESSN": [
              "2150-5608"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "400-413"
    ],
    "abstractText": [
      "Ongoing with current combinations of antiretroviral drugs for the treatment of Human Immunodeficiency Virus (HIV) infection can successfully maintain long-term suppression of HIV-1 replication in plasma. Still, none of these therapies is capable of extinguishing the virus from the long-lived cellular reservoir, including monocyte-derived macrophages (MDM), that means the principal obstacle to HIV cure. MDM are widely distributed in all tissues and organs, including central system nervous (CNS) where they represent the most frequent HIV-infected cells that means the principal obstacle to HIV cure. Current FDA-approved antiretroviral drugs target viral reverse transcriptase, protease, integrase, and entry processes (coreceptor or fusion blockade). It is desirable to continue to develop new antiretrovirals directed against alternative targets in the virus lifecycle in order to further optimize therapeutic options, overcome resistance to existing medications, and potentially contribute to the elimination of viral reservoirs.This review provides a comprehensive overview of the activity of antiretroviral drugs (classical and upcoming) in monocytes-derived macrophages (MDM). Defining the antiviral activity of these drugs in this important cellular HIV-1 reservoir provides crucial hints about their efficacy in HIV-1 infected patients."
    ],
    "affiliation": [
      "Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "review-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "HIV-1",
          "Macrophages",
          "Virus Reservoir",
          "Antiretroviral Drugs Target"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/21505594.2020.1760443"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7219522"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7219522?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-05-08"
    ],
    "firstIndexDate": [
      "2020-05-12"
    ],
    "fullTextReceivedDate": [
      "2020-05-21"
    ],
    "dateOfRevision": [
      "2020-06-01"
    ],
    "firstPublicationDate": [
      "2020-12-01"
    ]
  },
  {
    "id": [
      "PMC7484566"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7484566"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7484566"
        ]
      }
    ],
    "title": [
      "Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine–promising therapeutic strategy for SARS-CoV-2 treatment"
    ],
    "authorString": [
      "Ansari M, Almatroudi A, Alzohairy M, AlYahya S, Alomary M, Al-Dossary H, Alghamdi S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ansari M"
            ],
            "firstName": [
              "Mohammad Azam"
            ],
            "lastName": [
              "Ansari"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Department of Epidemic Disease Research, Institute for Research & Medical Consultations (IRMC),  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Almatroudi A"
            ],
            "firstName": [
              "Ahmad"
            ],
            "lastName": [
              "Almatroudi"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Department of Medical Laboratories, College of Applied Medical Sciences,  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alzohairy M"
            ],
            "firstName": [
              "Mohammad A."
            ],
            "lastName": [
              "Alzohairy"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Department of Medical Laboratories, College of Applied Medical Sciences,  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "AlYahya S"
            ],
            "firstName": [
              "Sami"
            ],
            "lastName": [
              "AlYahya"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "c National Center for Biotechnology,  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alomary M"
            ],
            "firstName": [
              "Mohammad N."
            ],
            "lastName": [
              "Alomary"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "d National Center for Biotechnology, Life Science and Environmental Research Institute,  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Al-Dossary H"
            ],
            "firstName": [
              "Hanan A."
            ],
            "lastName": [
              "Al-Dossary"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Department of Epidemic Disease Research, Institute for Research & Medical Consultations (IRMC),  ,  ,"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Alghamdi S"
            ],
            "firstName": [
              "Saad"
            ],
            "lastName": [
              "Alghamdi"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "e Laboratory Medicine Department, Faculty of Applied Medical Sciences,  ,  ,"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3011227"
        ],
        "dateOfPublication": [
          " "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "0"
        ],
        "journal": [
          {
            "title": [
              "Expert opinion on drug delivery"
            ],
            "ISOAbbreviation": [
              "Expert Opin Drug Deliv"
            ],
            "medlineAbbreviation": [
              "Expert Opin Drug Deliv"
            ],
            "NLMid": [
              "101228421"
            ],
            "ISSN": [
              "1742-5247"
            ],
            "ESSN": [
              "1744-7593"
            ]
          }
        ]
      }
    ],
    "pageInfo": [
      "1-4"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Editorial"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Vaccine",
          "Pandemic",
          "Drug Delivery",
          "Tat-peptide",
          "Covid-19",
          "Sars-cov-2",
          "Silver Bullet",
          "Lipid-based Nanocarriers",
          "Outbreak; Nanoformulations"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484566/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484566/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7484566"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7484566?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-13"
    ],
    "firstIndexDate": [
      "2020-09-13"
    ],
    "fullTextReceivedDate": [
      "2020-09-13"
    ],
    "dateOfRevision": [
      "2020-09-14"
    ],
    "firstPublicationDate": [
      "2020-09-13"
    ]
  },
  {
    "id": [
      "21699699"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "21699699"
    ],
    "pmcid": [
      "PMC3136400"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3136400"
        ]
      }
    ],
    "doi": [
      "10.1186/1479-0556-9-11"
    ],
    "title": [
      "Antiviral drugs against hepatitis C virus."
    ],
    "authorString": [
      "Rehman S, Ashfaq UA, Javed T."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Rehman S"
            ],
            "firstName": [
              "Sidra"
            ],
            "lastName": [
              "Rehman"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Molecular Medicine, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ashfaq UA"
            ],
            "firstName": [
              "Usman A"
            ],
            "lastName": [
              "Ashfaq"
            ],
            "initials": [
              "UA"
            ],
            "authorId": [
              {
                "_": "0000-0002-5495-805X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Molecular Medicine, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Javed T"
            ],
            "firstName": [
              "Tariq"
            ],
            "lastName": [
              "Javed"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Molecular Medicine, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-5495-805X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2578746"
        ],
        "dateOfPublication": [
          "2011 Jun"
        ],
        "monthOfPublication": [
          "6"
        ],
        "yearOfPublication": [
          "2011"
        ],
        "printPublicationDate": [
          "2011-06-01"
        ],
        "journal": [
          {
            "title": [
              "Genetic vaccines and therapy"
            ],
            "ISOAbbreviation": [
              "Genet Vaccines Ther"
            ],
            "medlineAbbreviation": [
              "Genet Vaccines Ther"
            ],
            "NLMid": [
              "101178414"
            ],
            "ESSN": [
              "1479-0556"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2011"
    ],
    "pageInfo": [
      "11"
    ],
    "abstractText": [
      "Hepatitis C virus (HCV) infection is a major worldwide problem causes acute and chronic HCV infection. Current treatment of HCV includes pegylated interferon-α (PEG IFN- α) plus ribavirin (RBV) which has significant side effects depending upon the type of genotype. Currently, there is a need to develop antiviral agents, both from synthetic chemistry and Herbal sources. In the last decade, various novel HCV replication, helicase and entry inhibitors have been synthesized and some of which have been entered in different phases of clinical trials. Successful results have been acquired by executing combinational therapy of compounds with standard regime in different HCV replicons. Even though, diverse groups of compounds have been described as antiviral targets against HCV via Specifically Targeted Antiviral Therapy for hepatitis C (STAT-C) approach (in which compounds are designed to directly block HCV or host proteins concerned in HCV replication), still there is a need to improve the properties of existing antiviral compounds. In this review, we sum up potent antiviral compounds against entry, unwinding and replication of HCV and discussed their activity in combination with standard therapy. Conclusively, further innovative research on chemical compounds will lead to consistent standard therapy with fewer side effects."
    ],
    "affiliation": [
      "Division of Molecular Medicine, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Journal Article"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21699699/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21699699/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/1479-0556-9-11"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3136400"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3136400?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "11"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2011-11-10"
    ],
    "dateOfCreation": [
      "2011-07-15"
    ],
    "firstIndexDate": [
      "2011-06-27"
    ],
    "fullTextReceivedDate": [
      "2013-04-03"
    ],
    "dateOfRevision": [
      "2017-07-18"
    ],
    "electronicPublicationDate": [
      "2011-06-23"
    ],
    "firstPublicationDate": [
      "2011-06-23"
    ]
  },
  {
    "id": [
      "32763818"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32763818"
    ],
    "pmcid": [
      "PMC7392152"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7392152"
        ]
      }
    ],
    "doi": [
      "10.1016/j.biopha.2020.110582"
    ],
    "title": [
      "Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19."
    ],
    "authorString": [
      "Norinder U, Tuck A, Norgren K, Munic Kos V."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Norinder U"
            ],
            "firstName": [
              "Ulf"
            ],
            "lastName": [
              "Norinder"
            ],
            "initials": [
              "U"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Tuck A"
            ],
            "firstName": [
              "Astrud"
            ],
            "lastName": [
              "Tuck"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Norgren K"
            ],
            "firstName": [
              "Kalle"
            ],
            "lastName": [
              "Norgren"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Munic Kos V"
            ],
            "firstName": [
              "Vesna"
            ],
            "lastName": [
              "Munic Kos"
            ],
            "initials": [
              "V"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: vesna.munic.kos@ki.se."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "130"
        ],
        "journalIssueId": [
          "2979838"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"
            ],
            "ISOAbbreviation": [
              "Biomed. Pharmacother."
            ],
            "medlineAbbreviation": [
              "Biomed Pharmacother"
            ],
            "NLMid": [
              "8213295"
            ],
            "ISSN": [
              "0753-3322"
            ],
            "ESSN": [
              "1950-6007"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "110582"
    ],
    "abstractText": [
      "Given the speed of viral infection spread, repurposing of existing drugs has been given the highest priority in combating the ongoing COVID-19 pandemic. Only drugs that are already registered or close to registration, and therefore have passed lengthy safety assessments, have a chance to be tested in clinical trials and reach patients quickly enough to help in the current disease outbreak. Here, we have reviewed available evidence and possible ways forward to identify already existing pharmaceuticals displaying modest broad-spectrum antiviral activity which is likely linked to their high accumulation in cells. Several well studied examples indicate that these drugs accumulate in lysosomes, endosomes and biological membranes in general, and thereby interfere with endosomal pathway and intracellular membrane trafficking crucial for viral infection. With the aim to identify other lysosomotropic drugs with possible inherent antiviral activity, we have applied a set of clear physicochemical, pharmacokinetic and molecular criteria on 530 existing drugs. In addition to publicly available data, we have also used our in silico model for the prediction of accumulation in lysosomes and endosomes. By this approach we have identified 36 compounds with possible antiviral effects, also against coronaviruses. For 14 of them evidence of broad-spectrum antiviral activity has already been reported, adding support to the value of this approach. Presented pros and cons, knowledge gaps and methods to identify lysosomotropic antivirals, can help in the evaluation of many drugs currently in clinical trials considered for repurposing to target COVID-19, as well as open doors to finding more potent and safer alternatives."
    ],
    "affiliation": [
      "Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "brief-report",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral drugs",
          "Drug Repositioning",
          "Lysosomotropism",
          "Endosomal Pathway",
          "Broad Spectrum Antivirals",
          "Covid-19"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.biopha.2020.110582"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7392152"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7392152?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-09"
    ],
    "firstIndexDate": [
      "2020-08-10"
    ],
    "fullTextReceivedDate": [
      "2020-08-05"
    ],
    "dateOfRevision": [
      "2020-08-14"
    ],
    "electronicPublicationDate": [
      "2020-07-30"
    ],
    "firstPublicationDate": [
      "2020-07-30"
    ]
  },
  {
    "id": [
      "PMC7501528"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7501528"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7501528"
        ]
      }
    ],
    "title": [
      "From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic☆ Del empirismo a la evidencia científica en el tratamiento con antivíricos en los casos graves de infección por Coronavirus en tiempos de epidemia"
    ],
    "authorString": [
      "Estella Á, Garnacho-Montero J."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Estella Á"
            ],
            "firstName": [
              "Ángel"
            ],
            "lastName": [
              "Estella"
            ],
            "initials": [
              "Á"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Servicio de Medicina Intensiva, Hospital Universitario de Jerez, Jerez (Sevilla), Spain"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Garnacho-Montero J"
            ],
            "firstName": [
              "Jose"
            ],
            "lastName": [
              "Garnacho-Montero"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Servicio de Medicina Intensiva, Hospital Unversitario Virgen Macarena, Sevilla, Spain"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3009664"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "Medicina Intensiva"
            ],
            "ESSN": [
              "2173-5727"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "brief-report",
          "Brief Report"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501528/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501528/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7501528"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7501528?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "N"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-24"
    ],
    "firstIndexDate": [
      "2020-09-24"
    ],
    "fullTextReceivedDate": [
      "2020-09-24"
    ],
    "dateOfRevision": [
      "2020-09-24"
    ],
    "electronicPublicationDate": [
      "2020-09-19"
    ],
    "firstPublicationDate": [
      "2020-09-19"
    ]
  },
  {
    "id": [
      "32786284"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32786284"
    ],
    "pmcid": [
      "PMC7437450"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7437450"
        ]
      }
    ],
    "doi": [
      "10.1021/acsinfecdis.0c00522"
    ],
    "title": [
      "Anti-SARS-CoV-2 Potential of Artemisinins In Vitro."
    ],
    "authorString": [
      "Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, Zhang H, Yan Y, Zhao L, Li W, Zhang T, Xiao D, Guo X, Li Y, Yang J, Hu Z, Wang M, Zhong W."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Cao R"
            ],
            "firstName": [
              "Ruiyuan"
            ],
            "lastName": [
              "Cao"
            ],
            "initials": [
              "R"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hu H"
            ],
            "firstName": [
              "Hengrui"
            ],
            "lastName": [
              "Hu"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China.",
                  "University of the Chinese Academy of Sciences, Beijing 100049, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Li Y"
            ],
            "firstName": [
              "Yufeng"
            ],
            "lastName": [
              "Li"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China.",
                  "University of the Chinese Academy of Sciences, Beijing 100049, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang X"
            ],
            "firstName": [
              "Xi"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xu M"
            ],
            "firstName": [
              "Mingyue"
            ],
            "lastName": [
              "Xu"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China.",
                  "University of the Chinese Academy of Sciences, Beijing 100049, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu J"
            ],
            "firstName": [
              "Jia"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang H"
            ],
            "firstName": [
              "Huanyu"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China.",
                  "University of the Chinese Academy of Sciences, Beijing 100049, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yan Y"
            ],
            "firstName": [
              "Yunzheng"
            ],
            "lastName": [
              "Yan"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhao L"
            ],
            "firstName": [
              "Lei"
            ],
            "lastName": [
              "Zhao"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Li W"
            ],
            "firstName": [
              "Wei"
            ],
            "lastName": [
              "Li"
            ],
            "initials": [
              "W"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang T"
            ],
            "firstName": [
              "Tianhong"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.",
                  "Guoke Excellence (Beijing) Medicine Technology Research Co., Ltd., Beijing 100176, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xiao D"
            ],
            "firstName": [
              "Dian"
            ],
            "lastName": [
              "Xiao"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Guo X"
            ],
            "firstName": [
              "Xiaojia"
            ],
            "lastName": [
              "Guo"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Li Y"
            ],
            "firstName": [
              "Yuexiang"
            ],
            "lastName": [
              "Li"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yang J"
            ],
            "firstName": [
              "Jingjing"
            ],
            "lastName": [
              "Yang"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hu Z"
            ],
            "firstName": [
              "Zhihong"
            ],
            "lastName": [
              "Hu"
            ],
            "initials": [
              "Z"
            ],
            "authorId": [
              {
                "_": "0000-0002-1560-0928",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang M"
            ],
            "firstName": [
              "Manli"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, P. R. China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhong W"
            ],
            "firstName": [
              "Wu"
            ],
            "lastName": [
              "Zhong"
            ],
            "initials": [
              "W"
            ],
            "authorId": [
              {
                "_": "0000-0002-0536-620X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-1560-0928",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-0536-620X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "9"
        ],
        "volume": [
          "6"
        ],
        "journalIssueId": [
          "3010037"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "ACS infectious diseases"
            ],
            "ISOAbbreviation": [
              "ACS Infect Dis"
            ],
            "medlineAbbreviation": [
              "ACS Infect Dis"
            ],
            "NLMid": [
              "101654580"
            ],
            "ISSN": [
              "2373-8227"
            ],
            "ESSN": [
              "2373-8227"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "2524-2531"
    ],
    "abstractText": [
      "The discovery of novel drug candidates with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) potential is critical for the control of the global COVID-19 pandemic. Artemisinin, an old antimalarial drug derived from Chinese herbs, has saved millions of lives. Artemisinins are a cluster of artemisinin-related drugs developed for the treatment of malaria and have been reported to have multiple pharmacological activities, including anticancer, antiviral, and immune modulation. Considering the reported broad-spectrum antiviral potential of artemisinins, researchers are interested in whether they could be used to combat COVID-19. We systematically evaluated the anti-SARS-CoV-2 activities of nine artemisinin-related compounds in vitro and carried out a time-of-drug-addition assay to explore their antiviral mode of action. Finally, a pharmacokinetic prediction model was established to predict the therapeutic potential of selected compounds against COVID-19. Arteannuin B showed the highest anti-SARS-CoV-2 potential with an EC50 of 10.28 ± 1.12 μM. Artesunate and dihydroartemisinin showed similar EC50 values of 12.98 ± 5.30 μM and 13.31 ± 1.24 μM, respectively, which could be clinically achieved in plasma after intravenous administration. Interestingly, although an EC50 of 23.17 ± 3.22 μM was not prominent among the tested compounds, lumefantrine showed therapeutic promise due to high plasma and lung drug concentrations after multiple dosing. Further mode of action analysis revealed that arteannuin B and lumefantrine acted at the post-entry step of SARS-CoV-2 infection. This research highlights the anti-SARS-CoV-2 potential of artemisinins and provides leading candidates for anti-SARS-CoV-2 drug research and development."
    ],
    "affiliation": [
      "National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Vero Cells"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Artemisinins"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drugs, Chinese Herbal"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antimalarials"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Discovery"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Repositioning"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chlorocebus aethiops"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Artemisinin",
          "Antiviral Drug",
          "Drug Repurposing",
          "Covid-19",
          "Sars-cov-2"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antimalarials"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Drugs, Chinese Herbal"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Artemisinins"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1021/acsinfecdis.0c00522"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7437450"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7437450?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-09-23"
    ],
    "dateOfCreation": [
      "2020-08-14"
    ],
    "firstIndexDate": [
      "2020-08-14"
    ],
    "fullTextReceivedDate": [
      "2020-08-21"
    ],
    "dateOfRevision": [
      "2020-09-23"
    ],
    "electronicPublicationDate": [
      "2020-08-18"
    ],
    "firstPublicationDate": [
      "2020-08-18"
    ]
  },
  {
    "id": [
      "PMC7457938"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7457938"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7457938"
        ]
      }
    ],
    "title": [
      "Drug repurposing and cytokine management in response to COVID-19: A review"
    ],
    "authorString": [
      "Heimfarth L, Serafini M, Martins-Filho P, Quintans J, Quintans-Júnior L."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Heimfarth L"
            ],
            "firstName": [
              "Luana"
            ],
            "lastName": [
              "Heimfarth"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Graduate Program of Health Sciences (PPGCS), São Cristóvão, SE 49100-000 Brazil"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Serafini M"
            ],
            "firstName": [
              "Mairim Russo"
            ],
            "lastName": [
              "Serafini"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "c Graduate Program of Pharmaceutical Sciences (PPGCF). Federal University of Sergipe (UFS), São Cristóvão, SE 49100-000 Brazil"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Martins-Filho P"
            ],
            "firstName": [
              "Paulo Ricardo"
            ],
            "lastName": [
              "Martins-Filho"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Graduate Program of Health Sciences (PPGCS), São Cristóvão, SE 49100-000 Brazil"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Quintans J"
            ],
            "firstName": [
              "Jullyana de Souza Siqueira"
            ],
            "lastName": [
              "Quintans"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Graduate Program of Health Sciences (PPGCS), São Cristóvão, SE 49100-000 Brazil"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Quintans-Júnior L"
            ],
            "firstName": [
              "Lucindo José"
            ],
            "lastName": [
              "Quintans-Júnior"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "c Graduate Program of Pharmaceutical Sciences (PPGCF). Federal University of Sergipe (UFS), São Cristóvão, SE 49100-000 Brazil"
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "88"
        ],
        "journalIssueId": [
          "2993404"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "International immunopharmacology"
            ],
            "ISOAbbreviation": [
              "Int. Immunopharmacol."
            ],
            "medlineAbbreviation": [
              "Int Immunopharmacol"
            ],
            "NLMid": [
              "100965259"
            ],
            "ISSN": [
              "1567-5769"
            ],
            "ESSN": [
              "1878-1705"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "106947-106947"
    ],
    "abstractText": [
      "Highlights • Rational strategy to carry out drugs repurposing for management COVID-19 patients.• Anti-inflammation therapy plays a pivotal role in the management COVID-19 patients.• Drugs mitigate the cytokines production induced by SARS-CoV-2‘s immunological activation.• Reduction in hyperinflammation lead to a decrease in multiple organ failure. Coronavirus disease 2019 (COVID-19), the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease that attacks the respiratory tract and has a higher fatality rate than seasonal influenza. The COVID‐19 pandemic is a global health crisis, and no specific therapy or drug has been formally recommended for use against SARS-CoV-2 infection. In this context, it is a rational strategy to investigate the repurposing of existing drugs to use in the treatment of COVID-19 patients. In the meantime, the medical community is trialing several therapies that target various antiviral and immunomodulating mechanisms to use against the infection. There is no doubt that antiviral and supportive treatments are important in the treatment of COVID-19 patients, but anti-inflammatory therapy also plays a pivotal role in the management COVID-19 patients due to its ability to prevent further injury and organ damage or failure. In this review, we identified drugs that could modulate cytokines levels and play a part in the management of COVID-19. Several drugs that possess an anti-inflammatory profile in others illnesses have been studied in respect of their potential utility in the treatment of the hyperinflammation induced by SAR-COV-2 infection. We highlight a number of antivirals, anti-rheumatic, anti-inflammatory, antineoplastic and antiparasitic drugs that have been found to mitigate cytokine production and consequently attenuate the “cytokine storm” induced by SARS-CoV-2. Reduced hyperinflammation can attenuate multiple organ failure, and even reduce the mortality associated with severe COVID-19. In this context, despite their current unproven clinical efficacy in relation to the current pandemic, the repurposing of drugs with anti-inflammatory activity to use in the treatment of COVID-19 has become a topic of great interest."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Cytokine",
          "IL-6",
          "New drug",
          "Ace-2",
          "Covid-19"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7457938"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7457938?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "doi"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-09-03"
    ],
    "firstIndexDate": [
      "2020-09-03"
    ],
    "fullTextReceivedDate": [
      "2020-09-03"
    ],
    "dateOfRevision": [
      "2020-09-10"
    ],
    "electronicPublicationDate": [
      "2020-08-31"
    ],
    "firstPublicationDate": [
      "2020-08-31"
    ]
  },
  {
    "id": [
      "32761523"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32761523"
    ],
    "pmcid": [
      "PMC7406694"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7406694"
        ]
      }
    ],
    "doi": [
      "10.1007/s13238-020-00769-9"
    ],
    "title": [
      "Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase."
    ],
    "authorString": [
      "Xu Y, Jiang H."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Xu Y"
            ],
            "firstName": [
              "Yechun"
            ],
            "lastName": [
              "Xu"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.",
                  "University of Chinese Academy of Sciences, Beijing, 100049, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jiang H"
            ],
            "firstName": [
              "Hualiang"
            ],
            "lastName": [
              "Jiang"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. hljiang@simm.ac.cn.",
                  "University of Chinese Academy of Sciences, Beijing, 100049, China. hljiang@simm.ac.cn.",
                  "Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China. hljiang@simm.ac.cn."
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "10"
        ],
        "volume": [
          "11"
        ],
        "journalIssueId": [
          "3020327"
        ],
        "dateOfPublication": [
          "2020 Oct"
        ],
        "monthOfPublication": [
          "10"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-10-01"
        ],
        "journal": [
          {
            "title": [
              "Protein & cell"
            ],
            "ISOAbbreviation": [
              "Protein Cell"
            ],
            "medlineAbbreviation": [
              "Protein Cell"
            ],
            "NLMid": [
              "101532368"
            ],
            "ISSN": [
              "1674-800X"
            ],
            "ESSN": [
              "1674-8018"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "699-702"
    ],
    "affiliation": [
      "CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1007/s13238-020-00769-9"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7406694"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7406694?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-08"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-08-08"
    ],
    "dateOfRevision": [
      "2020-09-25"
    ],
    "firstPublicationDate": [
      "2020-10-01"
    ]
  },
  {
    "id": [
      "32753646"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32753646"
    ],
    "pmcid": [
      "PMC7403393"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7403393"
        ]
      }
    ],
    "doi": [
      "10.1038/s41598-020-70143-6"
    ],
    "title": [
      "In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication."
    ],
    "authorString": [
      "Touret F, Gilles M, Barral K, Nougairède A, van Helden J, Decroly E, de Lamballerie X, Coutard B."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Touret F"
            ],
            "firstName": [
              "Franck"
            ],
            "lastName": [
              "Touret"
            ],
            "initials": [
              "F"
            ],
            "authorId": [
              {
                "_": "0000-0002-4734-2249",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France. franck.touret@univ-amu.fr."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gilles M"
            ],
            "firstName": [
              "Magali"
            ],
            "lastName": [
              "Gilles"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Barral K"
            ],
            "firstName": [
              "Karine"
            ],
            "lastName": [
              "Barral"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Aix-Marseille Univ, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, CRCM, Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Nougairède A"
            ],
            "firstName": [
              "Antoine"
            ],
            "lastName": [
              "Nougairède"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "van Helden J"
            ],
            "firstName": [
              "Jacques"
            ],
            "lastName": [
              "van Helden"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0002-8799-8584",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Institut Français de Bioinformatique (IFB), UMS 3601-CNRS, Université Paris-Saclay, Orsay, France.",
                  "Aix-Marseille Univ, INSERM, Lab. Theory and Approaches of Genome Complexity (TAGC), Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Decroly E"
            ],
            "firstName": [
              "Etienne"
            ],
            "lastName": [
              "Decroly"
            ],
            "initials": [
              "E"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "AFMB UMR 7257, Aix-Marseille Université, CNRS, Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "de Lamballerie X"
            ],
            "firstName": [
              "Xavier"
            ],
            "lastName": [
              "de Lamballerie"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Coutard B"
            ],
            "firstName": [
              "Bruno"
            ],
            "lastName": [
              "Coutard"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France. bruno.coutard@univ-amu.fr."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-4734-2249",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8799-8584",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data",
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "10"
        ],
        "journalIssueId": [
          "2990842"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Scientific reports"
            ],
            "ISOAbbreviation": [
              "Sci Rep"
            ],
            "medlineAbbreviation": [
              "Sci Rep"
            ],
            "NLMid": [
              "101563288"
            ],
            "ISSN": [
              "2045-2322"
            ],
            "ESSN": [
              "2045-2322"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "13093"
    ],
    "abstractText": [
      "A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to SARS-Cov-2, there is an urgent need to propose molecules that could quickly enter into clinics. Repurposing of approved drugs is a strategy that can bypass the time-consuming stages of drug development. In this study, we screened the PRESTWICK CHEMICAL LIBRARY composed of 1,520 approved drugs in an infected cell-based assay. The robustness of the screen was assessed by the identification of drugs that already demonstrated in vitro antiviral effect against SARS-CoV-2. Thereby, 90 compounds were identified as positive hits from the screen and were grouped according to their chemical composition and their known therapeutic effect. Then EC50 and CC50 were determined for a subset of 15 compounds from a panel of 23 selected drugs covering the different groups. Eleven compounds such as macrolides antibiotics, proton pump inhibitors, antiarrhythmic agents or CNS drugs emerged showing antiviral potency with 2 < EC50 ≤ 20 µM. By providing new information on molecules inhibiting SARS-CoV-2 replication in vitro, this study provides information for the selection of drugs to be further validated in vivo. Disclaimer: This study corresponds to the early stages of antiviral development and the results do not support by themselves the use of the selected drugs to treat SARS-CoV-2 infection."
    ],
    "affiliation": [
      "Unité Des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection), 13005, Marseille, France. franck.touret@univ-amu.fr."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "REACTing"
            ],
            "agency": [
              "Institut National de la Santé et de la Recherche Médicale"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "871029"
            ],
            "agency": [
              "H2020 Research Infrastructures"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Caco-2 Cells"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Vero Cells"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Approval"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Evaluation, Preclinical"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cell Survival"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Small Molecule Libraries"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "CH"
                    ],
                    "qualifierName": [
                      "chemistry"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Repositioning"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IP"
                    ],
                    "qualifierName": [
                      "isolation & purification"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PH"
                    ],
                    "qualifierName": [
                      "physiology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chlorocebus aethiops"
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Small Molecule Libraries"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1038/s41598-020-70143-6"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7403393"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7403393?pdf=render"
            ]
          }
        ]
      }
    ],
    "commentCorrectionList": [
      {
        "commentCorrection": [
          {
            "id": [
              "PPR139564"
            ],
            "source": [
              "PPR"
            ],
            "type": [
              "Preprint in"
            ],
            "note": [
              "Link created based on a title-first author match"
            ],
            "orderIn": [
              "10002"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-08-12"
    ],
    "dateOfCreation": [
      "2020-08-06"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-08-09"
    ],
    "dateOfRevision": [
      "2020-09-08"
    ],
    "electronicPublicationDate": [
      "2020-08-04"
    ],
    "firstPublicationDate": [
      "2020-08-04"
    ]
  },
  {
    "id": [
      "24143932"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "24143932"
    ],
    "pmcid": [
      "PMC3854647"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC3854647"
        ]
      }
    ],
    "doi": [
      "10.1186/2050-6511-14-55"
    ],
    "title": [
      "Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands."
    ],
    "authorString": [
      "Hooiveld M, van de Groep T, Verheij TJ, van der Sande MA, Verheij RA, Tacken MA, van Essen GA."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Hooiveld M"
            ],
            "firstName": [
              "Mariëtte"
            ],
            "lastName": [
              "Hooiveld"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht, the Netherlands. m.hooiveld@nivel.nl."
                ]
              }
            ]
          },
          {
            "fullName": [
              "van de Groep T"
            ],
            "firstName": [
              "Tine"
            ],
            "lastName": [
              "van de Groep"
            ],
            "initials": [
              "T"
            ]
          },
          {
            "fullName": [
              "Verheij TJ"
            ],
            "firstName": [
              "Theo J M"
            ],
            "lastName": [
              "Verheij"
            ],
            "initials": [
              "TJ"
            ]
          },
          {
            "fullName": [
              "van der Sande MA"
            ],
            "firstName": [
              "Marianne A B"
            ],
            "lastName": [
              "van der Sande"
            ],
            "initials": [
              "MA"
            ],
            "authorId": [
              {
                "_": "0000-0002-4778-6739",
                "$": {
                  "type": "ORCID"
                }
              }
            ]
          },
          {
            "fullName": [
              "Verheij RA"
            ],
            "firstName": [
              "Robert A"
            ],
            "lastName": [
              "Verheij"
            ],
            "initials": [
              "RA"
            ]
          },
          {
            "fullName": [
              "Tacken MA"
            ],
            "firstName": [
              "Margot A J B"
            ],
            "lastName": [
              "Tacken"
            ],
            "initials": [
              "MA"
            ]
          },
          {
            "fullName": [
              "van Essen GA"
            ],
            "firstName": [
              "Gerrit A"
            ],
            "lastName": [
              "van Essen"
            ],
            "initials": [
              "GA"
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-4778-6739",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "14"
        ],
        "journalIssueId": [
          "2003466"
        ],
        "dateOfPublication": [
          "2013 "
        ],
        "monthOfPublication": [
          "0"
        ],
        "yearOfPublication": [
          "2013"
        ],
        "printPublicationDate": [
          "2013-01-01"
        ],
        "journal": [
          {
            "title": [
              "BMC pharmacology & toxicology"
            ],
            "ISOAbbreviation": [
              "BMC Pharmacol Toxicol"
            ],
            "medlineAbbreviation": [
              "BMC Pharmacol Toxicol"
            ],
            "NLMid": [
              "101590449"
            ],
            "ISSN": [
              "2050-6511"
            ],
            "ESSN": [
              "2050-6511"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2013"
    ],
    "pageInfo": [
      "55"
    ],
    "abstractText": [
      "BACKGROUND: After the clinical impact of the A(H1N1) pdm09 virus was considered to be mild, treatment with antiviral drugs was recommended only to patients who were at risk for severe disease or who had a complicated course of influenza. We investigated to what extent antiviral prescriptions in primary care practices were in accordance with the recommendations, what proportion of patients diagnosed with influenza had been prescribed antiviral drugs, and to what extent prescriptions related to the stated indications for antiviral treatment. METHODS: We used data from routine electronic medical records of practices participating in the Netherlands Information Network of General Practice LINH in the period August-December 2009. We considered patient and practice characteristics, clinical diagnoses and drug prescriptions of all patients who contacted their general practitioner in the given period and who had been prescribed antiviral medication (n=351) or were diagnosed with influenza (n=3293). RESULTS: Of all antiviral prescriptions, 69% were in accordance with the recommendations. Only 5% of patients diagnosed with influenza were prescribed antiviral drugs. This percentage increased to 12% among influenza patients belonging to the designated high risk groups. On the other hand, 2.5% of influenza patients not at high risk of complications received antiviral treatment. In addition to the established high risk factors, the total number of drug prescriptions for a patient in this year was a determinant of antiviral prescriptions. Information on time since onset of symptoms and the clinical presentation of patients was not available. CONCLUSIONS: General practitioners in the Netherlands have been restrictive in prescribing antiviral drugs during the influenza pandemic, even when patients met the criteria for antiviral treatment."
    ],
    "affiliation": [
      "NIVEL, Netherlands Institute for Health Services Research, Utrecht, PO Box 1568, 3500 BN Utrecht, the Netherlands. m.hooiveld@nivel.nl."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Research Support, Non-U.S. Gov't",
          "research-article",
          "Journal Article",
          "Observational Study"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adolescent"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Adult"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Middle Aged"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Child"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Child, Preschool"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Infant"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Utilization Review"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Netherlands"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Female"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Male"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Influenza, Human"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "CO"
                    ],
                    "qualifierName": [
                      "complications"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Oseltamivir"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Practice Guidelines as Topic"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ST"
                    ],
                    "qualifierName": [
                      "standards"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Prescriptions"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "SN"
                    ],
                    "qualifierName": [
                      "statistics & numerical data"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Young Adult"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Electronic Health Records"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "General Practitioners"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "ST"
                    ],
                    "qualifierName": [
                      "standards"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "SN"
                    ],
                    "qualifierName": [
                      "statistics & numerical data"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Pandemics"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "SN"
                    ],
                    "qualifierName": [
                      "statistics & numerical data"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Oseltamivir"
            ],
            "registryNumber": [
              "20O93L6F9H"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24143932/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24143932/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/2050-6511-14-55"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3854647"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC3854647?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "5"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2014-06-27"
    ],
    "dateOfCreation": [
      "2014-01-17"
    ],
    "firstIndexDate": [
      "2013-10-28"
    ],
    "fullTextReceivedDate": [
      "2013-12-10"
    ],
    "electronicPublicationDate": [
      "2013-10-21"
    ],
    "firstPublicationDate": [
      "2013-10-21"
    ]
  },
  {
    "id": [
      "PMC7457942"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7457942"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7457942"
        ]
      }
    ],
    "title": [
      "Antiviral potential of natural products from marine microbes"
    ],
    "authorString": [
      "Yi M, Lin S, Zhang B, Jin H, Ding L."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Yi M"
            ],
            "firstName": [
              "Mengqi"
            ],
            "lastName": [
              "Yi"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          },
          {
            "fullName": [
              "Lin S"
            ],
            "firstName": [
              "Sixiao"
            ],
            "lastName": [
              "Lin"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang B"
            ],
            "firstName": [
              "Bin"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "B"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jin H"
            ],
            "firstName": [
              "Haixiao"
            ],
            "lastName": [
              "Jin"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ding L"
            ],
            "firstName": [
              "Lijian"
            ],
            "lastName": [
              "Ding"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  {
                    "$": {
                      "xmlns:xsi": "http://www.w3.org/2001/XMLSchema-instance",
                      "xsi:nil": "true"
                    }
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "207"
        ],
        "journalIssueId": [
          "2999056"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "European journal of medicinal chemistry"
            ],
            "ISOAbbreviation": [
              "Eur J Med Chem"
            ],
            "medlineAbbreviation": [
              "Eur J Med Chem"
            ],
            "NLMid": [
              "0420510"
            ],
            "ISSN": [
              "0223-5234"
            ],
            "ESSN": [
              "1768-3254"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "112790-112790"
    ],
    "abstractText": [
      "Humans have been suffered from viral infections over the centuries, such as influenza, HSV, and HIV, which have killed millions of people worldwide. However, the availability of effective treatments for infectious diseases remains limited until now, as most of the viral pathogens resisted to many medical treatments. Marine microbes are currently one of the most copious sources of pharmacologically active natural products, which have constantly provided promising antivirus agents. To date, a large number of marine microbial secondary metabolites with antiviral activities have been widely reported. In this review, we have summarized the potential antivirus compounds from marine microorganisms over the last decade. In addition, the structures, bioactivities, and origins of these compounds were discussed as well. Graphical abstract Image 1 Highlights • Marine microbes-derived natural products with various antiviral activities were summarized (2009–2019).• 18 compounds demonstrated significant antivirus activities stronger than the corresponding positive drugs.• This review highlighted the potential development of these natural products as antiviral lead compounds."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "marine natural products",
          "antivirus",
          "anti-HIV",
          "Marine Microbes",
          "Anti-influenza",
          "Anti-hsv"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457942/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457942/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7457942"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7457942?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-03"
    ],
    "firstIndexDate": [
      "2020-09-03"
    ],
    "fullTextReceivedDate": [
      "2020-09-03"
    ],
    "dateOfRevision": [
      "2020-09-15"
    ],
    "electronicPublicationDate": [
      "2020-08-31"
    ],
    "firstPublicationDate": [
      "2020-08-31"
    ]
  },
  {
    "id": [
      "32845164"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32845164"
    ],
    "pmcid": [
      "PMC7451411"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7451411"
        ]
      }
    ],
    "doi": [
      "10.2217/fmb-2020-0082"
    ],
    "title": [
      "Phages in the fight against COVID-19?"
    ],
    "authorString": [
      "Górski A, Międzybrodzki R, Żaczek M, Borysowski J."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Górski A"
            ],
            "firstName": [
              "Andrzej"
            ],
            "lastName": [
              "Górski"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0002-0863-6041",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Bacteriophage Laboratory & Phage Therapy Unit, Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.",
                  "Department of Clinical Immunology, Infant Jesus Clinical Hospital, 02-006 Warsaw, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Międzybrodzki R"
            ],
            "firstName": [
              "Ryszard"
            ],
            "lastName": [
              "Międzybrodzki"
            ],
            "initials": [
              "R"
            ],
            "authorId": [
              {
                "_": "0000-0001-7379-7290",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Bacteriophage Laboratory & Phage Therapy Unit, Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.",
                  "Department of Clinical Immunology, The Medical University of Warsaw, 02-006 Warsaw, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Żaczek M"
            ],
            "firstName": [
              "Maciej"
            ],
            "lastName": [
              "Żaczek"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0001-9556-2820",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Bacteriophage Laboratory & Phage Therapy Unit, Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Borysowski J"
            ],
            "firstName": [
              "Jan"
            ],
            "lastName": [
              "Borysowski"
            ],
            "initials": [
              "J"
            ],
            "authorId": [
              {
                "_": "0000-0001-5256-1959",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Clinical Immunology, The Medical University of Warsaw, 02-006 Warsaw, Poland."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-0863-6041",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-7379-7290",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-9556-2820",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-5256-1959",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "15"
        ],
        "journalIssueId": [
          "3015904"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Future microbiology"
            ],
            "ISOAbbreviation": [
              "Future Microbiol"
            ],
            "medlineAbbreviation": [
              "Future Microbiol"
            ],
            "NLMid": [
              "101278120"
            ],
            "ISSN": [
              "1746-0913"
            ],
            "ESSN": [
              "1746-0921"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1095-1100"
    ],
    "affiliation": [
      "Bacteriophage Laboratory & Phage Therapy Unit, Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Editorial"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "DEC-2013/B/NZI/02107"
            ],
            "agency": [
              "National Science Centre (NCN)"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Phage",
          "Coronavirus",
          "Phage Therapy",
          "Covid"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.2217/fmb-2020-0082"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7451411"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7451411?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-27"
    ],
    "firstIndexDate": [
      "2020-08-27"
    ],
    "fullTextReceivedDate": [
      "2020-08-30"
    ],
    "dateOfRevision": [
      "2020-09-22"
    ],
    "electronicPublicationDate": [
      "2020-08-26"
    ],
    "firstPublicationDate": [
      "2020-08-26"
    ]
  },
  {
    "id": [
      "PMC7474825"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7474825"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7474825"
        ]
      }
    ],
    "title": [
      "Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations"
    ],
    "authorString": [
      "Dawoud D, Soliman K."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Dawoud D"
            ],
            "firstName": [
              "Dalia M"
            ],
            "lastName": [
              "Dawoud"
            ],
            "initials": [
              "D"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "1 Faculty of Pharmacy, Clinical Pharmacy Department, Cairo University, Cairo, Egypt"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Soliman K"
            ],
            "firstName": [
              "Khaled Y"
            ],
            "lastName": [
              "Soliman"
            ],
            "initials": [
              "K"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "2 Accident and Emergency Department, North Middlesex University Hospital, London, UK"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3009549"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"
            ],
            "ISOAbbreviation": [
              "Value Health"
            ],
            "medlineAbbreviation": [
              "Value Health"
            ],
            "NLMid": [
              "100883818"
            ],
            "ISSN": [
              "1098-3015"
            ],
            "ESSN": [
              "1524-4733"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "Objective To review published economic evaluations of antiviral treatment for pandemics and outbreaks of respiratory illnesses. Methods We conducted a systematic review to identify economic evaluations of antiviral treatment for pandemics and outbreaks of respiratory illnesses, including coronavirus disease 2019 (COVID-19). We searched Medline (EBSCOhost), EMBASE (Ovid), EconLit (Ovid), National Health Service Economic Evaluation Database (Ovid), and Health Technology Assessment (Ovid). The search was last rerun on July 5, 2020. Citation tracking and reference checking were used. Only full economic evaluations published as peer-reviewed articles in the last 10 years were included. Studies were quality assessed using the National Institute for Health and Care Excellence economic evaluation checklist. Results Overall, 782 records were identified, of which 14 studies met the inclusion criteria. The studies were mostly conducted in high-income countries. All were model-based. Seven (50%) were cost-utility analyses, 4 (28.6%) were cost-effectiveness analyses, 2 (14.3%) were cost-consequences analyses, and 1 (7.1%) was a cost-benefit analysis. Strategies including antiviral treatment were found to be either cost-saving or cost-effective, at the study-specific willingness-to-pay thresholds. Empirical treatment was more cost-effective than test-guided treatment for young adults but less so for older adults. Conclusions Antiviral treatment for managing pandemics and outbreaks of respiratory illnesses that have very high case fatality rate, similar to COVID-19 pandemic, are likely to be cost-effective either as a standalone intervention or part of a multifaceted strategy. Investing in the development of such curative treatments and promptly evaluating their cost-effectiveness, relative to other strategies in use at the time of their introduction should be the focus going forward to inform resource allocation decisions particularly in low- and middle-income countries. Highlights What is already known about this topic?• A number of mitigation strategies for pandemics and outbreaks of respiratory illnesses, similar to coronavirus disease 2019 (COVID-19), exist. These include both pharmaceutical and non-pharmaceutical strategies.• The potential cost-effectiveness of antiviral treatment is currently uncertain, and the factors affecting it are not fully understood. What does this article add to the body of knowledge?• This review confirms the potential cost-effectiveness of antiviral treatment as a mitigation strategy.• The review also identifies factors that affect the cost-effectiveness of these agents, including their relative effectiveness, cost, the severity of the pandemic, and its case fatality rate. What insights does the article provide for informing healthcare-related decision making?• This review provides a rationale for continued investment in the development of novel antivirals and other potentially curative treatments for COVID-19 in addition to the focus on vaccine development• There is a clear need for healthcare systems in low- and middle-income countries to undertake economic evaluations of antivirals and other mitigation strategies for pandemics and outbreaks of respiratory illnesses, given the lack of studies applicable to their settings, to inform the widespread use of such strategies."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Influenza",
          "Economic evaluation",
          "Coronavirus",
          "Systematic review",
          "Outbreaks",
          "Pandemics",
          "Health Technology Assessment",
          "Covid-19"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474825/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474825/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7474825"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7474825?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-10"
    ],
    "firstIndexDate": [
      "2020-09-10"
    ],
    "fullTextReceivedDate": [
      "2020-09-10"
    ],
    "dateOfRevision": [
      "2020-09-10"
    ],
    "electronicPublicationDate": [
      "2020-09-06"
    ],
    "firstPublicationDate": [
      "2020-09-06"
    ]
  },
  {
    "id": [
      "32758225"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32758225"
    ],
    "pmcid": [
      "PMC7409489"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7409489"
        ]
      }
    ],
    "doi": [
      "10.1186/s12941-020-00372-0"
    ],
    "title": [
      "Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis."
    ],
    "authorString": [
      "Zhang Y, Zhou T, Huang M, Gu G, Xia Q."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhang Y"
            ],
            "firstName": [
              "Yu"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "Y"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhou T"
            ],
            "firstName": [
              "Tao"
            ],
            "lastName": [
              "Zhou"
            ],
            "initials": [
              "T"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Huang M"
            ],
            "firstName": [
              "Mingzhu"
            ],
            "lastName": [
              "Huang"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gu G"
            ],
            "firstName": [
              "Guangxiang"
            ],
            "lastName": [
              "Gu"
            ],
            "initials": [
              "G"
            ],
            "authorId": [
              {
                "_": "0000-0001-9168-7415",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China. guguangxiang@163.com."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xia Q"
            ],
            "firstName": [
              "Qiang"
            ],
            "lastName": [
              "Xia"
            ],
            "initials": [
              "Q"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-9168-7415",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "19"
        ],
        "journalIssueId": [
          "2992542"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Annals of clinical microbiology and antimicrobials"
            ],
            "ISOAbbreviation": [
              "Ann. Clin. Microbiol. Antimicrob."
            ],
            "medlineAbbreviation": [
              "Ann Clin Microbiol Antimicrob"
            ],
            "NLMid": [
              "101152152"
            ],
            "ISSN": [
              "1476-0711"
            ],
            "ESSN": [
              "1476-0711"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "34"
    ],
    "abstractText": [
      "BACKGROUND:Cytomegalovirus infection is one of the most common complications after solid organ transplantation. There have been several classes of antiviral drugs for the prevention of cytomegalovirus infection, such as acyclovir, valacyclovir, ganciclovir and valganciclovir. METHODS:We searched relevant prospective and multi-armed studies on PubMed from Jan. 1984 up to Mar. 2018. RESULTS:Seventeen prospective studies involving 2062 patients were included in the analysis. In the case of cytomegalovirus infection, the ganciclovir group (OR = 0.24, 95% CI 0.09-0.57) and the valacyclovir group (OR = 0.20, 95% CI 0.04-0.69) provided significantly better outcomes than the control group. The ganciclovir (OR = 0.37, 95% CI 0.13-0.86) and valacyclovir groups (OR = 0.31, 95% CI 0.07-0.98) showed moderate superiority compared to the acyclovir group. As for cytomegalovirus disease, the ganciclovir, valacyclovir and valganciclovir groups showed significant advantages compared with the control group (ganciclovir group: OR = 0.17, 95% CI 0.07-0.31, valacyclovir group: OR = 0.08, 95% CI 0.01-0.33, valganciclovir group: OR = 0.14, 95% CI 0.02-0.45). Similarly, the ganciclovir group (OR = 0.38, 95% CI 0.12-0.71) and the valacyclovir group (OR = 0.17, 95% CI 0.03-0.72) showed better results than the acyclovir group. CONCLUSION:Valacyclovir showed to be the most efficient antiviral for the prevention of cytomegalovirus infection and disease. Additional studies are required to evaluate putative side effects associated with valacyclovir administration."
    ],
    "affiliation": [
      "Department of Liver Surgery and Liver Transplantation Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Pudong New District, Shanghai, 200 127, China."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "81700570"
            ],
            "agency": [
              "National Natural Science Foundation of China"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Prevention",
          "Cytomegalovirus",
          "Solid Organ Transplantation",
          "Bayesian Network Analysis"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1186/s12941-020-00372-0"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7409489"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7409489?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-08"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-08-09"
    ],
    "dateOfRevision": [
      "2020-08-11"
    ],
    "electronicPublicationDate": [
      "2020-08-05"
    ],
    "firstPublicationDate": [
      "2020-08-05"
    ]
  },
  {
    "id": [
      "32751615"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32751615"
    ],
    "pmcid": [
      "PMC7463888"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7463888"
        ]
      }
    ],
    "doi": [
      "10.3390/jcm9082441"
    ],
    "title": [
      "A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era."
    ],
    "authorString": [
      "Napoli PE, Mangoni L, Gentile P, Braghiroli M, Fossarello M."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Napoli PE"
            ],
            "firstName": [
              "Pietro Emanuele"
            ],
            "lastName": [
              "Napoli"
            ],
            "initials": [
              "PE"
            ],
            "authorId": [
              {
                "_": "0000-0001-7020-0823",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy.",
                  "Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Mangoni L"
            ],
            "firstName": [
              "Lorenzo"
            ],
            "lastName": [
              "Mangoni"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Gentile P"
            ],
            "firstName": [
              "Pietro"
            ],
            "lastName": [
              "Gentile"
            ],
            "initials": [
              "P"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Braghiroli M"
            ],
            "firstName": [
              "Mirco"
            ],
            "lastName": [
              "Braghiroli"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Fossarello M"
            ],
            "firstName": [
              "Maurizio"
            ],
            "lastName": [
              "Fossarello"
            ],
            "initials": [
              "M"
            ],
            "authorId": [
              {
                "_": "0000-0003-1520-7760",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy.",
                  "Department of Surgical Sciences, Eye Clinic, University of Cagliari, 09124 Cagliari, Italy."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-7020-0823",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-1520-7760",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "8"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2984560"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of clinical medicine"
            ],
            "ISOAbbreviation": [
              "J Clin Med"
            ],
            "medlineAbbreviation": [
              "J Clin Med"
            ],
            "NLMid": [
              "101606588"
            ],
            "ISSN": [
              "2077-0383"
            ],
            "ESSN": [
              "2077-0383"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "The coronavirus disease 2019 (COVID-19) represents a global concern of public health caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its clinical manifestations are characterized by a heterogeneous group of symptoms and pictures (ranging from asymptomatic to lethal courses). The prevalence of conjunctivitis in patients with COVID-19 is at present controversial. Although it has been reported that only 0.9% developed signs of conjunctivitis, other report indicates that up to 31.6% of hospitalized patients had conjunctivitis. Considering the widespread use of topical ophthalmic medications (e.g., eye drops) by the general population, for various reasons (e.g., artificial tears, anti-glaucoma medications, topical antibiotics, etc.), the existence of their side effects as antiviral action should be investigated in-depth because it could possibly explain the aforementioned controversial data and represent a potential antiviral treatment for SARS-CoV-2 replication/diffusion on the ocular surface. Here, we discuss and elucidate the antiviral side effect of many eye drops and ophthalmic ointments commonly used for others purposes, thus showing that these secondary effects (not to be confused with the 'adverse effects') might be of primary importance in a number of viral infections (e.g., those for which there is no validated treatment protocol), according to a drug repurposing approach. Some active ingredients or excipients described here have activity against other types of viruses, thus suggesting potential broad-spectrum applications."
    ],
    "affiliation": [
      "Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, 09124 Cagliari, Italy."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Therapy",
          "Treatment",
          "Drug",
          "Antiviral",
          "Coronavirus",
          "Ocular Surface",
          "Eye Drop",
          "Repurposing",
          "Coronavirus Disease 2019 (Covid-19)",
          "Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2)"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/jcm9082441"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7463888"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7463888?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-06"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-09-06"
    ],
    "dateOfRevision": [
      "2020-09-05"
    ],
    "electronicPublicationDate": [
      "2020-07-30"
    ],
    "firstPublicationDate": [
      "2020-07-30"
    ]
  },
  {
    "id": [
      "32752109"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32752109"
    ],
    "pmcid": [
      "PMC7464166"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7464166"
        ]
      }
    ],
    "doi": [
      "10.3390/polym12081727"
    ],
    "title": [
      "Polymers in the Medical Antiviral Front-Line."
    ],
    "authorString": [
      "Jarach N, Dodiuk H, Kenig S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Jarach N"
            ],
            "firstName": [
              "Natanel"
            ],
            "lastName": [
              "Jarach"
            ],
            "initials": [
              "N"
            ],
            "authorId": [
              {
                "_": "0000-0003-0838-5411",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "The Department of Polymer Materials Engineering, Pernick Faculty of Engineering, Shenkar College of Engineering and Design, Raman-Gan 52562, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Dodiuk H"
            ],
            "firstName": [
              "Hanna"
            ],
            "lastName": [
              "Dodiuk"
            ],
            "initials": [
              "H"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "The Department of Polymer Materials Engineering, Pernick Faculty of Engineering, Shenkar College of Engineering and Design, Raman-Gan 52562, Israel."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kenig S"
            ],
            "firstName": [
              "Samuel"
            ],
            "lastName": [
              "Kenig"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "The Department of Polymer Materials Engineering, Pernick Faculty of Engineering, Shenkar College of Engineering and Design, Raman-Gan 52562, Israel."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-0838-5411",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "8"
        ],
        "volume": [
          "12"
        ],
        "journalIssueId": [
          "2984576"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "Polymers"
            ],
            "ISOAbbreviation": [
              "Polymers (Basel)"
            ],
            "medlineAbbreviation": [
              "Polymers (Basel)"
            ],
            "NLMid": [
              "101545357"
            ],
            "ISSN": [
              "2073-4360"
            ],
            "ESSN": [
              "2073-4360"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "Antiviral polymers are part of a major campaign led by the scientific community in recent years. Facing this most demanding of campaigns, two main approaches have been undertaken by scientists. First, the classic approach involves the development of relatively small molecules having antiviral properties to serve as drugs. The other approach involves searching for polymers with antiviral properties to be used as prescription medications or viral spread prevention measures. This second approach took two distinct directions. The first, using polymers as antiviral drug-delivery systems, taking advantage of their biodegradable properties. The second, using polymers with antiviral properties for on-contact virus elimination, which will be the focus of this review. Anti-viral polymers are obtained by either the addition of small antiviral molecules (such as metal ions) to obtain ion-containing polymers with antiviral properties or the use of polymers composed of an organic backbone and electrically charged moieties like polyanions, such as carboxylate containing polymers, or polycations such as quaternary ammonium containing polymers. Other approaches include moieties hybridized by sulphates, carboxylic acids, or amines and/or combining repeating units with a similar chemical structure to common antiviral drugs. Furthermore, elevated temperatures appear to increase the anti-viral effect of ions and other functional moieties."
    ],
    "affiliation": [
      "The Department of Polymer Materials Engineering, Pernick Faculty of Engineering, Shenkar College of Engineering and Design, Raman-Gan 52562, Israel."
    ],
    "publicationStatus": [
      "epublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Metal-containing Polymers",
          "Ionomers",
          "Antiviral Coating",
          "Antiviral Polymers",
          "Drug-delivery Polymers"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.3390/polym12081727"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7464166"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7464166?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-06"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-09-06"
    ],
    "dateOfRevision": [
      "2020-09-05"
    ],
    "electronicPublicationDate": [
      "2020-07-31"
    ],
    "firstPublicationDate": [
      "2020-07-31"
    ]
  },
  {
    "id": [
      "32432977"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32432977"
    ],
    "pmcid": [
      "PMC7448857"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7448857"
        ]
      }
    ],
    "doi": [
      "10.1080/22221751.2020.1772676"
    ],
    "title": [
      "Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture."
    ],
    "authorString": [
      "Zhang YN, Zhang QY, Li XD, Xiong J, Xiao SQ, Wang Z, Zhang ZR, Deng CL, Yang XL, Wei HP, Yuan ZM, Ye HQ, Zhang B."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhang YN"
            ],
            "firstName": [
              "Ya-Nan"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "YN"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.",
                  "University of Chinese Academy of Sciences, Beijing, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang QY"
            ],
            "firstName": [
              "Qiu-Yan"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "QY"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "The Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou, People's Republic of China.",
                  "The Joint Center of Translational Precision Medicine, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Li XD"
            ],
            "firstName": [
              "Xiao-Dan"
            ],
            "lastName": [
              "Li"
            ],
            "initials": [
              "XD"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.",
                  "School of Medicine, Hunan Normal University, Changsha, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xiong J"
            ],
            "firstName": [
              "Jin"
            ],
            "lastName": [
              "Xiong"
            ],
            "initials": [
              "J"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Xiao SQ"
            ],
            "firstName": [
              "Shu-Qi"
            ],
            "lastName": [
              "Xiao"
            ],
            "initials": [
              "SQ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wang Z"
            ],
            "firstName": [
              "Zhen"
            ],
            "lastName": [
              "Wang"
            ],
            "initials": [
              "Z"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang ZR"
            ],
            "firstName": [
              "Zhe-Rui"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "ZR"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.",
                  "University of Chinese Academy of Sciences, Beijing, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Deng CL"
            ],
            "firstName": [
              "Cheng-Lin"
            ],
            "lastName": [
              "Deng"
            ],
            "initials": [
              "CL"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yang XL"
            ],
            "firstName": [
              "Xing-Lou"
            ],
            "lastName": [
              "Yang"
            ],
            "initials": [
              "XL"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Wei HP"
            ],
            "firstName": [
              "Hong-Ping"
            ],
            "lastName": [
              "Wei"
            ],
            "initials": [
              "HP"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Yuan ZM"
            ],
            "firstName": [
              "Zhi-Ming"
            ],
            "lastName": [
              "Yuan"
            ],
            "initials": [
              "ZM"
            ],
            "authorId": [
              {
                "_": "0000-0002-3234-9616",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ye HQ"
            ],
            "firstName": [
              "Han-Qing"
            ],
            "lastName": [
              "Ye"
            ],
            "initials": [
              "HQ"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhang B"
            ],
            "firstName": [
              "Bo"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "B"
            ],
            "authorId": [
              {
                "_": "0000-0002-8895-3679",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China.",
                  "The Joint Center of Translational Precision Medicine, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou, People's Republic of China.",
                  "The Joint Center of Translational Precision Medicine, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China.",
                  "Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, People's Republic of China."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-3234-9616",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8895-3679",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "9"
        ],
        "journalIssueId": [
          "2893331"
        ],
        "dateOfPublication": [
          "2020 Dec"
        ],
        "monthOfPublication": [
          "12"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-12-01"
        ],
        "journal": [
          {
            "title": [
              "Emerging microbes & infections"
            ],
            "ISOAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "medlineAbbreviation": [
              "Emerg Microbes Infect"
            ],
            "NLMid": [
              "101594885"
            ],
            "ISSN": [
              "2222-1751"
            ],
            "ESSN": [
              "2222-1751"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "1170-1173"
    ],
    "abstractText": [
      "The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxysophoridine against SARS-CoV-2 in cell culture. We found that all three tested compounds inhibited viral replication in Vero-E6 cells at noncytotoxic concentrations. The antiviral effect of gemcitabine was suppressed efficiently by the cytidine nucleosides. Additionally, combination of gemcitabine with oxysophoridine had an additive antiviral effect against SARS-CoV-2. Our results demonstrate that broad-spectrum antiviral compounds may have a priority for the screening of antiviral compounds against newly emerging viruses to control viral infection."
    ],
    "affiliation": [
      "Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People's Republic of China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Letter"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Vero Cells"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Animals"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Alkaloids"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Amaryllidaceae Alkaloids"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chloroquine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Phenanthridines"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Deoxycytidine"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AA"
                    ],
                    "qualifierName": [
                      "analogs & derivatives"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Combinations"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PD"
                    ],
                    "qualifierName": [
                      "pharmacology"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Virus Replication"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Cell Survival"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Dose-Response Relationship, Drug"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Synergism"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "GD"
                    ],
                    "qualifierName": [
                      "growth & development"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "ME"
                    ],
                    "qualifierName": [
                      "metabolism"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Chlorocebus aethiops"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Alkaloid",
          "Novel Coronavirus",
          "Broad-spectrum Antiviral",
          "2019-Ncov",
          "Sars-cov-2"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "oxysophoridine"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Alkaloids"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Drug Combinations"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Phenanthridines"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Amaryllidaceae Alkaloids"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "lycorine"
            ],
            "registryNumber": [
              "I9Q105R5BU"
            ]
          },
          {
            "name": [
              "gemcitabine"
            ],
            "registryNumber": [
              "B76N6SBZ8R"
            ]
          },
          {
            "name": [
              "Chloroquine"
            ],
            "registryNumber": [
              "886U3H6UFF"
            ]
          },
          {
            "name": [
              "Deoxycytidine"
            ],
            "registryNumber": [
              "0W860991D6"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1080/22221751.2020.1772676"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7448857"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7448857?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-06-12"
    ],
    "dateOfCreation": [
      "2020-05-21"
    ],
    "firstIndexDate": [
      "2020-05-22"
    ],
    "fullTextReceivedDate": [
      "2020-09-12"
    ],
    "dateOfRevision": [
      "2020-09-11"
    ],
    "firstPublicationDate": [
      "2020-12-01"
    ]
  },
  {
    "id": [
      "32739476"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32739476"
    ],
    "pmcid": [
      "PMC7391054"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7391054"
        ]
      }
    ],
    "doi": [
      "10.1016/j.ijantimicag.2020.106125"
    ],
    "title": [
      "Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?"
    ],
    "authorString": [
      "Alonso DF, Farina HG."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Alonso DF"
            ],
            "firstName": [
              "Daniel F"
            ],
            "lastName": [
              "Alonso"
            ],
            "initials": [
              "DF"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Buenos Aires, Argentina. Electronic address: dfalonso@unq.edu.ar."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Farina HG"
            ],
            "firstName": [
              "Hernán G"
            ],
            "lastName": [
              "Farina"
            ],
            "initials": [
              "HG"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Buenos Aires, Argentina."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "3"
        ],
        "volume": [
          "56"
        ],
        "journalIssueId": [
          "3003144"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "International journal of antimicrobial agents"
            ],
            "ISOAbbreviation": [
              "Int. J. Antimicrob. Agents"
            ],
            "medlineAbbreviation": [
              "Int J Antimicrob Agents"
            ],
            "NLMid": [
              "9111860"
            ],
            "ISSN": [
              "0924-8579"
            ],
            "ESSN": [
              "1872-7913"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "106125"
    ],
    "affiliation": [
      "Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Buenos Aires, Argentina. Electronic address: dfalonso@unq.edu.ar."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "Letter"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PA"
                    ],
                    "qualifierName": [
                      "pathology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "VI"
                    ],
                    "qualifierName": [
                      "virology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Metformin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Ivermectin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Thiazoles"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Lovastatin"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antineoplastic Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Anticholesteremic Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Hypoglycemic Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiparasitic Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "TU"
                    ],
                    "qualifierName": [
                      "therapeutic use"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Administration Schedule"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Severity of Illness Index"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Host-Pathogen Interactions"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DE"
                    ],
                    "qualifierName": [
                      "drug effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Repositioning"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "PY"
                    ],
                    "qualifierName": [
                      "pathogenicity"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antineoplastic Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Hypoglycemic Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Anticholesteremic Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Thiazoles"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Ivermectin"
            ],
            "registryNumber": [
              "70288-86-7"
            ]
          },
          {
            "name": [
              "Antiparasitic Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Metformin"
            ],
            "registryNumber": [
              "9100L32L2N"
            ]
          },
          {
            "name": [
              "Lovastatin"
            ],
            "registryNumber": [
              "9LHU78OQFD"
            ]
          },
          {
            "name": [
              "nitazoxanide"
            ],
            "registryNumber": [
              "SOA12P041N"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.ijantimicag.2020.106125"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7391054"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7391054?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "doi"
        ]
      }
    ],
    "dateOfCompletion": [
      "2020-09-10"
    ],
    "dateOfCreation": [
      "2020-08-03"
    ],
    "firstIndexDate": [
      "2020-08-09"
    ],
    "fullTextReceivedDate": [
      "2020-08-04"
    ],
    "dateOfRevision": [
      "2020-09-10"
    ],
    "electronicPublicationDate": [
      "2020-07-30"
    ],
    "firstPublicationDate": [
      "2020-07-30"
    ]
  },
  {
    "id": [
      "32270760"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32270760"
    ],
    "pmcid": [
      "PMC7190394"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7190394"
        ]
      }
    ],
    "doi": [
      "10.1192/bjp.2020.84"
    ],
    "title": [
      "Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders."
    ],
    "authorString": [
      "Zhang K, Zhou X, Liu H, Liu H, Hashimoto K."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Zhang K"
            ],
            "firstName": [
              "Kai"
            ],
            "lastName": [
              "Zhang"
            ],
            "initials": [
              "K"
            ],
            "authorId": [
              {
                "_": "0000-0001-8581-9063",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Psychiatry, Chaohu Hospital, Anhui Medical University, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Zhou X"
            ],
            "firstName": [
              "Xiaoqin"
            ],
            "lastName": [
              "Zhou"
            ],
            "initials": [
              "X"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Psychiatry, Chaohu Hospital, Anhui Medical University, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu H"
            ],
            "firstName": [
              "Huanzhong"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "H"
            ],
            "authorId": [
              {
                "_": "0000-0002-4645-4353",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Psychiatry, Chaohu Hospital, Anhui Medical University, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Liu H"
            ],
            "firstName": [
              "Huanzhong"
            ],
            "lastName": [
              "Liu"
            ],
            "initials": [
              "H"
            ],
            "authorId": [
              {
                "_": "0000-0003-3095-5249",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Psychiatry, Chaohu Hospital, Anhui Medical University, China."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Hashimoto K"
            ],
            "firstName": [
              "Kenji"
            ],
            "lastName": [
              "Hashimoto"
            ],
            "initials": [
              "K"
            ],
            "authorId": [
              {
                "_": "0000-0002-8892-0439",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Japan."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0001-8581-9063",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-4645-4353",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0003-3095-5249",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0002-8892-0439",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "issue": [
          "1"
        ],
        "volume": [
          "217"
        ],
        "journalIssueId": [
          "2971251"
        ],
        "dateOfPublication": [
          "2020 Jul"
        ],
        "monthOfPublication": [
          "7"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-07-01"
        ],
        "journal": [
          {
            "title": [
              "The British journal of psychiatry : the journal of mental science"
            ],
            "ISOAbbreviation": [
              "Br J Psychiatry"
            ],
            "medlineAbbreviation": [
              "Br J Psychiatry"
            ],
            "NLMid": [
              "0342367"
            ],
            "ISSN": [
              "0007-1250"
            ],
            "ESSN": [
              "1472-1465"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "351"
    ],
    "abstractText": [
      "Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine) and valproate can be considered to be safe in combination with antiviral drugs."
    ],
    "affiliation": [
      "Department of Psychiatry, Chaohu Hospital, Anhui Medical University, China."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "editorial",
          "Journal Article"
        ]
      }
    ],
    "meshHeadingList": [
      {
        "meshHeading": [
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Humans"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Pneumonia, Viral"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PX"
                    ],
                    "qualifierName": [
                      "psychology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Coronavirus Infections"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "PX"
                    ],
                    "qualifierName": [
                      "psychology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Psychotropic Drugs"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Antiviral Agents"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "AD"
                    ],
                    "qualifierName": [
                      "administration & dosage"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "AE"
                    ],
                    "qualifierName": [
                      "adverse effects"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Drug Therapy, Combination"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "MT"
                    ],
                    "qualifierName": [
                      "methods"
                    ],
                    "majorTopic_YN": [
                      "Y"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Behavioral Symptoms"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Mental Disorders"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "DT"
                    ],
                    "qualifierName": [
                      "drug therapy"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  },
                  {
                    "abbreviation": [
                      "EP"
                    ],
                    "qualifierName": [
                      "epidemiology"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Comorbidity"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Infection Control"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Drug Interactions"
            ]
          },
          {
            "majorTopic_YN": [
              "Y"
            ],
            "descriptorName": [
              "Pandemics"
            ]
          },
          {
            "majorTopic_YN": [
              "N"
            ],
            "descriptorName": [
              "Betacoronavirus"
            ],
            "meshQualifierList": [
              {
                "meshQualifier": [
                  {
                    "abbreviation": [
                      "IP"
                    ],
                    "qualifierName": [
                      "isolation & purification"
                    ],
                    "majorTopic_YN": [
                      "N"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Antiviral",
          "Coronavirus",
          "Antipsychotics",
          "Psychotic Disorders",
          "Drug Interactions And Side-effects"
        ]
      }
    ],
    "chemicalList": [
      {
        "chemical": [
          {
            "name": [
              "Antiviral Agents"
            ],
            "registryNumber": [
              "0"
            ]
          },
          {
            "name": [
              "Psychotropic Drugs"
            ],
            "registryNumber": [
              "0"
            ]
          }
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1192/bjp.2020.84"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7190394"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7190394?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "4"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "Y"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "license": [
      "cc by"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCompletion": [
      "2020-07-15"
    ],
    "dateOfCreation": [
      "2020-04-10"
    ],
    "firstIndexDate": [
      "2020-04-10"
    ],
    "fullTextReceivedDate": [
      "2020-05-02"
    ],
    "dateOfRevision": [
      "2020-07-15"
    ],
    "firstPublicationDate": [
      "2020-07-01"
    ]
  },
  {
    "id": [
      "32803762"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32803762"
    ],
    "pmcid": [
      "PMC7461398"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7461398"
        ]
      }
    ],
    "doi": [
      "10.1002/cbf.3576"
    ],
    "title": [
      "Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review."
    ],
    "authorString": [
      "Rahimkhoei V, Jabbari N, Nourani A, Sharifi S, Akbari A."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Rahimkhoei V"
            ],
            "firstName": [
              "Vahid"
            ],
            "lastName": [
              "Rahimkhoei"
            ],
            "initials": [
              "V"
            ],
            "authorId": [
              {
                "_": "0000-0002-5061-2609",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jabbari N"
            ],
            "firstName": [
              "Nassrollah"
            ],
            "lastName": [
              "Jabbari"
            ],
            "initials": [
              "N"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Nourani A"
            ],
            "firstName": [
              "Aynaz"
            ],
            "lastName": [
              "Nourani"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Department of Health Information Technology, School of Allied Medical Sciences, Urmia University of Medical Sciences, Urmia, Iran."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Sharifi S"
            ],
            "firstName": [
              "Sina"
            ],
            "lastName": [
              "Sharifi"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Disruptive Technology Laboratory, Massachusetts Eye and Ear and Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Akbari A"
            ],
            "firstName": [
              "Ali"
            ],
            "lastName": [
              "Akbari"
            ],
            "initials": [
              "A"
            ],
            "authorId": [
              {
                "_": "0000-0001-6027-292X",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0002-5061-2609",
            "$": {
              "type": "ORCID"
            }
          },
          {
            "_": "0000-0001-6027-292X",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics",
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2991107"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Cell biochemistry and function"
            ],
            "ISOAbbreviation": [
              "Cell Biochem. Funct."
            ],
            "medlineAbbreviation": [
              "Cell Biochem Funct"
            ],
            "NLMid": [
              "8305874"
            ],
            "ISSN": [
              "0263-6484"
            ],
            "ESSN": [
              "1099-0844"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "Since the new coronavirus known as 2019-nCoV (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has widely spread in Wuhan, China, with severe pneumonia, scientists and physicians have made remarkable efforts to use various options such as monoclonal antibodies, peptides, vaccines, small-molecule drugs and interferon therapies to control, prevent or treatment infections of 2019-nCoV. However, no vaccine or drug has yet been confirmed to completely treat 2019-nCoV. In this review, we focus on the use of potential available small-molecule drug candidates for treating infections caused by 2019-nCoV."
    ],
    "affiliation": [
      "Solid Tumor Research Center, Research Institute for Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Iran."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "review-article",
          "Review",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Infection",
          "Small-molecule Drugs",
          "2019-Ncov"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1002/cbf.3576"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7461398"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7461398?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "nct"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-08-18"
    ],
    "firstIndexDate": [
      "2020-08-18"
    ],
    "fullTextReceivedDate": [
      "2020-09-04"
    ],
    "dateOfRevision": [
      "2020-09-09"
    ],
    "electronicPublicationDate": [
      "2020-08-17"
    ],
    "firstPublicationDate": [
      "2020-08-17"
    ]
  },
  {
    "id": [
      "32839634"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32839634"
    ],
    "pmcid": [
      "PMC7399655"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7399655"
        ]
      }
    ],
    "doi": [
      "10.1016/j.molliq.2020.113968"
    ],
    "title": [
      "Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation."
    ],
    "authorString": [
      "El-Hoshoudy AN."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "El-Hoshoudy AN"
            ],
            "firstName": [
              "A N"
            ],
            "lastName": [
              "El-Hoshoudy"
            ],
            "initials": [
              "AN"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Computational Chemistry Group, Egyptian Petroleum Research Institute, 11727 Nasr City, Cairo, Egypt."
                ]
              }
            ]
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "supporting_data"
        ]
      }
    ],
    "journalInfo": [
      {
        "volume": [
          "318"
        ],
        "journalIssueId": [
          "3000464"
        ],
        "dateOfPublication": [
          "2020 Nov"
        ],
        "monthOfPublication": [
          "11"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-11-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of molecular liquids"
            ],
            "ISOAbbreviation": [
              "J Mol Liq"
            ],
            "medlineAbbreviation": [
              "J Mol Liq"
            ],
            "NLMid": [
              "9882716"
            ],
            "ISSN": [
              "0167-7322"
            ],
            "ESSN": [
              "1873-3166"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "pageInfo": [
      "113968"
    ],
    "abstractText": [
      "Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although the current medical research directed towards the development of a novel therapeutic agent, no anti-viral drug approved until now. On the medical scale, the development of an approved drug is a time-consuming process, so research is directed towards screening of ligands and drugs multimodal structure-based-design and then docked to the main viral protease to investigate the active binding sites. The bioinformatic approaches used to evaluate the competence of a comprehensive range of ligands and drugs before their clinical implementation. In this study, a computational approach through molecular docking simulation is conducted for screening the antiviral activity of drugs, natural sources, and inhibitory compounds against the SARS-CoV-2 genome. The main virus protease was collected from a Protein Data Bank (PDB# 6YB7) and docked with a sequence of 19 approved antiviral drugs, 10 natural inhibitory ligands against COVID-19 downloaded from PubChem, in addition to 10 natural sources optimized for Escherichia coli BL21 (DE3) to identify the antiviral activity of these candidates against COVID-19. The docking results were promised and indicated that the reported ligands can firmly bind to the SARS-CoV-2 main protease and leads to inhibition of its infectious impact."
    ],
    "affiliation": [
      "Computational Chemistry Group, Egyptian Petroleum Research Institute, 11727 Nasr City, Cairo, Egypt."
    ],
    "publicationStatus": [
      "ppublish"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Homology modeling",
          "Molecular docking",
          "Coronavirus",
          "Covid-19",
          "Sars-cov-2"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1016/j.molliq.2020.113968"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7399655"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7399655?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "Y"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "Y"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "Y"
    ],
    "tmAccessionTypeList": [
      {
        "accessionType": [
          "doi",
          "pdb"
        ]
      }
    ],
    "dateOfCreation": [
      "2020-08-26"
    ],
    "firstIndexDate": [
      "2020-08-26"
    ],
    "fullTextReceivedDate": [
      "2020-08-06"
    ],
    "dateOfRevision": [
      "2020-08-27"
    ],
    "electronicPublicationDate": [
      "2020-08-04"
    ],
    "firstPublicationDate": [
      "2020-08-04"
    ]
  },
  {
    "id": [
      "PMC7493736"
    ],
    "source": [
      "PMC"
    ],
    "pmcid": [
      "PMC7493736"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7493736"
        ]
      }
    ],
    "title": [
      "Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review"
    ],
    "authorString": [
      "Otręba M, Kośmider L, Rzepecka-Stojko A."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Otręba M"
            ],
            "firstName": [
              "Michał"
            ],
            "lastName": [
              "Otręba"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Department of Drug Technology, Medical University of Silesia, Katowice Faculty of Pharmaceutical Sciences in Sosnowiec, Jednosci 8, 41-200, Sosnowiec, Poland"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kośmider L"
            ],
            "firstName": [
              "Leon"
            ],
            "lastName": [
              "Kośmider"
            ],
            "initials": [
              "L"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "b Department of General and Inorganic Chemistry, Medical University of Silesia, Katowice Faculty of Pharmaceutical Sciences in Sosnowiec, Jagiellonska 4, 41-200, Sosnowiec, Poland"
                ]
              }
            ]
          },
          {
            "fullName": [
              "Rzepecka-Stojko A"
            ],
            "firstName": [
              "Anna"
            ],
            "lastName": [
              "Rzepecka-Stojko"
            ],
            "initials": [
              "A"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "a Department of Drug Technology, Medical University of Silesia, Katowice Faculty of Pharmaceutical Sciences in Sosnowiec, Jednosci 8, 41-200, Sosnowiec, Poland"
                ]
              }
            ]
          }
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "3006155"
        ],
        "dateOfPublication": [
          "2020 Sep"
        ],
        "monthOfPublication": [
          "9"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-09-01"
        ],
        "journal": [
          {
            "title": [
              "European journal of pharmacology"
            ],
            "ISOAbbreviation": [
              "Eur. J. Pharmacol."
            ],
            "medlineAbbreviation": [
              "Eur J Pharmacol"
            ],
            "NLMid": [
              "1254354"
            ],
            "ISSN": [
              "0014-2999"
            ],
            "ESSN": [
              "1879-0712"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "In 2020 the whole world focused on antivirus drugs towards SARS-CoV-2. Most of the researchers focused on drugs used in other viral infections or malaria. We have not seen such mobilization towards one topic in this century. The whole situation makes clear that progress needs to be made in antiviral drug development. The first step to do it is to characterize the potential antiviral activity of new or already existed drugs on the market. Phenothiazines are antipsychotic agents used previously as antiseptics, anthelminthics, and antimalarials. Up to date, they are tested for a number of other disorders including the broad spectrum of viruses. The goal of this paper was to summarize the current literature on activity toward RNA-viruses of such drugs like chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine. We identified 49 papers, where the use of the phenothiazines for 23 viruses from different families were tested. Chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine possess anti-viral activity towards different types of viruses. These drugs inhibit clathrin-dependent endocytosis, cell-cell fusion, infection, replication of the virus, decrease viral invasion as well as suppress entry into the host cells. Additionally, since the drugs display activity at nontoxic concentrations they have therapeutic potential for some viruses, still, further research on animal and human subjects are needed in this field to verify cell base research. Graphical abstract Diagrammatic summary of phenothiazine derivatives antiviral activity. All of the phenothiazines (chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine) possess antiviral activity towards RNA viruses. These drugs inhibit clathrin-dependent endocytosis, cell-cell fusion, infection, replication of the virus, decrease viral invasion as well as suppress entry into the host cells.Image 1 Highlights • Phenothiazines possess antiviral activity towards RNA viruses.• An antiviral activity can be achieved below toxic serum concentration.• Phenothiazines are characterized by multidirectional points of action."
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Undetermined"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "RNA viruses",
          "Antiviral Activity",
          "Phenothiazines",
          "Neuroleptic Drugs"
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493736/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "PubMedCentral"
            ],
            "url": [
              "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493736/pdf/?tool=EBI"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7493736"
            ]
          },
          {
            "availability": [
              "Free"
            ],
            "availabilityCode": [
              "F"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7493736?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "Y"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "N"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-09-19"
    ],
    "firstIndexDate": [
      "2020-09-23"
    ],
    "fullTextReceivedDate": [
      "2020-09-19"
    ],
    "dateOfRevision": [
      "2020-09-19"
    ],
    "electronicPublicationDate": [
      "2020-09-16"
    ],
    "firstPublicationDate": [
      "2020-09-16"
    ]
  },
  {
    "id": [
      "32767684"
    ],
    "source": [
      "MED"
    ],
    "pmid": [
      "32767684"
    ],
    "pmcid": [
      "PMC7436731"
    ],
    "fullTextIdList": [
      {
        "fullTextId": [
          "PMC7436731"
        ]
      }
    ],
    "doi": [
      "10.1002/jmv.26397"
    ],
    "title": [
      "Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells."
    ],
    "authorString": [
      "Ko M, Jeon S, Ryu WS, Kim S."
    ],
    "authorList": [
      {
        "author": [
          {
            "fullName": [
              "Ko M"
            ],
            "firstName": [
              "Meehyun"
            ],
            "lastName": [
              "Ko"
            ],
            "initials": [
              "M"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Jeon S"
            ],
            "firstName": [
              "Sangeun"
            ],
            "lastName": [
              "Jeon"
            ],
            "initials": [
              "S"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Ryu WS"
            ],
            "firstName": [
              "Wang-Shick"
            ],
            "lastName": [
              "Ryu"
            ],
            "initials": [
              "WS"
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "CEO Office, Institut Pasteur Korea, Seongnam, Korea."
                ]
              }
            ]
          },
          {
            "fullName": [
              "Kim S"
            ],
            "firstName": [
              "Seungtaek"
            ],
            "lastName": [
              "Kim"
            ],
            "initials": [
              "S"
            ],
            "authorId": [
              {
                "_": "0000-0003-3954-5908",
                "$": {
                  "type": "ORCID"
                }
              }
            ],
            "authorAffiliationsList": [
              {
                "authorAffiliation": [
                  "Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea."
                ]
              }
            ]
          }
        ]
      }
    ],
    "authorIdList": [
      {
        "authorId": [
          {
            "_": "0000-0003-3954-5908",
            "$": {
              "type": "ORCID"
            }
          }
        ]
      }
    ],
    "dataLinksTagsList": [
      {
        "dataLinkstag": [
          "altmetrics"
        ]
      }
    ],
    "journalInfo": [
      {
        "journalIssueId": [
          "2989715"
        ],
        "dateOfPublication": [
          "2020 Aug"
        ],
        "monthOfPublication": [
          "8"
        ],
        "yearOfPublication": [
          "2020"
        ],
        "printPublicationDate": [
          "2020-08-01"
        ],
        "journal": [
          {
            "title": [
              "Journal of medical virology"
            ],
            "ISOAbbreviation": [
              "J. Med. Virol."
            ],
            "medlineAbbreviation": [
              "J Med Virol"
            ],
            "NLMid": [
              "7705876"
            ],
            "ISSN": [
              "0146-6615"
            ],
            "ESSN": [
              "1096-9071"
            ]
          }
        ]
      }
    ],
    "pubYear": [
      "2020"
    ],
    "abstractText": [
      "Drug repositioning represents an effective way to control the current COVID-19 pandemic. Previously, we identified 24 FDA-approved drugs which exhibited substantial antiviral effect against severe acute respiratory syndrome coronavirus 2 in Vero cells. Since antiviral efficacy could be altered in different cell lines, we developed an antiviral screening assay with human lung cells, which is more appropriate than Vero cell. The comparative analysis of antiviral activities revealed that nafamostat is the most potent drug in human lung cells (IC50  = 0.0022 µM)."
    ],
    "affiliation": [
      "Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea."
    ],
    "publicationStatus": [
      "aheadofprint"
    ],
    "language": [
      "eng"
    ],
    "pubModel": [
      "Print-Electronic"
    ],
    "pubTypeList": [
      {
        "pubType": [
          "research-article",
          "Journal Article"
        ]
      }
    ],
    "grantsList": [
      {
        "grant": [
          {
            "grantId": [
              "NRF-2020M3E9A1041756"
            ],
            "agency": [
              "National Research Foundation of Korea"
            ],
            "orderIn": [
              "0"
            ]
          },
          {
            "grantId": [
              "NRF-2017M3A9G6068245"
            ],
            "agency": [
              "National Research Foundation of Korea"
            ],
            "orderIn": [
              "0"
            ]
          }
        ]
      }
    ],
    "keywordList": [
      {
        "keyword": [
          "Drug Repositioning",
          "Fda-approved Drug",
          "Covid-19",
          "Sars-cov-2"
        ]
      }
    ],
    "subsetList": [
      {
        "subset": [
          {
            "code": [
              "IM"
            ],
            "name": [
              "Index Medicus"
            ]
          }
        ]
      }
    ],
    "fullTextUrlList": [
      {
        "fullTextUrl": [
          {
            "availability": [
              "Subscription required"
            ],
            "availabilityCode": [
              "S"
            ],
            "documentStyle": [
              "doi"
            ],
            "site": [
              "DOI"
            ],
            "url": [
              "https://doi.org/10.1002/jmv.26397"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "html"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7436731"
            ]
          },
          {
            "availability": [
              "Open access"
            ],
            "availabilityCode": [
              "OA"
            ],
            "documentStyle": [
              "pdf"
            ],
            "site": [
              "Europe_PMC"
            ],
            "url": [
              "https://europepmc.org/articles/PMC7436731?pdf=render"
            ]
          }
        ]
      }
    ],
    "isOpenAccess": [
      "Y"
    ],
    "inEPMC": [
      "Y"
    ],
    "inPMC": [
      "N"
    ],
    "hasPDF": [
      "Y"
    ],
    "hasBook": [
      "N"
    ],
    "hasSuppl": [
      "N"
    ],
    "citedByCount": [
      "0"
    ],
    "hasData": [
      "N"
    ],
    "hasReferences": [
      "N"
    ],
    "hasTextMinedTerms": [
      "Y"
    ],
    "hasDbCrossReferences": [
      "N"
    ],
    "hasLabsLinks": [
      "Y"
    ],
    "authMan": [
      "N"
    ],
    "epmcAuthMan": [
      "N"
    ],
    "nihAuthMan": [
      "N"
    ],
    "hasTMAccessionNumbers": [
      "N"
    ],
    "dateOfCreation": [
      "2020-08-09"
    ],
    "firstIndexDate": [
      "2020-08-10"
    ],
    "fullTextReceivedDate": [
      "2020-08-21"
    ],
    "dateOfRevision": [
      "2020-09-09"
    ],
    "electronicPublicationDate": [
      "2020-08-07"
    ],
    "firstPublicationDate": [
      "2020-08-07"
    ]
  }
]